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Abstract 
 
Bioinformatics is the scientific discipline that collates, integrates and analyses data 
and information sets for the life sciences. Critically important in agricultural and 
biomedical fields, there is a pressing need to integrate large and diverse data sets 
into biologically significant information. This places major challenges on research 
strategies and resources (data repositories, computer infrastructure and software) 
required to integrate relevant data and analysis workflows. These challenges 
include: 
!  The construction of processes to integrate data from disparate and diverse 
resources and legacy systems that have variable data formats, qualities, 
availability and accessibility constraints.  
!  Substantially contributing to hypothesis driven research for biologically 
significant information. 
 
The hypothesis proposed in this thesis is that in organisms from divergent origins, 
with differing data availability and analysis resources, in silico approaches can 
identify genomic targets in a range of disease systems. The particular aims were 
to: 
1.  Overcome data constraints that impact analysis of different organisms.  
2.  Make functional genomic predictions in diverse biological systems. 
3.  Identify specific genomic targets for diagnostics and therapeutics in diverse 
disease mechanisms.  
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In order to test the hypothesis three case studies in human cancer, pathogenic 
bacteria, and parasitic arthropod were selected, the results are as follows.  
 
In case study 1 sequence information was integrated to make novel predictions, 
and generate novel findings for the role of the Alu repeat element in cancer. An 
under representation of Alu was found in cancerous transcript and most 
noncancerous Alu transcript found were of an unknown function. These findings 
led to an Alu-mediated siRNA model for the down regulation of Alu containing 
mRNA in cancer. 
 
Case study 2, comparative genomic analyses identified venereal diagnostic targets 
that discriminated Campylobacter fetus subspecies venerealis from other 
Campylobacter species and subspecies. Plasmid borne virulence Type IV 
secretory pathway genes specificity however varied for biovars, compromising their 
use for diagnostics. These findings resulted in the targeted sequencing of 
Campylobacter fetus subspecies venerealis biovar genomes.  
 
Case study 3, in cattle tick ectoparasite (Rhipicephalus microplus), a large highly 
complex and under researched genome, transcript sequence was analysed and 
tick vaccination targets identified. These vaccine candidates successfully imparted 
immunity in the bovine host. The developed high throughput vaccine target 
identification system is now being applied to other disease systems. 
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Through the shared bioinformatics approaches, novel functional targets and 
models in disease were determined. This thesis has developed and demonstrated 
in silico approaches for: 
1.  The collation, annotation and integration of data from divergent organisms 
with variable data constraints.  
2.  Novel functional predictions in diverse biological systems. 
3.  Novel vaccine and diagnostic candidate identification, in diverse disease 
mechanisms, substantially contributing to hypothesis driven research. 
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1  Chapter One – Introduction 
1.1  Thesis structure 
 
This thesis is set out in six chapters, with this chapter (Chapter 1) as an overview 
of the thesis structure, background, significance of study and aims. Chapter 2 is 
the literature review of bioinformatics analysis ‘state of play’ for resources and an 
introduction to three case studies for hypothesis driven research. Chapters 3-5 are 
the three bioinformatics case studies, human Alu repeat element in cancer, 
diagnostic target identification in Campylobacter and tick vaccine target 
identification for bovine. Chapter 6 is the concluding discussion on scientific 
contributions and future work.  
 
1.2  Background and significance of study 
 
The abundance of data associated with bioinformatics is increasing at an 
exponential rate, this is due to the increased number of sequencing projects and 
the technological and economical break throughs of next generation high through 
put sequencing. The advent of high performance computing capability has been 
essential for these advances. This data is critically important in biological research 
(agricultural and biomedical) fields, with a pressing need to integrate large and 
diverse data sets into biologically significant information.  
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Hypothesis driven analysis is an objective approach where a hypothesis must be 
clearly stated, analyses are planned prior, and the data must be collected in a 
repeatable manner. This is in contrast to the more subjective data driven analysis 
where analyses are post-hoc from data mining. Hypothesis driven approaches 
required for data and analysis workflow integration are a major bottleneck, 
especially when data and information repositories and resources are disparate and 
have variable data formats, qualities, availability and accessibility. Bioinformatics 
has many data and analysis constraints, as well as integration challenges that 
impact on the predictive power of in silico analyses, these include: 
1.  The lack of availability of an organism sequence data and the associated 
sequence information (metadata). Different organisms can be represented 
by only a few sequences through to whole genome projects, such as is 
found in the well-researched human and model species. Further scenarios 
are that a target species may have only a distant reference sequenced 
genome or none to make comparative analyses and prediction models. 
2.  The quality of the sequence data related to the stage of sequencing 
projects.  
!  In different stages of an assembly project, sequence may be available as 
unassembled reads, assembled contiguous sequences, scaffolds with 
sequence gaps or completed chromosome sequences. The incomplete 
assembly of sequence impacts predictive powers for identifying genomic 
features.  
!  The quality of the sequence information depends on the amount and  
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type of annotation and curation effort. While some sequences may be 
represented by variable information quality, a reference data set is 
expected to have high quality annotation.  
3.  The amount of known biological information associated with an organism. 
Certain organisms may be limited by the lack of biological research that has 
gone before. 
4.  Availability and access to analysis tools to process and analyse large sets of 
sequence data and information. 
!  The ability to access and share data can be resource dependent. 
Resources for special research interests can develop in an 
uncoordinated manner, using heterogeneous database management 
systems and data structures. 
!  Available tools and resources are too specialised for an organism, 
lacking robustness and flexibility.  
5.  In silico methods and approaches are poorly defined, as can be found in 
new emerging platform technologies (Proteomics, Metabolomics and 
Fluxomics).  
 
All these constraints and challenges can play a role and limit the effective 
identification of functional targets in disease, especially in non-model organisms. 
The development of systems centred on disease have to date focused on human 
and model organisms (rat and mouse), and as a result targeting candidate disease 
features in silico in non-model organisms is difficult.  
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It is the study of these data and resource integration challenges that forms the 
basis of this PhD thesis. Through developed bioinformatics approaches, functional 
predictions based on comparative analyses and predictive modelling tools are 
made for the genome sequence of simple pathogens (bacteria) through to complex 
eukaryotes (arthropod parasite and human), to identify unknown functional and 
structural genomic elements that play a role in disease. In developing in silico 
approaches to identify candidate genomic disease targets for diagnostics and 
therapeutics, this thesis examined three diverse disease mechanisms for 
organisms of diverse origin and different data availability (Table 1.1). In case study 
1, the well studied human transcriptome is analysed to determine from the 
distribution of Alu element the possible role of Alu in cancerous organs; Case study 
2 investigated venereal diagnostic targets for pathogenic Campylobacter fetus sub 
species based on a close reference genome; Case study 3, in a large highly 
complex, under researched and unsequenced cattle tick (ectoparasite) genome 
(Rhipicephalus microplus), tick candidate vaccination targets are identified. 
Case study 
organism 
Sequence reference  Disease 
mechanism 
Research level  
(sequence and biological) 
1. Human   Human transcriptome 
and genome 
Alu repeat in 
Cancer 
High 






3. Tick   No genome available  Ectoparasite 
vaccine 
Low on comparative ticks 
 
Table 1.1 Case study organisms, disease mechanisms and reference data availability 
The thesis aims and case studies are further described in the next section.  
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1.3  The aims of this thesis 
 
In summary the key major outstanding bioinformatics challenges from this chapter 
are: 
!  The refining of processes for data integration from disparate resources.  
!  Integrating data from diverse resources that have variable data formats, 
qualities, availability and accessibility. 
!  Substantially contributing to hypothesis driven research. 
 
The particular aims of this thesis are then to develop in silico strategies for: 
1.  The collation, annotation and integration of diverse data types. To overcome 
data accessibility, availability, format and quality variability that impact data 
analyses (integration and mining) in diverse organisms.  
2.  The identification of functional genomic targets in diverse biological systems 
with diverse disease mechanisms. To make functional predictions based on 
comparative analyses and prediction tools. 
3.  High through put vaccine and diagnostic candidate identification. To identify 
specific genomic pathogenic and disease targets in diverse disease 
mechanisms.  
 
The three overall thesis aims (above) and the corresponding chapter topics (below) 
are shown in Figure 1.1.  
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In case study 1 (Chapter 3), the human transcriptome sequence, associated 
sequence information and repetitive element data are integrated, for the statistical 
analysis of the human transposable element Alu in organ cancers, to determine the 
role of human Alu element in cancer.  
 
In case study 2 (Chapter 4), a partially sequenced pathogen is assembled and 
annotated for comparative genomic analysis to predict pathogen subspecies 
diagnostic targets.  
 
In case study 3 (Chapter 5), an under studied partial parasite transcriptome is 
annotated and de novo genomic features predicted to identify tick candidate 
targets, for a bovine vaccine that is protective against tick parasites.  
 
 
Figure 1.1 Thesis aims and case study chapters  
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Detail of bioinformatics approaches, thesis aims and the three case studies can be 
found in Table 1.2, which maps thesis aims (column 1) to the thesis approaches 
(column 2) and the three diverse case studies (column 3-5). To develop strategies 
to access data for analysis, diverse genomes selected had variable genomic 
sequence and reference availability and complexity (point 1 in Table 1.2). The 
identification of structure and functional features are explored by comparative 
analyses and de novo prediction methods. In all three cases comparative analyses 
were developed for making functional predictions (point 2 in Table 1.2). To develop 
bioinformatics approaches for identifying specific disease related genomic targets 
(point 3 in Table 1.2) each case study has different disease mechanisms.   
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Table 1.2 Table of Bioinformatics approaches, thesis aims and the three case studies. 
 
Thesis aims  Bioinformatics 
approach 
 
Case study 1 
Alu element in 
Cancer 
Case study 2 
Pathogen 
diagnostics 



















produce a data 





assembly of a 
partial genome to a 
close reference 






De novo genome 
assembly in the 
absence of a close 
reference genome.  
 
 





















species analysis to 
identify sequence 
specificity.  
De novo functional 


















analysis of Alu 
content in cancer 
Subspecies specific 
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2  Chapter Two - Literature Review 
2.1  General introduction 
 
Research and development in the systems biology of plants, animals and 
infectious disease (host-pathogen/parasite-environment), is increasingly dependent 
on integrating data from diverse and dynamic sources [1]. In current bioinformatics, 
data integration is significantly more challenging as the volume, rate of production, 
and complexity of data types in bioinformatics increases [1].  
Bioinformatics in the context of this thesis encompasses the tools (software and 
algorithms) and techniques used for the analysis of molecular biological data. 
Relying on computer science hardware to store data, and networks to 
communicate the results [2]. Often in bioinformatics a ‘one-size-fits-all’ program 
does not exist [3]. Knowledge is required about the different analysis steps in a 
given application and how software applications operate at each step [3]. In the 
construction of bioinformatics workflows the choice of software selected can 
influence the amount of biologically useful information that can be extracted from 
the data (data mining) [4]. 
 
The challenge for data integration is how to work across multiple database 
resources simultaneously; to integrate structured data, such as that found in 
relational databases, with unstructured data, such as literature; and to finally make 
data and information accessible in a usable format to life sciences researchers [1]. 
As these themes occur throughout bioinformatics, the focus of this thesis is on the 
particular data integration and mining challenges in three case studies. These case  
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studies investigate the identification of functional genomics target in disease to 
discover and develop new vaccines/therapeutics and diagnostics.  Figure 2.1 gives 




Figure 2.1 Chapter 2 topics overview 
2.2  Data mining and integration 
 
It is recognised that the ability to undertake data mining and computational analysis 
on a wide variety of data sources and data types has the potential to add 









      11 
Some limitations however exist to access and share data. For instance, many 
resources (created for special research interests) develop in an uncoordinated 
manner, using heterogeneous database management systems and data 
structures. The information sets and the semantics of data can differ and 
integrating information from these disparate sites is difficult [6].  
 
 The ever increasing gap between next generation sequencing technology output 
and the ability to process and analyze the resulting sequence data [4], can delay 
the extraction of, and access to, important biological information. The processing 
and analysis of this data can be computationally intense and requires information 
flows to be defined in order to select the appropriate bioinformatics tools for 
effective analysis and data mining [3]. 
 
Suitable access to the whole human genome sequence and it’s associated 
annotation for data mining was recognized as a key issue by the Human Genome 
Consortium, and a user's guide to three major human genome browsers was 
published [7]. Internet-based genome browser data and associated analyses were 
expected to expedite biological knowledge discovery. The three major genome 
browsers developed were the University of California at Santa Cruz (UCSC) 
Genome Browser [8], the National Center for Biotechnology Information (NCBI) 
MapViewer [9], and the Ensembl [10] Genome Browser which was developed in a 
joint project between the European Molecular Biology Laboratory European 
Bioinformatics Institute (EMBL-EBI) and the Sanger Institute [11, 12]. This  
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visualization software, designed for browsing was limited for downstream analysis 
and data mining, where queries can become complex and require additional 
information sourced elsewhere “combinational in nature” [13].   
 
As data and resources are often decentralised, the need to standardize 
methodologies to facilitate information exchange and access analytical resources 
has been widely recognised [14]. Data integration requires standardized data 
models and formats, that come from a sound and thorough knowledge of the 
domain, with well-defined and properly managed information and data (semantics) 
systems, procedures and processes [6].  
 
Romano in 2008 noted that systems are required to be flexible, expandable and 
adaptable to the evolving nature of biological theories and discoveries. Automated 
data access and analysis can only manage and control the disparate data sources 
as long as the correct information semantics and ontology is used [6].  
2.2.1  Semantics and ontology  
 
Integration of different platform data (Genomics, Proteomics, Transcriptomics and 
Metabolomics) can be limited due to lack of interoperability among life sciences 
resources, a perennial issue in bioinformatics [15]. Di Bernardo in 2008 noted that 
the global acceptance and application of standards for naming, representing, 
describing and accessing biological information is currently not fully adopted [16]. 
Important initiatives provide platforms in this area of data integration.  
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(1) The W3C-led Semantic Web initiative has standards and technologies to 
create a global Semantic Web for the Life Sciences (SWLS) [15]. 
Interoperability problems can be solved programmatically by annotating 
services and their interfaces with semantic information [16-19].  
(2) Open Source research projects such as BioMOBY [20], aim to generate the 
architecture for the distribution of biological data through web services. Here 
data and resources are disparate and only the interaction instructions 
(object-driven registry query system with object and service ontology’s) are 
registered in a central location. Knowledge is central and data is maintained 
at its primary source without a need for warehousing [21]. Objects are 
lightweight XML, and the query and the response transaction, simple object 
access protocol (SOAP) [14].  
(3) Current biological ontology, structured and controlled vocabularies, are 
being developed and curated by a consortium [22], where Gene Ontology’s 
(GO) terms are develop and maintained for gene products and sequences 
[23]. 
SWLS platforms provide interoperable access to thousands of bioinformatics 
resources, making the selection of services to build workflows at times 
unmanageable for users [14, 16]. A workflow assembly client can reduce the 
number of choices that users have to make by restricting the overall set of services 
presented, and ranking services so that the most desirable ones are presented first 
(automated service composition) [14, 16, 20]. 
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With emerging web-services technology and increased interoperability between 
multiple distributed architectures, easy to use predefined workflows, survey 
systems, and federated networks of curate bioinformatics portals were developed. 
These systems allowed easy access to semantic web service clients for 
bioinformatics and support systems for service providers [24-29]. 
 
Collaborative biological researcher networks and consortia establish 
comprehensive integrated databases utilising web services architecture to capture 
genomic information into a comprehensive integrated platform [21]. This facilitated 
systematic exploration that defined ontologies and generic data models with the 
relevant communities, to produce standardized nomenclature and data 
representation. Minimal data models allow simple but broad integration, and 
inheritance allows detail and depth to be added to more complex data objects 
without losing integration power [21].  
 
Web services are a key technology for bioinformatics, however incompatibilities 
between data resources and analysis services exist and some workflows remain 
non-interoperable. This is not surprising given: 1) the number of emerging life 
science fields (such as ‘Glycoinformatics’ and interaction networks); 2) the 
technical challenges involved with large data management and asynchronous 
services and security. A clear collaborative opening exists to standardize exchange 
format and services between key stakeholders (web service providers, client 
software developers and Open Bio* projects) [30]. This cooperation remains critical  
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between the major database resources and software developers to advance 
bioinformatics web service technology [30]. However it has been suggested that 
the primary hindrance to the creation of the SWLS is social rather than 
technological in nature, dependent primarily on the will and participation of its 
consumers [15, 19]. 
2.2.2  Major data resources  
Managed under a coordinated effort the three major primary sequence databases 
exchange data on a peer-to-peer basis under the framework of the International 
Nucleotide Sequence Database Collaboration [6]. The National Centre of 
Biotechnology Information, Bethesda, USA (NCBI) exchanges sequence data daily 
with the European Molecular Biology Laboratory (EMBL/EBI) [31] Nucleotide 
Sequence Database in Europe and the DNA Data Bank of Japan (DDBJ) to ensure 
worldwide coverage. NCBI GenBank [32], EBI and DDBJ also maintain and 
provide numerous database divisions, genome-related viewers, and bioinformatics 
software (sequence alignment and similarity search tools) [33-35], publications, 
and Gene expression databases (GEO, SAGE) [9, 36]. All NCBI and EBI 
databases are accessible through a search application interface NCBI Entrez 
retrieval system [37], and EBI-eye [38] respectively, these information retrieval 
systems access data from the major DNA and protein sequence databases along 
with taxonomy, gene, genome, protein structure, domain information and journal 
literature. The complete bi-monthly releases and daily updates of the GenBank 
database are freely available by FTP [32].   
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GenBank links to outside third party compatible resources, these include pathways 
[39], Gene Ontology’s [23] and major secondary databases such as H-InvDB [40]. 
 
Data derived from primary databases can be manually edited to remove errors, 
duplications and extend annotations to construct secondary databases. The 
information in secondary databases is therefore considered of a higher data 
quality. Integrating data from primary and secondary datasets are generally 
centred based on gene, gene regulation, protein, and disease. The following five 
points describe data integration resources with centred views of research 
approaches. 
1) Gene centred data integrated sites include, NCBI Entrez Gene, H-InvDB (JBIRC 
and DDBJ), and Ensembl (EBI and Sanger). Ensembl integrates genomic 
information for a comprehensive set of chordate genomes. Providing gene 
annotations for a subset of supported species in addition to specific resources that 
target genome variation, function and evolution. Ensembl data is accessible in a 
variety of formats including via a genome browser, API and BioMart [41]. Ensembl 
also includes assembly, enhanced visualisation and data-mining options for gene 
regulatory features [11]. EBI BioMart “High-Throughput Data Retrieval” generate 
annotation tables of large gene sets as input with no statistical analysis for gene 
ontology predictions [41]. The Biomart web server provides open access through a 
web interface (MartView), and supports programmatic access through a Perl API 
as well as RESTful and SOAP oriented web services [41]. This resource integrates 
functional predictions if available. EBI Biomart has functionality based on the  
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filtering of genes list via lists of accession numbers, IDs (like Gene division, 
RefSeq, MIM, InterPro, PDB, GO, Affymetrix), or via their expression (cell types, 
developmental stages), or via their homology to other species, or via the 
occurrence of SNPs. The human focused DAVID database for annotation [42], 
provides visualization and integrated discovery annotation and statistical analysis 
for GO terms, pathway assignments, and the clustering of orthologous groups 
(COG, KOG) [43]. PANTHER (Applied Biosystems) classification system was 
designed to classify proteins (and their genes) in order to facilitate high-throughput 
analysis for the alternative human Celera genome [44]. Proteins have been 
classified according to families and subfamilies, molecular functions, biological 
processes, pathways. The DFCI (TIGR) Gene Indices (TGI) provides species 
based EST project assembly of tentative consensus sequences and annotation for 
41 selected animals, 45 plant species, 15 Protist organisms, and 10 fungal 
organisms [45]. 
 
2) The following are some examples of gene regulation centred resources. 
The ENCODE project [46], has a gene regulation centred data integration focus. 
According to the ENCODE consortium the goal is to identify all functional elements 
encoded in the DNA sequence. This includes elements that act at the protein level 
(coding genes) and RNA level (non-coding genes), and regulatory elements that 
control the cells and circumstances in which a gene is active. Promoters and other 
transcriptional regulatory sequences, along with determinants of chromosome 
structure and function, such as origins of replication, remain largely unknown [46,  
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47]. Regulatory element information is integrated from DNA hypersensitivity 
assays, DNA methylation experiments [48], and chromatin immunoprecipitation 
(ChIP-Seq [49]) of proteins that interact with DNA, including modified histones and 
transcription factors [50]. These results are displayed on the UCSC Genome web 
based browser for human [8]. The data can also be downloaded to predict potential 
disease risks, and to stimulate the development of new therapies to prevent and 
treat diseases. 
 
3) Protein centred research has developed a number of resources dedicated to 
integrating protein related data. The EBI UniProt Knowledgebase (UniProtKB) is a 
portal for curated protein information, including function, classification, and cross-
references [51]. UniProtKB/Swiss-Prot is manually annotated and reviewed, while 
the UniProtKB/TrEMBL annotation is automatic and not reviewed. This protein-
centred data integration resource, provides access to complete species proteomes; 
and integrates data from a variety of sources, including UniProt, RefSeq proteins, 
InterPro, CluSTr, GOA, and ENSMBL Genomes [51]. 
 
4) Resources for disease centred research are largely based on human and the 
model human organisms such as mouse and rat. NCBI ‘s Genetic Association 
Database (GAD) [52] has human focused disease-centred data integration 
containing medically relevant polymorphism and mutational data. The standardized 
nomenclature is dependent on gene nomenclature standardization HUGO [53] and 
phenotype ontology projects [54]. Genetic association studies, whole genome  
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association studies (GWAS) and disease genetic models provide information on 
the genetics of common disease [55].The Online Mendelian Inheritance in Man 
(OMIM) is the largest knowledgebase of human genes, phenotypes and genetic 
disorders [56-60]. Tools that will assist researchers to integrate information from 
resources such as OMIM and NCBI PubMed to identify candidate genes from 
linkage and association studies are emerging [61, 62]. 
 
5) System centred databases and software like other integration resources 
requires controlled vocabularies for data and information storage, presentation, 
analysis and modelling of network data (IntAct). Web services allow direct 
computational access and retrieval of networks in an interoperable format (XML) 
[63-65]. The Reactome resource provides infrastructure for computation across the 
biological reaction networks especially for data mining human reactions and 
pathways [66-71]. System level understanding of protein-protein interactions is 
available in the STRING database [72-76]. 
 
6) Many more specific resources, with a greater diversity of data integrated, are 
those for an integrated view centred on model organisms. Many secondary 
database resources exist for the model organisms as a ‘one stop’ access site for 
genomic and related data, human [40] and mouse [77, 78]. In plant research 
communities have developed resources to access specific organism information 
and data, these include the Arabidopsis information Resource (TAIR) [79-84] and 
Gramene which contain diverse information on the major grass crop species, (rice,  
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maize, wheat and barley) [85-90]. In invertebrates FlyBase [91-95] and VectorBase 
are the major resources [96-99], involved in the development of controlled 
vocabularies for the species of interest [95, 100]. 
2.2.3  Bioinformatics workflow systems 
 
Sophisticated online research environments are emerging that provide to the end 
user, easy access and assembly of bioinformatics workflows, and access to Grid 
and High Performance Cluster Computing [101]. These systems allow the creation 
and reuse of workflows across distributed computing resources, simplify access to 
computer and data resources and leave the infrastructure transparent to the end 
user [101]. Bioinformatics systems available for data integration and mining 
automate the assembly of bioinformatics workflows. These workflow management 
systems are required to be extensible and scalable, and be able to access local 
and remote resources and analysis tools [17, 102-104].  
2.3  Genomic analysis and functional predictions  
 
Genomic features associated with diseases at the molecular level can be predicted 
through data mining and machine learning [105]. Targeting candidate gene 
features in silico decreases the scope of analysis that is required, and improves the 
accuracy of predictions. This reduces the cost and time involved in analysis [105, 
106], by improving model/prediction performance; providing faster and more cost-
effective models, and gaining a deeper insight into the underlying processes that 
generated the data [107]. 
As Yu in 2008 pointed out, complex diseases can involve the interaction of multiple 
genes and environmental factors [108]. Data mining using automated workflow  
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based strategies can significantly improve candidate feature/gene detection and 
interactions [108]. In concept, a functional genomic analysis, identifies some 
experimental output within the genome, these outputs are then segmented into 
defined blocks of initial annotation, followed by clustering into larger derived 
annotations and networks. Then based on comparative conservation a functional 
genomic annotation assignment is inferred [109]. 
 
In the prediction of protein-ligand interaction sites and the identification of genes in 
a genomic sequence, a set of manual classified rules are used to create a new set 
of rules by data-driven machine learning. These new rules are converted into 
models and applied to classify the statistical properties of unknown cases, Hidden 
Markov Models (HMMs) [110].  In sequence comparisons, Markov chain amino 
acid / nucleotide substitution matrices (PAM and BLOSUM) and profile HMMs can 
be used [111], HMMER is a software example [112]. In a set of homologous 
sequences with shared sequence motifs new unknown family members can be 
identified (pFAM) [113]. Gene finding HMM combine many values such as Open 
Reading Frames (ORFs) and splice regions to identify regions that can be 
translated and spliced to form a protein (GeneMark.hmm) for specific organisms. 
HMMs are also used for determining sequence structural predictions, fold 
assignment and function predictions for cluster sub families [114]. 
2.3.1  Identification of disease and pathogenic targets 
 
Modelling data using methods, such as HMM, provides reliable quantitative 
prediction to identify genomic elements involved in disease and pathogenicity  
      22 
[115]. Statistical methods to associate trait loci with diseases and phenotypes such 
as quantitative trait loci (QTL) and genome-wide association studies (GWAS) have 
limited resolution and small heritable variation respectively [116]. Therefore the 
predictive power and interpretation of QTL and GWAS results consequently have 
limitations [116] as they are best applied to genetically structured populations and 
more limited in human population studies. Models with high throughput genomic 
data can functionally associate genes with phenotypes and diseases to improve 
the diagnosis and treatment [116].  
 
Immuno-informatics is the application of informatics techniques to the immunity 
system, for vaccine design, and provides the basis for faster identification of 
diagnostic targets. This area of study is referred to as “computer aided vaccine 
design (CAVD) or computational vaccinology” [117, 118]. The prediction of 
functionally relevant targets based on functional characterisation in biological 
systems such as host-pathogen interactions and methods for predicting 
immunogenicity at epitope, subunit or attenuated pathogen levels increases the 
predictive power for the identification of vaccine candidates [117, 118]. In regards 
to immuno-informatics the prediction of epitope targets is important. Epitopes are 
the complementary protein to the Antibodies (Ab) Antigen (Ag) binding sites in Ag-
Ab reaction. Epitope sequence can be either conformational (discontinuous) or 
linear presenting [119]. A number of properties are required for epitope prediction 
for vaccine design, including that the epitope occur on the surface of the protein 
and are more flexible than the rest of the protein. The epitope region requires a  
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high degree of exposure to the solvent and the amino acids making the epitope 
charged and hydrophilic [120]. 
 
In the identification of epitopes many methods have been employed. The Parker 
Hydrophilic Prediction method [120] utilized 3 parameters, hydrophilicity, Janin’s 
scale accessibility and Karplus & Schultz’s flexibility [121]. The hydrophilicity 
parameter was calculated using HPLC from retention co-efficient of model 
synthetic peptides. The surface profile was determined by summing the 
parameters for each residue of a seven-residue segment and assigning the sum to 
the fourth residue, this is one of the most useful prediction algorithms [120]. Other 
methods include Emini Surface Accessibility Prediction [122], Chou and Fasman 
Beta-Turn Prediction [123], exposed surface, polarity and antigenic propensity of 
polypeptides chains (Kolaskar Tongaonkar Antigenicity) [124]  have been 
correlated with the location of continuous epitopes. Kolaskar semi-empirical 
method uses physiological properties of amino acid residues and the frequencies 
of occurrence of amino acids in experimentally known epitopes [124]. B-cell 
epitopes are recognized by antibodies of the immune system and are used in the 
design of vaccines and diagnostics tests. It is therefore of interest to develop 
improved methods for predicting B-cell epitopes [125]. 
 
Many immunological databases and analysis resources aid the design and 
interpretation of information for host pathogen interactions, autoimmune diseases, 
cancer, transplantation and allergies [126]. In this thesis these data resources were  
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used to explore, and refine, vaccine targets in ticks. The application of stringent in 
silico criteria and computational workflows allows a more targeted strategy for the 
identification and prioritisation of potential vaccine candidates lists for testing, 
reducing both time and cost [127].  
2.4  Informatics genomic case studies 
 
2.4.1  Human TE disease  
 
This section reviews current data and tools available for the human transposable 
element case study. The functional role of human transposable elements and their 




Figure 2.2 Case study one the human TE identification of functional targets in disease  
 
Case study 1: Novel predictions and findings for the possible role of human repeat 
element in disease.  
The Homo sapiens Alu elements, a major human repeat have been well 
researched and families classified. These transposable elements can be identified 
by sequence alignments with consensus subfamilies datasets as contained in 
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common computer programs such as Repeatmasker3 [129] and Censor [130]. 
Studies have surveyed the numbers of Alu in human transcript before [131-133], 
but the overall proportion of Alu containing transcript has remained essentially the 
same [134]. 
 
In case study one, a large amount of heterogeneous sourced transcriptome 
sequence is available for human. The public H-Invitational (Japan) [135] and NCBI 
GenBank (USA) [136] databases represent the largest and most complete 
collections of human transcript sequence information currently available. In H-
Invitational secondary database the reference data set for transcript sequence is 
highly curated with genomic and phenotypic metadata. Sequence tissue and cell 
type annotation, loci Entrez gene identifier, and the GenBank CDS start and end 
positions can be found in the JBIRC downloadable files [137]. The NCBI gene 
identifier and GO term [138] is bridged by data (gene2go.qz) available from the 
NCBI ftp website [139]. Therefore the human transcriptome and integrated 
phenotypic data is readily available for sequence analysis to quantify the Alu 
element content in cancer and determine possible functional roles.  
Databases are scalable and SQL compliant to access information from different 
integrated data types.  An open source object-relational PostgreSQL database 
[140] can be constructed to contain information on (1) H-Inv cDNA such as tissue 
type and disease trait, the cDNA CDS position, locus Entrez gene identifier and 
cDNA function (2) cDNA RepeatMasker3 output, (3) NCBI Entrez gene information 
[141], and (4) GO information extracted from gene ontology version1 with GO slim  
      26 
text files for the Homo sapiens taxon identifier 9636 [142]. The Alu element can 
then be investigated within the heterogeneous transcript sequence and metadata 
to identify Alu content in pathological sourced tissues. The functional role of Alu is 
presented in Chapter 3 and novel predictions and findings made for the possible 
role of human Alu repeat element in disease. 
2.4.2  Pathogenic Bacteria   
 
This section reviews current data and tools available for the pathogenic bacteria 
case study. This case study is described in detail in Chapter 4 for the possible 
functional roles of pathogenic bacteria virulence elements and their use in 




Figure 2.3 Pathogenic bacteria case study to identify functional targets in disease 
 
In case study 2, pathogen genomes can be comparatively analysed for the 
identification of gene targets for Campylobacter diagnostics. In the second case 
study, a Campylobacter fetus subspecies venerealis (Cfv) that can cause venereal 
disease in cattle is compared to a close sub species reference genome to identify 
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subspecies are conducted for the identification of gene targets for Campylobacter 
fetus diagnostics.  
 
The Campylobacter fetus venerealis genome (2Mb) is partially available. A subset 
of 273 Cfv contig sequences (lengths greater than 2Kb) from 1,187 of the 
assembled contigs was available from the UNSAM, Argentina for this analysis.  
The assembled contigs have been submitted to GenBank as a part of the WGS 
division (GenBank: ACLG00000000 and RefSeq: NZ_ACLG00000000). Fourteen 
Campylobacter genomic reference sequences are available for comparative 
analysis from NCBI RefSeq Genome (http://www.ncbi.nlm.nih.gov).  The sub 
species Campylobacter fetus subspecies fetus 82-40 is the closest reference 
genome available to Campylobacter fetus subspecies venerealis. All genomic 
detail for other Campylobacter species is available from NCBI 
(http://www.ncbi.nlm.nih.gov/genomes) genome division. Comparative genomic 
assembly of C. fetus subspecies venerealis based on the reference genome of 
Campylobacter fetus subspecies fetus 82-40 is possible through sequence 
similarity programs such as BLAT [143]. Comparative viewers such as Argo [144] 
enable quick genomic / gene overviews to identify the genomic regions shared and 
those unique to each genome.  
 
Open sourced tools such as Glimmer3 are available to predict open reading frames 
(ORF) and/or genes [145]. The annotation of predicted ORF sequences can be 
estimated from a similarity search with the BLAST program [146] against public  
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NCBI protein (nr, patent), String [147], COG [43], and NCBI Conserved Domain 
databases [148]. The results from Blast searches can then be readily parsed and 
categorised using BIOPERL [149] scripts based on alignment percent identity (PID) 
and target/query percent coverage thresholds. The functional categories of 
proteins can be determined based on the String Database [147] categories that 
have been developed upon the NCBI COG database role descriptions. The main 
categories being Cellular processes and signaling, Information storage and 
processing, Metabolism, Poorly characterized, No mapping, Non Orthologous 
Group (NOG) and KOG (euKaryote Orthologous Group).  Many genes that play 
important roles in pathogenesis and host specificity is relatively unknown, for 
bacteria such as Campylobacter many gene functions remain unknown or 
hypothetical [150].  
2.4.3  Ectoparasites and vector borne disease control 
 
This section reviews current data and tools available for the parasite vaccine case 
study. The functional genomic target identification in a large ectoparasite (tick) for 
vector control is described in further detail in Chapter 5 (Figure 2.4). 
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In case study 3 de novo gene target predictions are made in a large complex 
genome. The hard tick Rhipicephalus microplus is a serious pest and vector of 
disease for cattle. The cattle tick’s large, complex non-sequenced genome (7.1Gb) 
has available transcript data sets from a number of libraries [151, 152]. Only one 
hard tick genome, Ixodes scapularis, has been sequenced and is available for 
comparative analysis [153]. This genome is too distant to aid in the assembly of 
Rhipicephalus microplus but is valuable for the identification of gene sets. Through 
comparative analyses and data integration, genomic targets can be identified. 
Specialised arthropod resources that contain sequence and phenotypic data 
include VectorBase (Ixodes) [96-99] and FlyBase (Drosophila) [91-95, 100, 154-
161]. 
 
The choice of genome assembly tools to use depends on the sequence technology 
used. Sanger sequence (800bp read) assembly applications include phred/phrap 
[162], CAP3 [163], Phusion [164] and MIRA [165]. For the Pyrosequencing (454) 
Genome Sequencer (GS), the Newbler application assembles 300bp reads [166], 
Genome Analyzer (GA) sequencing by synthesis (Solexa) short reads use de Bruin 
graph assemblers such as ABySS [167], Velvet [168] and Euler-SR [169]. ABySS 
is the only tool to use message-passing interface (MPI)-cluster approach.  
 
An arthropod repeat data set (library) is available through Censor [170] and 
RepeatMasker3 [171]. However, the repeat sequence of under characterised / de 
novo assembled genomes in contrast to the human case study (see section 2.4.1)  
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require de novo repeat identification [172]. Once the repetitive elements are 
identified and masked the gene content can be predicted using eukaryote open 
source applications such as GlimmerHMM [173] and Genscan [174] and 
predictions trained for new models. Annotation can then be conducted as 
described in case study 2 (section 2.4.2) for the predicted protein and transcript 
sequence. Further resources are available to identify candidate epitope peptides 
(Table 2.1). These tools are reviewed for high throughput (HTP) analysis 
accessibility.  
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Site  Prediction  URL  HTP 
ABCPred 
[175]  B-Cell 
http://www.imtech.res.in/raghava/abcpred/  No 








http://www.imtech.res.in/raghava/bcipep/data.html  Yes 





















Table 2.1 Summary of B-Cell epitope prediction tools reviewed 
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3  Chapter three - The transcript repeat element: the 
Human Alu sequence as a component of gene 
networks influencing cancer 
 
The contents of this Chapter have been published as a review [177]. 
 
3.1  Introduction 
 
Transposable elements (TEs) contribute to about half the content of the human 
genome and have been found in abundance in gene sequences and in a significant 
portion of mature mRNAs [178]. Most of the TEs in the human genome are 
retroelements, such as the LTR, Alu, L1 and MIR sequences that have spread 
throughout the genome by transcription, retrotranscription, retrotransposition and 
insertion into various locations [178]. Retrotransposition and recombination of TEs 
can contribute to human molecular evolution, generating mutations associated with 
inherited disease, defining the organization of the genome into active and inactive 
regions, suppressing transcriptional noise and regulating transcript stability [179].   
3.1.1  The functional roles of human TE elements 
TEs can influence gene expression by a number of methods previously reviewed 
[180-182]. Feschotte described the ways TEs can influence gene expression at the 
transcriptional and posttranscriptional levels. At the transcription level an inserted 
TE can, provide an alternate gene promoter (transcription start site), disrupt or 
introduce new gene cis-regulatory element(s), drive antisense transcription, and 
act as a site for heterochromatin silencing [180].  
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At the posttranscriptional level a TE inserted into the ‘three prime’ (3!), untranslated 
region (UTR) can introduce, an alternate polyadenylation site, and provide a target 
site for microRNA (miRNA) or RNA-binding protein.  Pre-mRNA intron TEs can 
produce alternative splicing (intron retention, exon skipping) [180]. Alu elements 
inserted in opposite orientation have been reported to undergo base-pairing and 
affect the splicing patterns of downstream exon, shifting it from constitutive to 
alternative coding [183]. Pre-mRNA intron TEs can also be incorporated 
(‘exonized’) as an alternative exon. This results in the translation of a new protein 
isoform or in the destabilization or degradation of the mRNA via the Nonsense 
Mediated Decay (NMD) pathway, especially if the exonized TE introduces a 
premature stop codon [180].  
 
It is possible that genomic TE families can recruit the same regulatory motif(s) at 
many chromosomal locations, creating a multiple gene regulatory network [180, 
184-187]. It is also suggested that chromodomains could be responsible for the 
targeted integration of LTR retrotransposons, favourable for mobile elements, and 
avoiding negative selection from insertion into coding regions [188].  
 
TE families can be linked into a small RNA network, when co-transcription of the 
TE-host gene with a small RNA precursor containing a TE of the same family fold 
into a near perfect palindromic structure (as seen for MITEs) forming double-
stranded RNA. This is then processed into a mature miRNA, and TE-derived  
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miRNA can then pair with complementary TE sequences embedded within the 3! 
UTR of co-transcribed mRNAs [180]. 
 
Small non-protein-coding RNAs (ncRNAs) are important components in the 
regulation of eukaryotic gene expression [189]. Several classes of small regulatory 
RNA, including miRNAs, small interfering RNAs (siRNA), repeat-associated small 
interfering RNAs (rasiRNAs) and piwi-interacting RNAs (piRNAs), can use partially 
overlapping pathways similar to RNA interference (RNAi) to silence gene 
expression, by degradation or translation inhibition of mRNAs containing 
complementary sites [180]. A fully integrated small RNA pathway connecting 
ncRNA entities such as miRNAs, siRNAs, trans-acting small interfering RNA (ta-
siRNAs), and a natural antisense transcripts (NATs) pathway involving naturally 
occurring siRNAs (nat-siRNAs) have been reconstructed within Arabidopsis 
thaliana [181]. The relationship of piRNAs, siRNAs and rasiRNAs to TEs has been 
reported [181] and the proposed function of these small RNA is to silence invasive 
DNA from viruses and control the replication of TEs [190, 191]. Several 
mammalian miRNA precursors have been found to contain or be derived from TE 
sequences [192, 193] and a substantial number of predicted miRNA targets map 
within members of the same TE families [192-194], again pointing at a model 
whereby large sets of cis-regulatory sequences have been seeded by transposition 
[180]. Approximately 12% experimentally characterized human miRNA genes have 
originated from TEs [193]. Transcriptional gene silencing of elongation factor 1 
alpha (EF1A) has been shown in human tissue culture cells to inhibit mRNA  
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transcription by promoter-directed siRNA [195]. Small RNA gene silencing can 
occur through mRNA cleavage, translational repression, and transcriptional 
repression through the modification of DNA and/or histone, and DNA elimination 
through the modification of histone [182].  
 
Post-transcriptional regulation of gene networks by a single small RNA shared cis-
element is similar to transcriptional regulation by transcription factors [180, 196], 
this is supported by small RNAs homology-dependent transcriptional silencing and 
their participation in the nucleation of heterochromatin [180, 191, 197]. Small RNAs 
are also involved in the phenomenon of paramutation a homology-sensing 
mechanism of interaction described in several kingdoms, including human. It was 
hypothesised that pairing interactions between specific chromatin complexes and 
trans-RNA based communication are two non-mutually exclusive models [198, 
199]. A series of tandem repeat sequence upstream of the b1 transcription site 
activate the biosynthesis of flavonoid pigments in plant, when highly methylated at 
the B-I allele was dark purple relative to B' light purple, an inheritable change in 
phenotype [200]. A RNA-mediated trans-induction of chromatin mechanism was 
proposed for the role for small interfering RNA (siRNA) [201]. The dsRNA that is 
formed by transcription from the two strands of the repeated DNA is a target for 
Dicer, which produces siRNA. The siRNA is then believed to mediate chromatin 
changes, which alters the expression of the adjacent gene. These mechanisms 
include, but are not limited to, RNA-directed DNA methylation and RNA-directed 
histone modification [198].   
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The dsRNA generated from the repeats by sense and rare antisense transcription, 
produce siRNAs that could be efficiently amplified from tandem array transcripts by 
RNA dependent RNA Polymerase (RdRP) and Dicer. The RdRP activity, and 
complementary strand RNA using siRNA primers synthesis, results in increased 
amounts of siRNAs throughout the repeats. The production of dsRNA that trigger 
RNAi, can then result in: degradation of homologous mRNA; altered chromatin 
states associated with DNA methylation; or potentially, inhibition of translation 
[198]. 
3.1.2  Disease targets in human TE elements 
As described earlier almost half of the human genome is composed of 
transposable elements derived from exogenous genetic invaders, most related to 
retroviruses [202]. Two main classes are DNA transposons and the 
retrotransposons. Retrotansposons are comprised of three groups, the 
autonomous, long terminal repeat (LTR) ERV and non-LTR L1, and 
nonautonomous SINE and SVA.  
 
Due to the replication mechanism of retroelements hundred of thousands to 
millions of near identical DNA copies make favourable ground for rearrangements 
making retrotransposons a strong evolutionary force. A small number of LINE1s 
(L1s) are active, and move their own and SINE (nonautonomous elements that do 
not encode protein) sequences into new genomic locations and occasionally 
causes disease. There are 65 known human disease causing insertions of L1, Alu  
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and SVA [203].  
Retrotransposon recombination can cause deletions, duplications, or 
rearrangements of gene sequence, Alu elements alone have been implicated in 
almost 50 disease causing recombination events [203]. Endogenous reverse 
transcriptase activity has been detected in some tumors and patients with certain 
pathologies.  
 
It has been previously discussed that changes in global methylation, and the 
consequent pattern changes of the transcriptome, frequently involve 
hypomethylation of Alus, LINEs, and HERVs, however demethylation leading to 
increased endogenous retrotransposition was untested [179, 204]. Furthermore 
although untested it was possible that elevated retrotransposition within a 
developing cancer could alter the tumor phenotype or hasten tumor progression 
[179, 204]. An L1 insertion into a tumor suppressor gene has been reported in a 
case of colon cancer [205]. The synergy between retrotransposition and cancer is 
an unexplored question; and that by profiling de novo insertion events in tumor 
versus normal cells valuable information on mobile element regulation would be 
gained [179, 203]. 
 
Among the various retrotransposable element families, the primate specific Alu, so 
called because it contains a recognition site for the restriction endonuclease AluI 
[206], is the largest family of short interspersed nucleotide elements (SINEs). Alu  
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has an estimated 1.3 million copies contributing to 10% of the human genome 
[133, 178].  
 
Alu elements are dimeric sequences with a characteristic length of 300 base pairs 
that probably originated from a gene encoding the 7SL RNA [207] and then 
developed into dimeric sequences via the Alu monomeric forms FAM, FRAM and 
FLAM  [208, 209].  The full-length 300 base pair (bp) Alu element has evolved in 
primates into a number of different dimeric families and subfamilies that are 
distinguished from each by diagnostic markers within their sequences as well as by 
their evolutionary history or phylogeny [210]. Essentially, the three main Alu 
families or classes categorized as Alu-J, Alu-S and Alu-Y were estimated by 
sequence divergence to have evolved specifically in primates about 65-80 million 
years ago (mya), 30-50 mya and 15-30 mya, respectively [210]. Each of the three 
Alu families has additional subfamily members that can be identified by sequence 
alignments with consensus subfamilies using the computer program 
Repeatmasker3 [129], Censor [130] or other programs [133].  The Alu family found 
most commonly in transcripts and the human genome are from the AluS 
subfamilies [133]. Studies have surveyed the numbers of transcript [131, 132], but 
the overall proportion of Alu containing transcript has remained essentially the 
same [134]. 
 
Fragmented and/or full-length Alu elements have been found in the coding regions 
of mRNA and may be beneficial, neutral or deleterious to the function of the gene  
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and its transcripts.  Alu RNA levels have been reported to increase in response to 
cell stress [211, 212]. Alu sequences are known to regulate gene expression and 
translation at the transcriptional and posttranscriptional levels [213], modulate 
cellular growth, differentiation and tumour suppression [214] and function in 
exonization [215]. For example, Alu elements are a source of adenine and uracil 
rich elements at the 3’ UTR that may contribute to the stabilization or degradation 
of mRNA [216]. Approximately 5% of alternately spliced internal exons in the 
human genome were found to have an Alu sequence [215], with most Alu exons 
alternately spliced and with only a segment of the Alu sequence contributing to the 
new open reading frame (ORF) [217].  
 
Earlier studies suggested that Alu transcription is regulated by epigenetic 
mechanisms such as DNA methylation and histone modiﬁcation at Alu repeats 
[218, 219]. It has been found in gastric cancer that chromatin remodeling at Alu 
element repeats by DNA demethylation and histone deacetylase inhibition (HDI) 
can activate expression of Alu-associated miRNAs, which can down regulate target 
oncogenes in human [220]. 
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3.2  Material and Methods 
3.2.1  Databases and resources 
 
 
In order to better understand the TE content of transcripts and their possible 
functions in human, two of the public transcript databases the H-Invitational 
(Japan) [135] and NCBI (USA) [136] human transcript datasets were analyzed. 
These two data sets are the largest and most complete collections of human 
transcript sequence information currently available. The JBIRC Version 3.6 H-
InvDB from the H-Invitational human full-length cDNA annotation project (dated 
September 28
th 2006) provided 167,992 cDNA accessions representing 35,005 
cDNA clusters or ‘transcribed genes’ or loci.  
3.2.2  Sequence ontology 
 
All sequence annotation on tissue and cell type, loci Entrez gene identifier, and the 
GenBank CDS start and end positions were extracted from the NCBI GenBank 
[136] using Bioperl tools [221] and JBIRC downloadable text file FCFUN [135]. The 
H-InvDB functional annotation categories are also conveniently available as 
follows.  
Category I: identical to a known human protein with greater than or equal to 98% 
identity and 100% coverage.  
Category II: similar to known protein in another species with greater than or equal 
to 50% identity.   
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Category III:  containing an InterPro [40] protein domain. Category IV: conserved 
hypothetical protein, greater than or equal to 50% identity to a known hypothetical 
protein.  
Category V: hypothetical protein with an ORF length greater than or equal to 80 
amino acids, no pseudogene overlaps.  
Category VI: Hypothetical short protein, with an ORF length less than 80 amino 
acids.  
Category VII: pseudogene candidates. 
3.2.3  Bioworkflows 
 
Bioperl [221] and Perl [222] scripts were written to parse tissue and disease 
information from the H-Inv text files and the GenBank records.   
The tissue types and traits (diseased or normal) were defined and categorized 
using Perl scripts with a defined list of text string synonyms for different tissue and 
cell traits and types to extract the origin of the tissue or cell. Tissues were 
categorised by organ type for this study. 
3.2.4  Alu Analysis Within the cDNA 
 
All cDNA sequences were screened for Alu repeat elements using the computer 
program RepeatMasker3 [129]. The RepeatMasker3 outputs provided the Alu 
positions within the cDNA, Alu size, Alu subtypes and the Alu percentage 
sequence similarity to the consensus sequence. 
3.2.5  Gene Ontology 
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To bridge the gene identifier and GO ontology terms [138] the text file gene2go.qz 
(18/10/2006) was downloaded from the NCBI ftp website.  
3.2.6  PostgreSQL DB 
 
To query the different data types an object-relational PostgreSQL database was 
constructed. The database cDNA-Alu contains tables with information on (1) H-Inv 
cDNA such as tissue type and disease trait, the cDNA CDS position, locus Entrez 
gene identifier and cDNA function (2) cDNA RepeatMasker3 output, (3) NCBI 
Entrez gene information, and (4) GO ontology information extracted from gene 
ontology version1 with GO slim text files for the Homo sapiens taxon identifier 
9636. More than 115 H-Inv 3.6 cDNA Entrez gene identifiers were updated due to 
being recently discontinued or replaced in NCBI. The database was queried to find 
all cDNA containing Alu and their tissue source and disease trait state (Appendix 
3.1). The PostgreSQL database tables can be found in Appendix 3.2. 
3.2.7  Mapping H-Inv Loci 
 
The chromosome positions for cDNA loci were extracted for all the trait states and 
then mapped to the Human Genome assembly version 36.1 in the CMap [223] 
application to view genomic patterns in loci between cDNA normal and disease 
trait.  
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3.3  Results and discussion 
 
3.3.1  Bioinformatics workflow 
 
The bioinformatics approach to determine the Alu element content in human 
transcript involved eight steps (Figure 3.1). The first and second filters removed all 
sequences derived from cell culture, then those sequences not sourced or 
annotated from an organ respectively. The third filter classified sequences sourced 
from disease and the fourth filter retained only those annotated sequences sourced 
from cancer. In step five the data sets are statistically compared to analyse the Alu 
content, locations and function in the transcript data sets, steps six and seven 
respectively. In Figure 3.1 those sequences filtered to black boxes were eliminated 
from further analysis. The red box highlights the proposed Alu feedback model.  
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The bioinformatics workflow analysis steps are discussed in further detail in section 
3.3.2. 
3.3.2  Differentiating between the cancerous and normal tissue 
information within the integrated H-Inv database 
The H-Invitational human full-length transcript annotation project provides 
transcript accessions representing 35,000+ loci in the H-Invitational Database (H-
InvDB). This integrated data has been highly curated by experts to provide high- 
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quality manual and computational annotation of human genes and transcripts and 
information about gene structures, alternative splicing isoforms and non-coding 
functional RNAs [224].   
 
To ensure that the H-Invitational and NCBI human transcript datasets were of 
sufficient quality for investigation, general filters were applied as follows:  
(1) Transcripts derived from culture cells were removed and only those found in 
tissues retained. 
(2) Association of transcripts with cancerous tissues was determined by evaluating 
a match to the following 22 terms: adenocarcinoma, astrocytoma, carcinoma, 
choriocarcinoma, glioma, glioblastoma, gliosarcoma, hepatoma, leukaemia, 
lymphoma, melanoma, melanotic, neuroblastoma, neuroepithelioma, papilloma, 
pheochromocytoma, retinoblastoma, rhabdomyosarcoma, teratocarcinoma, 
tumour.  
(3) Tissue information was then categorised by organ type. 
(4) The dataset sizes for normal or cancerous tissues were examined and under 
represented tissues excluded from further analysis. 
(5) The transcript length qualities were evaluated in order to assess the Alu 
positional insertion within the transcript.  
Transcripts can be divided into three regions, a five prime untranslated region (5’ 
UTR), coding sequence (CDS) and a three prime untranslated region (3’ UTR), the 
Alu content represented based on quantified base pair percentage and the fraction 
of total transcript numbers. To further assess the quality of the transcripts between  
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the two categories of normal and cancerous tissues, the 3’UTR regions in 
housekeeping genes were investigated as EST sequencing was biased against 
this region. The average length of the 3’UTR sequence for the 149 expressed 
genes was 558.3 nucleotides for transcripts derived from cancerous tissues and 
957.9 nucleotides for transcripts derived from normal tissues, and the t-test 
significant (p<0.05) at p = 0.045. Since the statistical difference between the 
normal and cancerous tissues for the length of their 3’UTR was relatively 
borderline, it was assumed that the transcripts were of sufficient quality in both 
cancerous and normal tissues to undertake the following further comparisons. 
3.3.3  Human Alu repeat sequence as a component of gene networks  
The development and public access to primary and secondary databases based on 
sequence information gives an opportunity to investigate the distribution of Alu in 
transcripts. Previous analyses of Alu-transcript have resulted in the creation of 
databases that highlight Alu positions within transcript [131]. 
 
In order to better understand the possible regulatory functions of Alu within RNA, 
surveys of full-length transcript from a number of normal and cancerous tissues, 
were used to compile transcripts encompassing all the nucleotide sequences from 
the CAP site to the poly (A) addition site or at least the entire coding sequence of a 
protein.  The H-Invitational database (H-InvDB) provides 167,992 full-length and 
partial transcripts encoded by 35,005 human gene loci [225]. The loci gene 
transcript structures and alternative splicing forms, referred to here as isoforms can 
be found at H-InvDB website [135].  
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For the total 167,992 H-Inv transcript sequences, 107,001 sequences are derived 
from a tissue, those allocated to a gene loci and the number of Alu containing 
transcript (Alu-transcript) in normal and cancerous tissues were then calculated. 
Table 3.1 shows the relative numbers and percentages for the distribution of the 
gene or genomic loci containing transcripts with and without Alu sequences. It was 
also determined if these loci transcripts were either unique or common to both the 
cancerous and normal tissues. For the total 106,825 transcripts, 33,918 transcripts 
expressed from 13,798 loci were assigned to a cancerous tissue trait and 72,907 
transcript expressed from 26,677 loci were assigned to a normal tissue trait. The 
number of Alu-containing transcript (Alu-transcript) totaled 17,861 (17%) of the 
106,825 transcripts derived from tissues and was represented by 13,240 loci or 
44% of the total gene loci. This set of Alu-transcript is represented by 14,191 
normal-sourced tissue sequences (10,648 loci) and 3,670 cancer-sourced tissue 
sequences (2,592 loci), represented by 19% and 11% of normal and cancerous 
sourced tissue sequences, respectively.  For the represented 29,979 loci, 3,302 
loci (11%) produce transcript derived only from cancerous tissues, 16,181 loci 
(54%) produced transcript only from normal tissues and 10,496 (35%) of loci 
contained transcript produced from both cancerous and normal tissues.   
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Table 3.1 Percentage and number of unique and overlapping loci groups for loci containing 


















































































































































26,677  16,181  -  72,907  14,191  19  10,648  39.91 
Cancer 
condition 
13,798  -  3,302 
10,496 
33,918  3,670  11  2,592  18.79 
Total 
   29,979        106,825  17,861  17  13,240  44.16 
 
 
The fraction and relative tissue distribution of Alu-transcript to transcript within the 
cancerous or the normal tissue group is shown in Figure 3.2. Of the 25 tissues 
examined, 22 had a statistically significant proportional difference of Alu-transcript 
to transcript in the normal to the cancerous tissues as determined by Fisher’s exact 
two sided tests (P <= 0.001 for 14 tissues; and P <= 0.01 for 8 tissues), Appendix 
3.3. The four cancerous tissues with a significantly (P < 0.001) greater proportion 
of Alu-transcript to transcript in them than in the normal tissues were liver, oral 
cavity, ovary, and placenta. Of these four tissues, the greatest relative difference 
between the normal and cancerous tissue for Alu-transcript to transcript was in the 
ovary. Esophagus, pancreas and skin showed no significant (P > 0.05) difference 
between normal and cancerous tissues.  Of the cancerous tissues, the greatest 
proportion of Alu-transcript to transcript was in the oral tissues, whereas, of the  
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normal tissues, the greatest proportion of Alu-transcript to transcript was in the 
rectal tissues. 
 
Figure 3.2 Frequency of Alu containing transcript (Alu-transcript) in human normal and 
cancer tissue types. The frequency of Alu-transcript per transcript sequences represented 
in normal (blue bars) or cancerous tissues (red bars). The statistical significance of the 
differences between the normal and cancerous tissues by a Fisher’s exact two sided test 
is at a probability (P) less than or equal to 0.001. Symbols indicated next to the tissue 
names are * P <=0.005, ** P <= 0 .01, @ = Not significant. 
 
The tissue results are consistent with previous studies that reported that the RNA 
embedded with Alu showed variable patterns between tissue types, but that there 
was an overall two fold increase of edited Alu-transcript in normal cells relative to 
malignant cells [226]. Significant hypo-editing of the Alu elements within the 
transcripts of tumors from the brain, prostate, lung, kidney and the testis has been  
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reported and it was suggested that A-to-I RNA editing was an epigenetic 
mechanism relevant to cancer development and progression [227]. In their tissue 
analysis, they found that the placental tissue was an exception in that there was 
more editing of Alu within the transcripts of cancerous than normal tissue. Recently 
based on the results obtained for 9 different editing sites, it was determined that 
RNA editing is an epigenetic mechanism that does not participate in the evolution 
of urinary bladder cancer [228]. A significantly higher proportion of Alu-transcript to 
transcript in normal tissues than in the corresponding cancerous tissues of the 
bladder may suggest another mechanism for bladder cancers. Further, there is a 
significantly higher proportion of Alu-transcript to transcript in cancerous tissues 
than in the corresponding normal tissues of the liver, oral cavity, ovary and 
placenta.  This may suggest that the Alu-transcript oncogenic affect may occur in 
most, but not all tissues and as reported may not be completely reliant on A-I 
editing in certain cases. 
3.3.4  Alu-transcript functions 
The functional categories of the Alu-transcript collected from the H-Inv human 
transcript database were analysed by Gene Ontology (GO), which classifies the 
known functions of gene products into at least 5,175 categories according to 
biological processes, cellular components and molecular functions [138].  GO 
analysis was performed for transcripts with a NCBI gene identifier and CDS to 
determine the different metabolic and regulatory pathways that are possibly 
associated with the Alu-transcript in normal and cancerous tissues. Over 8,000 Alu 
containing transcripts (Alu-transcripts) from the H-Inv database were classified into  
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nearly 3000 of the GO functional categories, and then assigned into 35 GO Slim 
categories for the Homo sapiens taxa identifier 9636. Over 70% of the Alu-
transcript loci grouped into binding and catalytic activity molecular functions, and 
more than 80% were involved in biological processes, such as physiological 
process, nucleotide metabolism, cell communication and transport (Appendix 
Figure 3.4). Less than 3% of the transcript and Alu-transcript loci were designated 
“molecular function unknown” or “biological process unknown”. The molecular 
function, biological process and cellular component of loci unique to tissue traits for 
the full transcript and Alu-transcript subsets showed no Alu-transcript affect on the 
GO slims [229] category proportions. The proportion of loci unique to tissue traits 
for a few molecular functions did however vary between unique normal and cancer 
tissues for all transcripts and Alu-transcript. The molecular functions of both 
transcript and Alu-transcript were associated mainly with binding (DNA) (40%) and 
catalytic activity (20%). The number of loci products involved in the function of 
nucleic acid binding increased nearly two-fold for the disease loci, whereas loci 
associations with signal transducer activity and transporter activity decreased in 
the cancerous trait three and two fold, respectively. These shifts in function were 
significant by a Fisher’s exact test at P < 0.0001.  
3.3.5  Alu families and subfamilies 
When Alu elements were categorized into their particular families and subfamilies, 
the contribution of the Alu families in transcripts was similar to the proportion of Alu 
families within the genome; AluS 54%, AluJ 26%, AluY 10%, monomeric 8% and  
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Alu 2% [133].  The most frequent Alu subfamily was AluSx. No family bias was 
detected between the cancerous and normal tissue sets (Appendix 3.1). 
3.3.6  Alu locations within the transcript  
The relative position and size of Alu insertions within the transcript sequences was 
determined for 17,819 of 17,861 distinct transcript sequences with an annotated 
CDS that contained at least one Alu. The Alu positions were partitioned into three 
groups according to the regions in which they were found (1) overlapping the 
coding sequence (CDS), (2) exclusively in the 5’ UTR, or (3) exclusively in the 3’ 
UTR. The number of fragments and distinct transcripts in normal or cancerous 
tissues, and transcripts with known functions are indicated in red in Appendix 
Figure 3.5. The transcript Alu content was measured based on the proportion of 
transcripts containing an Alu fragment represented within the CDS, 5’UTR or 
3’UTR or represented by sequence length (base pairs) to the total sum of 
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3.3.7  Alu sequence quantification within transcripts 
Greater than 28,000 Alu fragmented or full-length elements were found in the 
17,000 Alu-transcript sequences surveyed, at an average of 1.6 Alu per sequence. 
The Alu elements ranged in size from10 nucleotides in length to full-sized. All these 
Alu fragments were within the RepeatMasker [171] recommended RM score to be 
outside the threshold for a false positive match. Appendix Figure 3.6A shows the 
number of Alu fragments plotted as a percentage of the consensus Alu sequence 
length for transcripts from cancerous and normal tissues, with known and unknown 
(hypothetical) functions. The plots show that the number of Alu-transcript in normal 
tissues is clearly higher than in cancerous tissues. In the Alu-transcript plot, minor 
peaks represent a slightly increased number of the monomeric form of the Alu 
structure (110-130 bp) and major peaks above 85% of the Alu consensus full-
length sequence represent a greatly increased number of the dimeric form of the 
Alu structure (>250 bp). This trend of minor and major peaks was similar for the 
Alu-transcript in both the normal and diseased tissues. Appendix Figure 3.6B 
shows the number of Alu fragments plotted as a percentage of the consensus Alu 
sequence length for transcripts from the different Alu families, AluS repeats are 
highly represented by lengths greater than 85%. 
 
While multiple fragments of Alu elements can overlap the CDS within a single 
transcript, the largest number of Alu contained in the CDS was 4 copies in one  
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particular transcript sequence. Full-length dimeric Alu (>280 bp) fragments that 
overlap the CDS, that represent half of the transcripts, potentially have cryptic 
splicing sites provided by the Alu sequences. 
 
In an examined subset, the majority of the transcript isoforms containing full-length 
Alu within the coding regions of the transcripts were categorised as hypothetical 
proteins rather than known proteins. As the function of these Alu-transcripts is not 
known or is labelled ‘hypothetical’, it is proposed that they are either untranslated 
or destined for rapid degradation or they serve a binding role against excessive 
retrotranspositional activity within the genome (Appendix 3.7). 
3.3.8  Incorporation of Alu elements as part of transcribed genes 
The size of the Alu within transcripts is surprisingly mostly full-length (Appendix 
Figure 3.5) without open reading frame disruption. The high prevalence of 
expressed full-length Alu, greater than 85% of the full element, in more than half 
available loci supports the view that the Alu within transcripts might have some 
important function rather than random insertions within transcripts with no 
molecular or biological function [211, 227, 230]. One important role for the 
complementary Alu transcript sequences may be to participate in RNA 
sense/antisense hybridisations [212] or dilution effects to protect the genome from 
unbridled Alu retrotransposition events by inhibiting or limiting the expression of the 
active Alu master copies involved with Alu retrotransposition. Overall, Alu within 
transcripts contribute significantly to various characteristics and patterns in 
transcriptome activity. Some examples of genes that have transcripts with Alu  
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sequences embedded in the 3’UTR are glucose -6-phosphatase, placental alkaline 
phosphatase and receptors for platelet activating factor, vitamin D, interferon-
alpha, epidermal growth factor and various other cytokines and interleukins. 
Consistently a larger proportion of Alu containing transcript is found in those mRNA 
derived from normal than cancerous tissues regardless of the Alu sequence 
position within the mRNA (Table 3.2). Some of the genes with Alu in their 5’ UTR 
are METTL8, LIPT1, BDKRB1, GBA, KCNH5 and SLC39A1. The orientation of Alu 
fragment within the transcript is predominately antisense in the 5’ UTR and coding 
sequence (CDS) regions and sense in the 3’UTR. 
 
In an earlier study of 87 Alu containing transcripts, only 4 Alu were found to overlap 
the CDS [134]. We found in our review of the H-Inv transcript database that 3,639 
of the 17,861 Alu-transcript sequences contained at least one Alu fragment that 
overlapped with the CDS. The distribution of the Alu within the CDS was 
determined as any overlap in the 5’ end of the CDS or the 3’ end of the CDS, 
spanning the entire CDS or contained entirely within the CDS (internal). From 
these distributions over 200 transcripts contained an Alu that spanned the entire 
CDS. 
3.3.9  The impact of Alu elements within the transcript UTR 
The relative proportion of Alu that overlapped the CDS in our study was increased 
approximately 10 fold above the numbers previously provided [134], and over half 
of the Alu sequences overlapping the CDS were greater than 85% of  full-length 
elements. A significantly higher number of Alu sequences were present in the 5’  
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and 3’ UTR regions than the CDS (Table 3.2). Therefore the Alu location within the 
transcript is strongly biased to the 5’ and 3’UTR end of the transcript (Table 3.2). 
This finding is in contrast to an Expressed Sequence Tag (EST) study on cell lines, 
where 82% of transposable elements that are found within the EST derived from 
cancerous tissues were located in the CDS [230]. The Alu sequences within the 3’ 
UTR may affect mRNA stability or degradation by A to I editing in Alu sequences 
[231] or by contributing adenine and uracil rich elements (ARE) to the transcript 
[216]. This Alu-associated RNA editing is a potential mechanism for marking non-
standard transcripts for degradation rather than for translation [232]. The Alu 
sequences within the 3’ UTR might also affect translational efficiency by providing 
secondary and tertiary structures to hinder translational editing or translational 
rates [212, 216]. The Alu sequences within the 5’ UTR of transcripts provide cryptic 
promoter sites, steroid binding sites or other regulatory elements and also 
secondary or tertiary structures that may hinder or enhance translation of the 
transcript [212]. The BRCA1 Alu-rich gene is an anti-oncogene involved with a 
hereditary predisposition to ovarian and breast cancer is a well-studied example of 
a gene that expresses variable forms of a transcript with and without an Alu 
insertion in its 5’UTR sequence [233]. Some of the genes with Alu in their 5’ UTR 
sequences, such as METTL8, LIPT1, BDKRB1, GBA, KCNH5 and SLC39A1, 
however, might exploit the same Alu regulatory mechanisms as BRCA1 in disease 
[233].   
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3.3.10 The impact of Alu elements within transcribed exons 
The Alu sequences within genes can contribute to different transcriptional isoforms 
by providing intron-exon recognition sites, exonization [234-236]. Approximately 
5% of alternately spliced internal exons in the human genome were found to 
originate from an Alu sequence [215]. Most Alu derived exons are alternately 
spliced and only a segment of the Alu contributes to the new ORF [237]. In this 
review we found that 16% of the Alu-transcript transcripts provided potential splice 
sites within CDS.  Coding sequence from some functioning human genes exist that 
are almost entirely derived from Alu elements, such as the AD7C gene that 
encodes a neuronal thread protein and has 99% of its transcript composed of 4 to 
5 Alu fragment elements [238, 239] although the validity of these findings has been 
questioned on the basis of EST and genomic sequence analysis [240]. It was 
further argued that functional proteins are unlikely to contain transposable 
cassettes derived from young transposable elements, but if so, then their role is 
probably limited to regulatory functions [241]. Some of the genes previously found 
to have Alu sequences contributing to exonization include ADARB1, DSCRB8, 
ITCH, CDK5RAP1 [132], RPE2-1, C-rel-2, MTO1-3 and PKP2b-4 [217]. Potentially, 
numerous new cryptic splice sites exist in the human transcriptome [242] and many 
of them await full structural and functional characterization. 
 
The CDS base pair coverage by Alu is nearly 40% in over a half of the Alu-
transcript with an Alu size greater than 280 base pairs. Of the 3,639 transcripts, 
2,473 were annotated as hypothetical proteins. To determine if the Alu content  
      59 
changed the location or structure of the ’normal’ CDS, a subset of transcript with 
full-length Alu sequences internal to the CDS were further investigated. In this 
subset 85 percent of the Alu-transcript were annotated as translating hypothetical 
products with no known function. The remainder were either identical to the known 
genes glucose-inhibited division protein A family protein and Penicillin-binding 
protein, dimerisation domain containing protein or similar to the genes, N4BP2, 
Alpha-COP, A1BG, dNT-1, GPI transamidase component PIG-U, RPIP8, PAOX, 
programmed cell death 6, enkurin, CRL2, G protein-coupled receptor 43, 
selenoprotein N precursor, CTAGE family member 5 isoform and a solute carrier 
family 24 (sodium/potassium/calcium exchanger), member 5 (Appendix 3.1, 
Appendix 3.7).   
 
The variation in the A1BG gene transcripts provided an example of how the Alu 
content of the transcripts might change their structure, function and tissue 
specificity of expression.  The protein encoded by the eight exons of the A1BG 
gene is a plasma alpha-1glycoprotein with sequence similarity to the variable 
regions of some immunoglobulin supergene family member proteins.  A1BG 
interacts in the plasma with the cysteine-rich secretory protein 3 (CRISP-3) that is 
secreted by neutrophilic granulocytes and it is believed to play a role in innate 
immunity. Some variants of the A1BG transcripts were transformed by the Alu 
insertions from full-length coding forms (1645 bp – 1810 bp) composed of eight 
exons into longer transcripts (1951 bp – 3466 bp), usually with shorter ORF of 1 to 
3 exons in the coding region. The Alu containing A1BG transcripts were found in  
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the amygdala, cerebellum and tetracarcinoma, while the Alu foetal and adult livers, 
primary hepatoblastoma and ovary expressed Alu free A1BG transcripts. 
3.3.11 Alu-siRNA mediated feedback model in disease 
 
The transcriptome-wide survey of human transcript, carried out in this Chapter 
represented nearly 30,000 gene loci, which is close to the full complement of 
known gene loci of the human genome. Overall, 13,240 loci  (44%) expressed a 
transcript that contains a partial or full-length Alu sequence. Alu fragments are far 
more abundant in the transcriptome than previously reported. No discernable bias 
for Alu families was identified between the normal and cancerous tissues, which 
confirmed that the Alu families in the transcriptome reflect the proportion of Alu 
families in the genome. For all the total transcript analysed, 17% contain an Alu 
fragment which is four times greater than previous estimates of Alu-transcript 
content made from smaller data sets and based on different search methods [134].  
 
Loci-based transcriptome-wide investigation of Alu sequence has highlighted that 
Alu fragments are proportionally more abundant in normal tissue transcript than the 
corresponding cancerous tissues, many with hypothetical functions. In our feed 
back model (Figure 3.3) we propose that a high proportion of the non-functional 
(hypothetical) Alu-transcript expressed in normal tissues or during cellular stress 
and infection does not undergo degradation, whereas the Alu-transcripts are 
degraded in cancerous tissues due to increased Alu small RNA activity.   
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Figure 3.3 Feedback model for Alu mediated siRNA interference of Alu containing 
transcripts in cancerous tissues 
 
Loss of genome-wide methylation is a common feature of cancer. Bollati in 2009 
hypothesized that DNA methylation initially evolved as a defence mechanism 
against viral and other DNA pathogens as a way to silence foreign DNA sequences 
[243-245] This is consistent with the observation that LINE and SINE (Alu) 
transposable elements, are heavily methylated in normal cells [246]. It has been 
found that global hypomethylation of LINE-1, Alu and SAT-alpha is significantly 
associated with tumour progression in Mus musculus and may contribute toward a 
more extensive stratification of the disease [247]. Our model proposes that in 
cancer tissues the hypomethylation of intergenic Alu-loci may result in transcription  
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of these elements to generate Alu-dsRNA molecules that are further cleaved into 
siRNAs. The generated Alu-siRNAs guide the RNA Silencing Complex (RISC) to 
Alu-containing mRNAs and mediate their posttranscriptional degradation (Figure 
3.3).  
 
Methylation and chromatin structure together play a role between retroelements 
and their host. Hypomethylation and expression in developing germ cells opens a 
"window of opportunity" for retrotransposition and recombination that contribute to 
human evolution, but also inherited diseases. In somatic cells, the presence of 
retroelements may be exploited to organize the genome into active and inactive 
regions, to separate domains and functional regions within one chromatin domain, 
to suppress transcription noise, and to regulate transcript stability. Retroelements, 
particularly Alu, may fulfil physiological and protective roles during responses to 
stress and infections [179].  
 
In support of our model it has been previously reported that reduction of the 
methylation index of L1 and Alu following treatment of three lung cell lines with 5-
aza-2'-deoxycitidine, consistently resulted in increased expression of both 
elements. This study demonstrated a strong link between hypomethylation of 
transposable elements with genomic instability in non-small cell lung cancer and 
provided early evidence for a potential active role of these elements in lung 
neoplasia. As demethylating agents are now entering lung cancer trials, it was 
viewed imperative to gain a greater insight into the potential reactivation of silent  
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retrotransposons in order to advance the clinical utilization of epigenetics in cancer 
therapy [248].  
 
To investigate the role of microRNAs (miRNAs) on epigenetic therapy of gastric 
cancer, the miRNA expression proﬁle was analysed in human gastric cancer cells 
treated with 5-aza-20-deoxycytidine (5-Aza-CdR) and 4-phenylbutyric acid (PBA). 
Microarray miRNA analysis shows that most of miRNAs activated by 5-Aza-CdR 
and PBA in gastric cancer cells are located at Alu repeats on chromosome 19 
[220]. Analyses of chromatin modiﬁcation showed that DNA demethylation and 
HDAC inhibition at Alu repeats activates silenced miR-512-5p by RNA polymerase 
II. These results suggest that chromatin remodeling at Alu repeats plays critical 
roles in the regulation of miRNA expression and that epigenetic activation of 
silenced Alu-associated miRNAs could be a novel therapeutic approach for gastric 
cancer [220].  
 
Hypomethylation of the genome largely affects the intergenic and intronic regions 
of the DNA, particularly repeat sequences such as transposable elements, and 
believed to result in chromosomal instability and increased mutation events [249]. It 
has been considered that global demethylation of repeat sequences including 
transposable elements and the site-specific hypomethylation of certain genes 
might contribute to the deleterious effects that ultimately result in the initiation and 
progression of cancer and other diseases [249]. In our model the increased 
hypomethylation of transposable elements is shown in the lower section of Figure 2  
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highlighted in red to represent the cancerous tissue state, while normal state is 
represented in the upper half of the diagram in blue.  
 
In the feedback model genomic hypomethylation (Figure 3.3) and the increase in 
TE sequences is shown correlated with the increased production of small RNA. 
The small RNA complementation to loci containing TE may then silence 
transcription and the production of mRNA (rasiRNA) and/or post-transcriptional 
binding TE containing transcripts (tasiRNA) leading to their degradation, mRNA 
cleavage. Mature miRNA sequences of approximately 50 additional human 
miRNAs have been shown to lie within Alu and other known repetitive elements, 
extending the current view of miRNA origins and the transcriptional machinery 
driving their expression [250]. Further, base-pair complementation can be 
demonstrated between the seed sequence of a subset of human miRNAs and Alu 
repeats that are integrated parallel (sense) in mRNAs [251]. 
3.4  Conclusion 
 
The key findings from this chapter are that TEs such as Alu elements can influence 
gene regulation/expression on both the transcriptional and post-transcriptional level 
(Figure 3.3). TEs are found to be an abundant source for small RNA and hence 
potential gene interference activity. In examining the available human transcript 
data in H-Inv, the Alu element was found with a much higher abundance in 
transcript than previously reported, serving as possible gene targets for repeat 
derived small RNA (Alu-siRNAs). Due to the curated nature of H-Inv, transcripts 
could be assigned to their tissue source, disease condition and function.  
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Transcripts from cancerous tissues revealed an underrepresentation of transcript 
containing Alu elements, and the majority of full length Alu containing transcripts 
derived from normal tissues were highly represented by hypothetical proteins. It 
was proposed that Alu derived small RNA interference activity increases in certain 
cancerous tissue with increased genome hypomethylation, thus suppressing the 
abundance of Alu derived transcripts. The proportion of Alu-transcript was 
significantly higher in 18 of the 22 normal tissue types than in the corresponding 
cancerous tissues (Figure 3.1). Therefore the Alu-transcript oncogenic effect may 
occur in most, but not all tissues and as reported may not be completely reliant on 
A-I editing in certain cases. The hybridised complementation between the small 
RNA and the repeat containing transcripts in hypomethylated diseased tissue may 
lead to reduced RNA-Alu transcript levels due to their degradation and/or 
interference (Figure 3.3).   
In summary the key findings from the developed bioinformatics approach for this 
chapter are: 1) Bioinformatics approaches have provided access to sequence and 
metadata for novel analysis; 2) through the integration and mining of sequence 
metadata, sequence was charted to organ and cancer for repeat element and 
functional analysis; 3) An over representation non cancerous Alu transcript with 
unknown function was found; 4) Alu transcripts were under represented in cancer 
sourced transcripts in the majority of tissues; 5) A model for an Alu transcript 
mechanism in cancer was presented.   
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4  Chapter Four - Genomic analysis of Campylobacter 
fetus subspecies: identification of candidate 
virulence determinants and diagnostic assay targets 
 
The contents of this chapter have been published [252]. The laboratory-wet 
chemistry that is reported in this chapter was carried out by cited co-authors in 
order to test the bioinformatics outputs from the work. 
4.1  Introduction 
 
Bacterial species level genome diversity has been attributed to mobile genetic 
elements (MGE) and bacteriophages, that confer new characteristics to the 
recipient genome [253]. The flexible gene pool of bacteria includes mobile and 
accessory genetic elements, such as bacteriophages, plasmids, pathogenicity 
islands, insertion sequence (IS) elements, transposons and integrons [254].  MGE 
such as plasmids (extra-chromosomal self-replicating DNA molecules) exist in cells 
as replicons and can insert into the chromosome [254].   
 
IS element DNA sequences, are generally less than 2.5 Kbp in length, that encode 
functions involved in their translocation, and transposition both within and between 
genomes. IS elements are a subset of a general group of elements named 
transposable elements. Transposons DNA molecules code for a transposase (and 
other genes), and are flanked by inverted repeat DNA sequences. Conjugative 
transposons also carry genes related to plasmid-encoded conjugation, are able to 
transfer between cells via conjugation [254]. Bacteriophages (Prokaryote-infecting  
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viruses), can modify the host coding genome, and are capable of inserting into the 
genome (prophages) [254]. The final genetic elements Integrons, encode an 
integrase gene and cassette-associated genes [255-257].  
 
Large bacterial chromosomal regions referred to as genomic islands (GI) contain 
clusters of functionally related genes or operons that are flanked by direct repeat 
sequences, these are located near an integrase/transposase gene and a tRNA 
gene [253, 254].  
 
Pathogenic IS genes, are known to be involved with antigenic variation of surface 
exposed proteins, and environmental adaptation [258, 259]. These IS transfer and 
integrate pathogenic islands (PAI) into the genome [259-261]. Common insertion 
sites for PAI are tRNA genes [254]. 
4.1.1  Bacterial virulence factors  
Pathogenomics is the genomic study of pathogenic microbes and how they interact 
with a host.  Pathogenic microbes sense, infect and then colonize their hosts [262]. 
Microbial pathogenesis/virulence is the measure of the likelihood of a pathogen to 
cause infection, therefore important for the control of disease [263]. Virulence 
factors (VF), the genetic elements (gene products) required by the pathogen to 
colonise, proliferate and cause damage in a host have many known mechanisms 
[264]. These known virulence mechanisms include motility, chemotaxis, adhesion, 
invasion and toxin production and regulation by two-component systems [150]. 
Other VFs such as secreted protein (protein toxins and enzymes) and cell-surface  
      68 
structures (capsular polysaccharides, lipopolysaccharides and outer membrane 
proteins), also contribute to the microbes disease process in the host [264].  
 
Virulent secretion mechanisms such as, siderophores (high-affinity iron chelating 
compounds), catalases, and regulators are indirectly involved in pathogenesis, and 
are important for the bacterium to establish infection [264]. The Type III secretion 
system, for example, injects virulence factors into the host cell [265]. 
4.1.2  Virulence targets for diagnostics 
The development of vaccines is recently based on a composition of prominent 
immunogenic parts of microorganisms (subunit vaccines) or genes. Traditional 
vaccines incorporate whole live attenuated or killed microorganisms. These have 
limited application due to concerns about safety, efficacy and/or ease of 
production, particularly for use in humans [253]. 
 
It is therefore possible from a genome sequence, using known prediction 
properties, to select potential peptide sequences for the construction of chemically 
synthesised vaccines based on peptide or DNA. The peptide approach can be 
used directly or used to construct a composite protein made from individual 
epitopes [253]. 
 
Common genomic targets for vaccines include those genes encoding outer 
membrane proteins or lipoproteins, transmembrane domains or export signal 
peptides. These surface-exposed or secreted proteins as well as virulence factors  
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(such as toxins or adhesive factors) can induce an immune response that may be 
protective for the host [266, 267]. 
 
Common target type epitopes are B cell, helper T lymphocyte and cytotoxic [253]. 
T lymphocyte and B cell targets have been made, and improved methods are 
constantly being developed [253]. These recombinant proteins from identified 
ORFs can be produced and screened for distribution in different serotypes, 
stability, immunogenicity and cross-protection tests [268-271]. 
 
Northern Australian beef herds have a 35% unexplained reduction in calf 
production. In Argentina, calf production has not declined, but remains at a 
constantly low rate (63%). Causative agents include Campylobacter fetus 
subspecies fetus and venerealis. To aid the detection and treatment of cattle 
infected with Campylobacter fetus our genomic analysis has identified candidate 
subspecies specific genes that can be used as diagnostic tools. 
 
The Campylobacter genus is a Gram-negative, spiral-shaped bacterium and 
includes 23-recorded species in the NCBI Taxonomy division. Campylobacter spp. 
colonise diverse hosts from livestock to humans with varying degrees of virulence 
[150]. Hosts include cattle, swine, bird, and can be the major cause of human 
bacterial gastroenteritis [272]. C. fetus subsp. venerealis (Cfv) is the causative 
agent of bovine genital campylobacteriosis, which causes conception failure and 
embryo loss, with bulls acting as asymptomatic carriers [273]. C. fetus subsp. fetus  
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(Cff) causes infertility and infectious abortions in domesticated sheep, goats and 
cattle [272]. It is also an opportunistic pathogen in humans that can severely affect 
immuno-compromised patients. Initially the bacterium can cause gastroenteritis, 
and then spread systemically throughout the blood (bacteremia) and cause 
septicaemia, meningitis, and other systemic infections [272]. Bovine genital 
campylobacteriosis is an Office International des Epizooties (OIE) notifiable 
disease considered to have socio-economic and public health implications, 
particularly with respect to the international trade of animals and animal products 
[274] . 
 
Although Campylobacter sub species have largely conserved genomes, sub 
species display variable virulence phenotypes in animal models and this 
phenotypic virulence has been speculated to be due to hyper-variable antigenic 
diversity and immune evasion [150, 275].  Very few gene targets have been 
identified for the differentiation of C. fetus subspecies, with members of the 
subspecies shown to be 86% similar based on Pulsed Field Gel Electrophoresis 
PFGE-DNA profiles [276]. Diagnostic testing of C. fetus colonies from transport 
medium and the biochemical differentiation of the 2 subspecies venerealis and 
fetus is important for the diagnosis of bovine venereal disease in cattle. Cff and Cfv 
can be differentiated from each other using a range of biochemical assays 
including H2S, selenite reduction, growth at 42
oC, susceptibility to metronidazole 
and cefoperazone, basic fuchsin, KMnO4 and glycine tolerance [276, 277]. Glycine 
tolerance is the OIE recommended assay. It is however difficult to isolate viable  
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colonies from transport medium for biochemical analysis due to prolonged 
transport, contaminant overgrowth and the fastidious nature of the bacteria [278-
280]. In addition doubts in regard to the stability of these biochemical markers has 
been suggested based on evidence from phage transduction [276, 281-283]. The 
H2S test although described as differentiating Cff (positive) and Cfv (negative), a 
Cfv strain subsequently named Cfv biovar intermedius is positive in this assay 
[284]. Molecular typing methods such as amplified fragment length polymorphism 
(AFLP) and multilocus sequence typing have been developed to differentiate C. 
fetus isolates [281, 285], but these methods require the isolation of pure colonies 
which are impractical for diagnostic application. Specific polymerase chain reaction 
(PCR) assays have been designed and applied to detect Cfv [286-288], however it 
has been suggested that the gene targets are plasmid borne and that in some 
cases have not reliably detected all Cfv isolates [289].   
 
A sensitive real time assay designed to target the parA gene originally targeted by 
PCR assay [287], identified a high prevalence of Cfv in Australia cattle not 
associated with venereal cases [274]. It was thus postulated that isolates of Cfv 
differ in virulence and that other methods may be required to confirm the presence 
of pathogenic Cfv in clinical samples. Genomic Campylobacter comparisons of 
C. fetus subspecies and a list of Cfv specific genes will provide the basis for 
developing specific diagnostic assays and improving our understanding of C. fetus 
virulence and epidemiology. No studies to date have reported the putative 
identification or extensive analysis of Cfv virulence genes.    
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Based on comparative analysis on recently available genome data for both C. fetus 
subsp. venerealis (Cfv) (incomplete) and C. fetus subsp. fetus (Cff) the work in this 
chapter has developed a number of assays targeting virulence factors previously 
identified in C. jejuni, C. coli, C. lari, and C. upsaliensis genomes. These virulence 
mechanisms include motility, chemotaxis, adhesion, invasion and toxin production 
and regulation by two-component systems, as discussed by Fouts et al. in 2005 
[150]. This paper provides the first detailed analysis of available genome 
sequences in order to identify targets for differentiating C. fetus subspecies. Based 
on the analysis, several targets were identified and confirmed using PCR assays. 
 
Our aims were to (1) identify and compare C. fetus putative virulence genes, and 
(2) characterise genomic features to differentiate the highly conserved C. fetus 
subspecies for diagnostic assays. The genomic features of Campylobacter 
provided subspecies markers that discriminate C. fetus species and subspecies, in 
particular the C. fetus sub species (Cfv and Cff) from each other and other 
Campylobacter species.  
4.2  Materials and Methods 
4.2.1  Bacterial strains, culture conditions and DNA preparation 
Campylobacter fetus subsp. venerealis AZUL-94, an Argentinean field strain 
isolated from a bovine aborted fetus in 1994, was grown routinely on Tryptic Soy 
Agar plates or in Brain Heart Infusion (BHI) and cultivated under microaerobic  
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conditions in anaerobic jars with CampyGen envelopes (OXOID) at 37°C. Total 
DNA from Campylobacter fetus venerealis was isolated by the classical 
SDS/proteinase K/Phenol/Chloroform extraction method [290]. The Pfizer strains 
were originally isolated by CSIRO Australia [291]. 
4.2.2  Library construction, DNA sequencing and assembly 
Genomic DNA was randomly sheared by nebulization, treated with Bal31 nuclease 
and blunt ended with T4 DNA polymerase. Fragments were size fractionated by 
agarose gel electrophoresis and ligated to dephosphorylated HincII-digested pBS 
plasmid. Three libraries with insert size of approximately 2 Kbp (Cf1), 4 Kbp (Cf2), 
and 6 Kbp (Cf3) were generated. Template preparation and DNA sequencing were 
performed as described [292] from randomly selected clones. Single-pass 
sequencing was performed on each template using T7 or T3 primer. Sequencing 
reads, obtained from the three genomic libraries (Cf1, Cf2, Cf3) were masked 
against plasmid vector and base called with phred (-trim_qual). Those sequences 
with at least 50 good quality bases after trimming were retained for assembly. After 
reaching ~ 4.5X shotgun coverage, assembly was done using the phredPhrap 
script provided with phrap. The autofinish functionality of consed was used to 
select candidate clones for re-sequencing to increase sequence coverage, 
decrease the number of contigs and increase the consensus quality in a number of 
cases.  Additional information on Campylobacter fetus venerealis sequencing can 
be found in Appendix file 4.1. 
The genomic sequence data have been deposited in the WGS division of GenBank 
under the following accession numbers: ACLG01000001…ACLG0101187  
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4.2.3  Genomic data 
A subset of 273 Cfv contig sequences (lengths greater than 2Kb) from 1,187 the 
assembled contigs was generously supplied by the UNSAM, Argentina for this 
analysis.  The assembled contigs have been submitted to GenBank as a part of the 
WGS division (GenBank: ACLG00000000 and RefSeq: NZ_ACLG00000000). All 
manuscript referenced contig ORFs are listed in the Appendix 4.2 and 4.3. 
 
Completed Campylobacter genomic sequences were obtained from NCBI RefSeq 
Genome [293].  All genomic sequences for the genus Campylobacter listed were 
downloaded from NCBI genome division, 28
th April 2008. Campylobacter species 
included C concisus 13826, C. curvus 525.92, C. fetus subsp. fetus 82-40, C. 
hominis ATCC BAA-381, C. jejuni RM1221, C. jejuni subsp. doylei 269.97, C. jejuni 
subsp. jejuni 81-176 and C. jejuni subsp. jejuni 81116.   
 
Alignment of Campylobacter genomes was conducted using BLAT [143]. The 
BLAT results were then filtered for a minimum 50% alignment coverage at greater 
than 90% identity. The two C. fetus subspecies were then displayed in Argo [144]. 
4.2.4  Alignment of genomic Cfv contigs based on Cff 
The 273 Cfv AZUL-94 contigs were aligned to the Cff 82-40 genome (NC_008599) 
using BLAT [143] (>90% identity). Cfv contigs were assembled (order and 
orientation) based on the best BLAT alignments between Cfv and Cff into a 
contiguous pseudomolecule. Unaligned contigs were concatenated to the 
pseudomolecule linear sequence.  
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4.2.5  Cfv Open reading frame identification & annotation 
ORF prediction was conducted on the 273 Cfv contigs using Glimmer3 [145] for 
ORF lengths greater than 100 nucleotide bases, resulting in 1474 open reading 
frames (ORF), Appendix 4.4. The 273 Cfv contigs and 1474 ORF were 
subsequently screened against NCBI protein (nr, patent), String [147], COG [43], 
and NCBI Conserved Domain databases with the BLAST program [146]. These 
results were then categorised using BIOPERL [149] scripts based on alignment 
percent identity (PID) and query coverage to provide the following six alignment 
categories, (1) known protein > 80% PID and  > 80% query coverage, (2) known 
protein > 30% PID and > 80% query coverage, (3) hypothetical protein > 80% PID 
and > 80% query coverage (4) hypothetical protein > 30% PID and > 80% query 
coverage, (5) alignments with an expected value less than 1e-05,  < 30% PID and 
< 80% query coverage, and (6) alignments greater than 1e-05 < 30%  PID, < 80% 
query coverage. 
4.2.6  Campylobacter protein similarity to Cfv ORF 
Campylobacter complete proteome sequence and protein detail were downloaded 
from NCBI (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi). The 8 complete 
campylobacter proteome sets were compared to our Cfv ORF set using BlastMatrix 
[294] at an ARL 0.75 and an expected value less than 1e-05 (results in Appendix 
4.5).   
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4.2.7  Putative virulence genes 
The functional categories for Cfv ORFs were determined based on the String 
Database [147] categories developed on NCBI COG database role descriptions. 
The main categories being Cellular processes and signaling, Information storage 
and processing, Metabolism, Poorly characterized, No mapping, Non Orthologous 
Group (NOG) and KOG (euKaryote Orthologous Group).  The ORFs identified in 
Cfv were screened against the String database and alignment results were filtered 
using Bioperl for greater than 80% query coverage and 30% PID or with an 
expected value  less than 1e-05.  These ORFs were then screened against NCBI 
protein database to determine selected putative virulence gene representation in 
the Campylobacter genus. 
4.2.8  Primer design 
Primer sets were designed using EMBOSS [295] Primer3 [296] on Cfv putative 
virulence genes and genes unique to Cfv. Primers were screened against the Cfv 
AZUL-94 strain and Cff (strain 82-40) genome data and public databases to 
confirm specificity. Assays were conducted in 20 µl reaction volumes, using 10nM 
of each forward and reverse primer, 1 x PCR reaction buffer with 25mM Mg
2+ 
(HotMaster Taq buffer, Eppendorf, Germany), 200µM dNTPs, 1U Hotmaster™ Taq 
DNA polymerase and 1 ng of C. fetus DNA. The reactions were cycled in a 
Gradient Palm Cycler (Corbett Research, Australia), using the following 
temperature profile: an initial denaturation at 94
oC for 2 min, followed by 35 cycles 
of denaturation at 94
oC for 20s, annealing at 45 to 57
oC (dependent on primer pair, 
Table 4.1) for 10 s, and extension at 72
oC for 30s including a final single extension  
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for 7 min at the end of the profile. Amplification products were separated in 2% 
TBE (89 mM Tris borate, 2 mM EDTA, pH 8) agarose gels using 100bp ladder 
(Invitrogen) and were visualised under UV illumination by ethidium bromide 
staining. DNA preparations from strains were screened in all assays. 
4.3  Results 
4.3.1  Bioinformatics workflow 
In Figure 4.1 the assembled genomic contigs of Cfv were scaffolded into a Phase 
Two (ordered and oriented contigs) genomic assembly 
(pseuochromosome/molecule) using the complete genome of Cff.   The Cfv gene 
predictions were then compared to the Cff protein and NCBI NR datasets and 
functional ontology assigned. The unique Cfv gene set as compared to Cff were 
then presented as candidate diagnostic targets for PCR analysis.  
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Figure 4.1 Bioinformatics workflow for the identification of candidate diagnostic genes for 
discriminating campylobacter subspecies 
 
The bioinformatics workflow analyses are described in further detail in the following 
sections. 
4.3.2  Assembly of Cfv for identifying targets for diagnostics 
The available genomic sequence information (ca 75-80% Cfv genome) was 
compiled using the complete Cff 82-40 genome sequence (NC_008599) in order to 
identify diagnostic targets for the detection of Cfv. The ordering of available  
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genome segments generally aligned well with the Cff genome as shown in Figure 
4.2 
 
Figure 4.2 Genomic nucleotide alignments of C. fetus subsp. venerealis (Cfv) contigs to 
the C. fetus subsp. fetus genome. Genomic nucleotide comparison of C. fetus subsp. 
venerealis (Cfv) contigs (1.08Mb) as aligned to the C. fetus subsp. fetus (Cff) completed 
genome (1.8Mb). Orange shaded regions between the parallel sequences of Cfv (top) and 
Cff (bottom) highlight contigs in common; unshaded regions are unique between the two 
Campylobacter subspecies. 
 
Several striking features were evident in the subspecies comparison. Firstly, an 80 
Kb suite of 22 Cfv specific contigs (relative to Cff) housed a range of putative 
virulence factors such as Type IV secretion systems (Appendix 4.2). Secondly a 
number of potential virulence factors were also identified in the genomic 
sequences that were shared between Cfv and Cff (Appendix 4.3). Table 4.1 
summarises virulence factors by comparing the ORFs of the 2 C. fetus subspecies 
with 4 Campylobacter species as described previously [150].  In general similar  
      80 
numbers of genes potentially associated with 2 component systems, toxin 
production, outer membrane proteins, and motility were identified.  Only one 
bacterial adherence gene was identified in both C. fetus subspecies with 2 and 3 
ORFs identified in Cfv and Cff respectively (Table 4.1).  However an additional 
adhesion homologue fibronectin (FN) binding ORF was identified in Cfv but not Cff. 
A large surface array protein was found highly conserved between the two 
subspecies as evident in the genomic sequence alignments (Figure 4.2). 
 
Table 4.1 C. fetus subsp. fetus (Cff) and subsp. venerealis (Cfv) virulence factors 
compared with 4 other Campylobacter spp.  
 
Putative virulence type  Other spp.
a  Cff  Cfv* 
Bacterial adherence  9  3
b  4
b 
Motility  55-66  41  46 
Two-component system 
genes 
11-15  16  14 
Toxin and resistance  15-20  9
c  7
c 
Membrane proteins  185-218  209  202 
 
Summary of C. fetus virulence gene ORFs in C. fetus subsp. fetus (Cff) and subsp. venerealis (Cfv) 
compared with 4 other Campylobacter spp. (adapted from Fouts et al). 
a C. jejuni, C. lari, C. upsaliensis, C. coli (Fouts et al. 2005) 
b Cff – PEB1 (3) – no other adherence homologues found; Cfv ORFs – PEB1(2), cadF(0), jlpA (1-
poor homology), Fibronectin binding (1), 43-kDA MOMP (0) 
c not including resistance genes for Cff and Cfv, toxin subunit ORFs only 
*N.B. Cfv genome incomplete 
 
The nucleotide alignment of Cfv contigs to the closest sequenced genome Cff 
displayed those Cfv contig sequence in common between the two genomes (not 
specific to Cfv) and Cfv contig sequence not found in Cff (specific to Cfv) (Figure  
      81 
4.2). Of the 273 Cfv contigs, 251 contigs (993569 bp) were conserved with Cff and 
22 contigs (86999 bp) specific to the Cfv genome compared to Cff. Contigs specific 
to Cfv were Contig1018, Contig1021, Contig1023, Contig1024, Contig1030, 
Contig1031, Contig1042, Contig1120, Contig1139, Contig1165, Contig1181, 
Contig1185, Contig1186, Contig419, Contig733, Contig846, Contig851, Contig872, 
Contig875, Contig914, Contig958 and Contig991 (note all ORF without strong 
homology to Cff are listed in Appendix 4.2).   
 
When probed against all available genome protein sequence information the Cfv 
specific contigs (Table 4.2) had the following alignments; two contigs (~4.9 Kb) with 
short alignments to only non-campylobacter bacterial species (Contigs914 and 
875) (Campylobacter specific); five contigs (~20 Kb) with significant alignments to 
C. jejuni and C. coli plasmid genomes and short alignments to C. hominis and C. 
lari; ten contigs completely unique to Cfv (Cfv specific) (~32 Kb); and five contigs 
(~27 Kb) with significant protein alignments to Cff although this was not evident at 
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4.3.3  Cfv open reading frame analysis 
The C. fetus subsp. venerealis 1474 ORFs protein database search found 67 
unique to Cfv (no protein alignments), 1174 conserved top match alignment to Cff, 
116 conserved top match alignment to any other species, and 117 low significance 
alignments. ORF alignments to the non-redundant protein database found 12% Cfv 
insignificant and unique (Appendix 4.2), 51% with significant alignments and 37% 
with highly significant alignments. Comparison of the 9 Campylobacter genome 
protein datasets found approximately 50% of proteins were in common for all C. 
jejuni (including subsp. jejuni and doyley) except C. jejuni subsp. jejuni 81-116 
which had 20-25% similar. This level of similarity was also found between the Cff 
subspecies while between all Campylobacter species this similarity decreased to 
between 0.5-5.5%. The BlastMatrix [294] result can be found in Appendix 4.5  
4.3.4  Cfv Open reading frame analysis of the Cfv specific suite of 
genomic regions 
Eighteen Cfv specific contig ORFs were analysed against all available protein 
datasets. These Cfv specific regions contained 90 ORFs, 15 with alignments to 
hypothetical proteins, 32 with non-significant protein alignments and 43 ORFs with 
significant alignments. As a separate category these latter 43 ORFs were found to 
have significant alignments to plasmid/phage like proteins within Campylobacter 
species (34 ORFs) and to other bacteria (9 ORFs). In the 34 Campylobacter ORFs, 
best matches were found in two Cfv ORFs, namely a putative type IV secretion  
  84 
system protein identified in IsCfe1 [288] and a putative TrbL/VirB6 plasmid 
conjugal transfer protein. The remaining 32 ORFs had significant hits to 
Campylobacter species other than Cfv such as C. curvus (1), C. concisus (2), C. 
coli (4), C. fetus (5), C. jejuni (13) and C. hominis (17). 
  
Functional assignments for the Cfv specific ORFs were as follows: cellular 
processes and signalling, chromosome partitioning, cell motility and intracellular 
trafficking, secretion and vesicular transport (16); information storage and 
processing, replication, recombination and repair, transcription, translation (12); 
metabolism and transport amino acid, carbohydrate and inorganic ion, energy 
production and conversion (5); and poorly characterized, general function 
prediction only (7) (Appendix 4.2).  
4.3.5  Cfv ISCfe1 insertion elements 
Specific sites previously identified for the ISCfe1 insertion element [288] were 
searched in Cfv alignments to Cff (Figure 4.2) : (a) the sodium ⁄ hydrogen 
exchanger protein gene nahE (YP_891382 ) was found in the Cfv pseudomolecule 
positioned 159601-160764 bp  (Contig1097), a region conserved with Cff; (b) the 
putative methyltransferase protein gene metT (YP_892765) was found in the Cfv 
pseudomolecule positioned 1,605,092-1,603,530 bp  (Contig1155) a region also 
conserved in Cff; and (c) the putative VirB6 protein gene was found in a number of 
Cfv contigs, these include contigs with ORFs not in common with Cff Contig1023 
and Cfv specific Contig1165, Contig733, Contig875  and Contig958.  
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Cfv contigs were searched for the ISCfe1 insertion containing sequences 
(AM260752, AM286430, AM286431 and AM286432). All the ISCfe1 sequences 
aligned to Contig993 (39-1464 bp) with greater than 90 percent identity. Contig993 
Cff position is indicated in Figure 4.2. The ISCfe1 genes tnpA and tnpB matched 
Contig993 orf1 partial transposase A (Cfv) (14-157) and Contig993 orf2 
transposase B (Cfv) (144-1436). Upstream ORF regions in Contig993 are: 
Contig993 orf3 anaerobic C4-dicarboxylate transporter (Cff) 1509-1697bp; 
Contig993 orf4, anaerobic C4-dicarboxylate transporter (Cff) 1705-2493bp; and 
Contig993 orf6 which had no protein alignments 2795-2968bp.  
 
Contig875 only aligned with AM286432 (21-1235 bp) putative virulence genes with 
less than 90% sequence identity. Contig875 orf3 (499-1068 bp) partially to the 
partial putative virulence gene VirB5 and Contig875 orf5 (1302-2069 bp) to the 
truncated putative TrbL/VirB6 plasmid conjugal transfer (Cfv) gene. Downstream in 
Contig875 were Contig875 orf1 transposase OrfA (Helicobacter pylori) 30-170 bp 
and Contig875 orf2 (274-489 bp) with no protein alignments.  
4.3.6  Genomic plasmid analysis 
Plasmid-containing Campylobacter includes C. coli, C. lari, C. concisus 13826 (2 
plasmids), C. hominis ATCC BAA-381 (1 plasmid), C. jejuni subsp. jejuni 81-176 (2 
plasmids) and C. fetus subsp venerealis strain 4111/108. Complete plasmids have 
been sequenced for C. coli (6), C. lari (2), other C. jejuni strains (6) and C. fetus 
subsp venerealis (1). A direct search of these extrachromosomal Campylobacter 
plasmid sequences against Cfv specific sequence determined plasmid borne  
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genes in common between the species. Plasmid sequences from C. coli, C. 
hominus and C. jejuni represent over a third of the Cfv specific ORFs (37/90). 
These include type IV secretion system (Vir and Cmg), ParA, Ssb, RepE, 
mobilization and plasmid (Cpp and pTet) proteins (Table 4.3). Transposase genes 
were absent in the other Campylobacter spp. plasmids and found in Cfv 
Contigs1185 (2), Contig872 (1) and Contig875 (1).  The C. fetus subsp. venerealis 
plasmid pCFV108  (EF050075) contains four genes, putative mobC, putative 
mobA, repE and an uncharacterised orf3 [297]. Plasmid pCFV108 was not found in 
the Cfv contigs. A protein search however found significant alignments for 
Contig1185.orf00004 to MobA (ABK41363 489 aa) and Contig1185.orf00007 to 
RepE (ABK41364 351 aa) (Figure 4.3)   





Figure 4.3 Plasmid pCFV108 insertion elements and Contig1185 ORFs with CFV protein 
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4.3.7  COG Analysis -Virulence Genes 
The STRING database analyses identified 1141 Cfv ORFs that aligned significantly 
to STRING assigned COG functions. Comparative analysis between Cfv to the 
Cluster Orthologous groups found: 273 ORF in cellular processing and signalling a 
COG role known to contain virulence determinants; 164 information storage and 
processing; 406 metabolism; 153 poorly characterised; 87 hypothetical proteins; 
and the remaining without assignments to COG roles.   
COG role distributions for virulence ORFs can be found in Appendix 4.4.  
In putative virulence roles, 49 Cfv ORFs are involved in cell motility, 83 in cell 
wall/membrane/envelope biogenesis, 21 defence mechanisms, 25 intracellular 
trafficking, secretion and vesicular transport and 29 signal transduction 
mechanisms. 
 
To identify virulence genes unique to Cfv or other Campylobacter species and 
distinguish the two subspecies, the Cff and Cfv virulence genes and Cfv contigs 
were aligned to the Cff genome. The non-redundant protein search also identified 
virulence genes such as Cytolethal distending toxin proteins (Cdt) [150], currently 
characterised as a hypothetical protein within the non-supervised orthologous 
groupings of STRING, although previously characterized and reported [298, 299].   
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Based on COG analyses (Appendix 4.4) the following sequences were selected for 
PCR validation.  Those selected for PCR included virulence genes (including the 
Type IV secretion genes specific to Cfv) (8), flagella (6), cytolethal distending toxin 
(3), response regulator-sensor (6), membrane (4), fibronectin (1), haemolysin (1), 
Fe ABC transporter (1) and mannose-1-phosphate guanylyltransferase/mannose-
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4.3.8  PCR diagnostics based on sequence identified in Cfv 
To validate the subspecies specificity of virulence genes and Cfv specific 
sequences identified above, 31Cfv ORF sequences were selected in Cfv and 
primer sets tested using Cff and Cfv isolates (Table 4.4). Reference and type 
strains screened are described in Table 4.5 and Cfv reference strains included 4 
Cfv biovar venerealis isolates (DPI, ATCC [300], UNSAM and Pfizer) and a Cfv 
biovar intermedius (Pfizer) isolate.  Cff strains used were DPI and ATCC isolates 
as described in Table 4.5. All primers were based on the Cfv biovar venerealis 
AZUL-94 strain contig sequences except for flhA and flhB which were based on Cff 
sequence for these 2 flagella genes not identified in Cfv contigs. Conserved 
amplification of virulence genes in both C. fetus subspecies included flagella, outer 
membrane proteins, 2 component systems (response regulators and sensors), 
haemolysin, iron uptake and a fibronectin type III domain protein (Table 4.4). For 
assays based on ORFs selected as absent in Cff, contigs 1120 orf4, 1165 orfs 4, 8 
and 875 orf5 assays amplified the Cfv biovar venerealis strains but not Cfv biovar 
intermedius or the Cff reference strains.  These contigs were identified as: VirB4, 
VirB11, VirD4 and VirB6 type IV secretion system proteins respectively. Three 
assays (1023 orf2/VirB10, 1023 orf3/VirB11 and 733 orf1/VirB4) were specific for 
Cfv biovar venerealis AZUL-94 strain and did not amplify other biovar venerealis 
strains.  One of these assays Contig 1023 orf3 (VirB11) also amplified Cfv biovar 
intermedius. Cfv biovar intermedius was negative in all other ‘Cfv’ specific assays, 
which in the current study appear to be specific for Cfv biovar venerealis. 
Curiously, an assay based on 1165 orf2 (Cfv VirB9) was positive for Cfv biovar  
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venerealis AZUL-94, Cfv biovar intermedius and both Cff strains tested but did not 
amplify the other 3 Cfv biovar venerealis strains including the ATCC 19438 strain.  
All assays were specific for C. fetus subspecies, testing negative in related strains 
and reproductive disease pathogens listed in Table 4.5 including: C. coli, C. jejuni, 
C. sputorum subsp. bubulus, C. hyointestinalis, Pseudomonas aeruginosa, Proteus 
vulgaris, Neospora caninum and Tritrichomonas foetus (results not presented).  
However no single assay amplified all Cfv strains inclusive of both biovars 
venerealis and intermedius. Figure 4.4 demonstrates the specificity of selected 
primer sets Contig1023 orf2 and orf3, Contig1154 orf3 and Contig1165 orf4. 
Contig1023 orf3 and Contig1165 orf4 primers amplified sequences specific for Cfv, 
while Contig1154 orf3 primers amplified sequences in both Cfv and Cff strains.  
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Table 4.5 Reference strains tested in C. fetus PCR assays 
 
Species and subspecies  Strain  Source
1 
C. fetus subsp. venerealis  98-109383 (Biovar 
venerealis) 
Field Isolate (DPI&F, QLD)
 




C. fetus subsp. venerealis  AZUL-94 (Biovar 
venerealis) 
UNSAM, Argentina 
C. fetus subsp. venerealis  Biovar venerealis  Pfizer Animal Health 
C. fetus subsp. venerealis  Biovar intermedius  Pfizer Animal Health 
C. fetus subsp. fetus  98- 118432  Field Isolate (DPI&F, QLD)
 
C. fetus subsp. fetus  15296  ATCC 15296
 
C. coli  11353  NTCC
 
C. jejuni subsp. jejuni  11168  NTCC
 
C. hyointestinalis  N3145  Field Isolate (DPI&F, QLD)
 
C. sputorum subsp. bubulus  Y4291-1  Field Isolate (DPI&F, QLD)
 
Pseudomonas aeruginosa  27853  ATCC
 
Proteus vulgaris  6380  ATCC
 
Neospora caninum  50843  ATCC
 
Tritrichomonas foetus  YVL-W  Field Isolate (DPI&F, QLD)
 
 
1Legend: ATCC – American Type Culture Collection; NTCC – National Type Culture Collection; 
UNSAM – Universidad Nacional de General San Martín; DPI&F – Department of Primary Industries 
and Fisheries 
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Figure 4.4 PCR assay specificity for C. fetus subspecies and C. fetus subsp venerealis 
Examples of PCR assay specificity for C. fetus subspecies and C. fetus subsp venerealis 
biovars (venerealis and intermedius). Lanes numbered 1-4, N and M represent: 1 Cfv 
biovar venerealis 19438 ATCC, 2 Cfv biovar intermedius (Pfizer strain), 3 Cfv Argentina 
AZUL-94 strain, 4 Cff 15296 ATCC, N= negative no template control and M=molecular 
weight marker 100bp ladder (Invitrogen). Results are shown for assays based on 
Contig1154 orf3 (429 bp), Contig 1165 orf4 (233 bp), Contig 1023 orf2 (159bp) and 
Contig1023 orf3 (349 bp). 
 
4.4  Discussion 
 
The available Cfv genomic sequence information was aligned to the complete Cff 
genome sequence 82-40 in order to identify targets for the diagnostics for detecting 
Cfv. Based on the genome size estimates of Cfv [276, 301] and the completed Cff 
genome size, it is estimated that approximately 72% of the Cfv genome has been 
sequenced (unpublished, Prof Daniel Sanchez, Universidad Nacional de San 
Martin, Argentina). The ordering of available genome segments generally aligned 
well with the Cff genome as shown in Figure 4.2 and made evident a suite of Cfv  
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specific contigs. This suite of contigs contained a large range of type IV secretion 
factors, and plasmid/phage like proteins. A number of potential virulence factors 
were clearly identified as shared between Cfv and Cff. These virulence factors 
include an outer surface array membrane protein, chemotaxis types, motility 
associated, regulatory and secretion systems. The existence of these classes of 
genes with roles in the infection process, but not showing sub species specificity, is 
consistent with a two-tier infection model. ‘Surface/membrane components provide 
necessary (but not sufficient) structural components for attachment to host cells.  
Specific components that complete the features of the surface/membrane 
structures are required for infection’ [150]. Many genes involved in host 
colonization have been found conserved across the Campylobacter genus [150]. 
Variations that were species specific were evident for a lipo-oligosaccharide locus, 
a capsular (extracellular) polysaccharide locus, and a novel Campylobacter 
putative licABCD virulence locus (not found in available Cfv).  These observations 
are consistent with the suggestions that interactions between a pathogen’s 
surface-exposed proteins and host cells represent a pivotal step in pathogenesis 
and virulence [302]. In pathogens several of the key players are proteins involved 
in adhesion, invasion, secretion, signalling, annulling host responses, toxicity, 
motility and lipoproteins [303].  
 
Motility and chemotaxis genes have been found conserved among related 
Campylobacter species with flagella implicated in adhesion, protein secretion, 
invasion and virulence in pathogenic C. jejuni [150, 304-307]. Biosynthesis of  
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flagella requires the involvement of more than 40 structural and regulatory proteins 
including a type III secretion system for flagellar assembly [305, 307-309].  The Cff 
flhA gene based on genome alignments was found to be absent in the available 
Cfv sequence contigs, and coincided with the ordered alignment gap/non-
sequenced section relative to Cff. However, one chemotaxis regulatory protein 
campy.fasta.screen.Contig1091 orf6 appears to be absent in Cff (Appendix 4.2). A 
lower complement of homologues associated with motility in Cff (n=41) compared 
with the other Campylobacter spp. (n=55-66) [150] has been identified in this 
study. However, the analysis of the incomplete Cfv genome identified a higher 
number of homologues (n=46) than the total Cff sequence.  PCR assays based on 
a subset of flagellar genes (flgH, flhF, fliH, flhA and fhlB), demonstrated 
conservation of these sequences at least among the members of our panel of C. 
fetus strains including both subspecies (although flhA could not be identified in the 
available Cfv contigs).  An additional assay designed to amplify the flaB sequence 
of the Cfv AZUL-94 strain did not amplify other Cfv biovar venerealis strains but did 
amplify Cfv intermedius and the Cff isolates. It has not been confirmed if this is 
attributed to flaB sequence variation or an absence of the gene in different 
geographical Cfv biovar venerealis strains, this gene has been targeted however 
for genotyping studies in other Campylobacter species [310]. This study does 
confirm that the complete Cfv genome may harbour more flagellar/motility 
homologues than Cff.  Virulent C. jejuni harbours more flagellar genes than less 
virulent species C. coli, C. lari and C. upsaliensis [150].  
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Adherence of other Campylobacter species to gut epithelial cells is mediated by 
multiple adhesins including cadF (Campylobacter adhesion to fibronectin); [311], 
PEB1 protein (putative binding component of an ABC transporter), [312], JlpA 
(jejuni lipoprotein A), [313] and a 43-kDa major outer membrane protein [314], 
confirmed as conserved in C. jejuni, C. lari, C. upsaliensis and C. coli genomes 
[150].  Cfv homologues for PEB1 and fibronectin-binding (FN-binding) proteins 
were confirmed with the remaining 3 absent in the genome contigs currently 
available. However, only the PEB1 protein was identified in the complete Cff 
genome sequence 82-40.  Fibronectin is known to enhance C. fetus attachment 
[315] however in the absence of an identified C. fetus cadF homologue, it appears 
that the adherence mechanisms in C. fetus may differ from other Campylobacter 
species.  In the case of C. fetus subsp. venerealis, this is perhaps not surprising as 
Cfv colonise the genital tract and not the intestinal tract, thus perhaps novel 
adhesins will be identified with completion of a Cfv genome sequence. 
 
Toxin sequences, two component regulatory systems, plasmids and type IV 
secretion systems have also been recognised as components in pathogenic 
Campylobacter spp. [150]. Three cytolethal distending toxin (cdt) subunits A, B and 
C are confirmed as conserved across the four Campylobacter species (C. jejuni, 
C.lari, C. coli, C. upsaliensis) and C. fetus [298, 299].  In addition, the presence of 
cdt genes is linked to C. jejuni, C coli and C. fetus pathogenesis, where cdt 
negative strains were found to be less efficient during adherence and invasion in 
vitro [298, 316]. A similar survey of C. fetus will assist to confirm if a cdt positive  
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result is associated with an increase in pathogenicity.  Two-component regulatory, 
TCR, systems are commonly used by bacteria to respond to specific environmental 
signals such as temperature [146]. Five TCR systems (pairs of adjacent histidine 
kinase and response regulator genes) have been identified as conserved across 
Campylobacter species and confirmed in C. fetus subspecies.  
 
The type IV secretory genes, which are possibly involved in conjugative plasmid 
transfer or the secretion of virulence factors [150, 288, 317], were absent in the Cff 
genome and unique to Cfv. A large proportion of Cfv subspecies specific ORFs 
(30%) were harboured in the Cfv contig specific regions. C. upsaliensis and C. 
jejuni are known to harbour plasmids and evidence does suggest that these 
plasmids can play a role in pathogenesis.  One basic difference between the list of 
genes absent in Cff and present in Cfv is that many of them are in common to 
genes present on the plasmids of these related Campylobacter. The type IV 
secretion system is also found in C. jejuni, C. lari and C. coli plasmid sequence. 
The unique Cfv genome sequences also harboured many phage-like derived 
genes. The presence of type IV secretion system has also been described by Abril 
et al. in 2007 [288], of which the putative VirB6 protein gene was found to be 
truncated by the insertion element (IScfe1). It is possible that contigs within this Cfv 
unique 80Kb suite of contigs represent a number of extrachromosomal DNA 
plasmids. A wider survey of C. fetus isolates and the presence of plasmids (type IV 
secretion systems) and phage genes will assist to confirm our observations. 
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The work presented in this chapter analysis has provided diagnostic markers to 
discriminate the Campylobacter subspecies Cfv and Cff, which can be investigated 
for more general applicability in field use. Most of the Cfv assays based on the 
incomplete AZUL-94 genome sequence, showed amplification preference for Cfv 
biovar venerealis strains. The Cfv biovar intermedius strains were negative in all 
but one assay, which was otherwise positive for Cfv AZUL-94 strain only. 
Curiously, one of the assays designed to Cfv AZUL-94 strain virB9 (type IV 
Secretion gene) did not amplify other Cfv biovar venerealis isolates but did amplify 
biovar intermedius and the Cff strains tested here. However, as described above 
the Cff genome sequence (Strain 82-40) does not appear to have type IV secretion 
genes. A confounding factor in interpreting this data is that different Cff strains may 
also possess putative plasmid-borne genes and these may potentially be shared 
between subspecies and Cfv biovars.  The Cfv AZUL-94 strain could also either 
consist of a mix of the 2 biovars or represent a novel strain of Cfv. However, 
assays based on putative plasmid-borne genes have previously demonstrated 
inconsistencies when applied for subspecies identification in some regions [289].  
The parA (plasmid partitioning protein gene), [318] assay target is thought to be 
plasmid borne, however evidence for plasmids containing parA in Cfv has not been 
confirmed to date [289, 318]. Very little research has been undertaken to compare 
the Cfv biovars and the diagnostic targets reported here now need to be further 
tested in multiple field strains to assess the stability of these markers and therefore 
the genomic regions in Cfv. However, the results presented do suggest that the Cfv 
research community could benefit from the generation of full genome sequence  
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from both biovars as well as isolates from different geographical continents. Our 
results also demonstrated putative plasmid sequences are present in Cfv, absent 
in Cff, suggesting plasmid profiling and sequencing from C. fetus subspecies, 
biovars and strains will assist to confirm our findings.   
4.5  Conclusion 
 
The PCR assays have highlighted the complexity of virulence factor specificity 
within C. fetus subspecies and strains, which are probably due to plasmid borne 
gene elements. We found that most genes important for interactions between a 
pathogen’s surface-exposed proteins and host cells that represent a pivotal step in 
pathogenesis and virulence were conserved in C. fetus. These genes, although 
important, did not differentiate the subspecies and therefore were not the virulence 
factors that determined specificity. Instead we found the suite of extrachromosomal 
type IV secretion system, T4SS, vir genes specific to the Campylobacter fetus 
subspecies venerealis biovar venerealis AZUL-94 were able to consistently 
discriminate the C. fetus subspecies fetus in our PCR assays.  The results provide 
the basis for the immediate identification of additional diagnostic tools as Cfv 
genomes are sequenced to completion, to develop the definitive diagnostic tool for 
comprehensive Campylobacter fetus subspecies differentiation. An ARC linkage 
project (LP0883837) with industry partners Pfizer Australia and Gribbles Veterinary 
Pathology will now characterise and study Australian isolates of Cfv. This project 
will use an integrated genomics sequencing approach, comparative genomics plus 
molecular and phenotypic screening to improve the understanding of the biology of 
genital campylobacteriosis in beef cattle.  
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In summary the key findings from this chapter are: 1) the bioinformatics approach 
provided the direct comparison of a partially sequenced genome to another 
reference sequence to identify genome specific regions; 2) the direct comparison 
of Cfv to Cff genome sequence identified an 80Kb region for Cfv specific analysis, 
3) functional analysis of the Cfv 80Kb sequence found CFV specific virulence 
genes for diagnostics testing. 
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5  Chapter Five - Predicting gene targets in complex 
genomes: Rhipicephalus microplus target gene 
predictions for parasite control  
 
The contents of this chapter have been published [319]. Laboratory tools, 
chemistries carried out by QDEEDI, Ala Lew-Tabor and Jessica Morgan. 
5.1  Introduction 
 
Ticks are obligate ectoparasite bloodsuckers, divided into two families the 
Argasidae (soft tick) and Ixodidae (hard ticks), that can transmit a wide variety of 
pathogens both these direct and indirect effects respectively can be lethal [320].  
Tick control methods rely heavily on chemicals (acaricides), most of which target 
the central nervous system [321]. Neural-specific gene sequences are the target of 
acaricide chemicals. Increasing acaricide resistance, the contamination of 
ecosystems and food by chemical residues has led to alternative methods for 
control [322, 323]. 
5.1.1  Functional roles of genes in ectoparasite required for feeding 
 
Tick salivary glands produce a complex mixture of proteins with a variety of 
functions important for prolonged attachment and feeding to the host [324]. 
Salivary component functions include, a cement latex-like secretion for secure 
attachment, antigenic and non-antigenic proteins (lipo and glycoproteins), 
anticoagulants to inhibit host blood clotting, host anti-inflammatory agents, 
vasodilators, antihistamines and agents that suppress components of the host  
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immune system, and agents that reduce the sensitivity of the receptors in the 
host’s skin [324-329]. The host releases histamine proteins at the site tick 
attachment; the tick then secretes a histamine binding protein, HBP, that binds to 
the free histamine, suppressing the effect of the host response [328, 329]. 
5.1.2  Genomic targets for tick control 
In response to the disadvantages that come from the use of chemical products for 
tick control, research into immunological methods to control tick have been 
conducted worldwide and constitute an important biological alternative [330]. The 
inoculation of cattle with appropriate synthetic oligopeptides derived from different 
regions of a protein can induce a protective immune response against the tick 
[320]. Synthetic peptides as a vaccine are advantageous as the quality and stability 
is more assured for cattle inoculations [331]. The synthetic peptides of epitopes 
defined in the tick could elicit protective antibodies in the host [332]. 
 
A single vaccine against tick currently exists, the tick vaccine (TickGARDTM in 
Australia and GAVACTM in South America) is derived from the ‘concealed’ 
antigen, Bm86, a midgut membrane-bound protein of the cattle tick, Rhipicephalus 
(Boophilus) microplus (Rmi) [333]. Anti-ectoparasite vaccines developed that 
control tick targets such as an ‘exposed’ tick saliva antigen and cross-reacts with 
‘concealed’ tick midgut antigens have a dual target approach [334]. This approach 
of targeting antigens that are normally concealed from the host, and therefore not 
subjected to immune selection pressure [333] has been adopted in the 
development of vaccines for other ectoparasites [330, 335] . Vaccine-induced  
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immunity is usually antibody dependent [336]. In Rmi, the Bm86-derived tick 
vaccine antibodies bind to antigenic epitopes on the midgut cells of the feeding 
tick, this causes damage and leakage of blood into the body cavity, killing the tick 
or reducing fecundity [337]. The Bm86 vaccine is however only effective against 
adult and not the immature stages of Rmi tick species [338]. 
 
 
Pharmacological action of tick saliva on sera [339, 340], and the immunological 
profiles of cattle infested with Rmi based on local reactions to tick bites have been 
previously reported [341, 342]. These new approaches to the development of 
vaccines [343] have been tested including immune responses against recombinant 
tick antigen, for the development of vaccine Bm95 [344, 345]. Purified extracts of 
cement proteins secreted by tick salivary glands, infiltrate the epidermal/dermal 
layers of the host skin [346], and have been shown to be immunogenic and 
immunoprotective [347]. Anchoring tick salivary anti-complement proteins to a 
membrane increases immunogenicity [348] and antigen-specific antibody response 
in vivo to tick blood-feeding [349]. 
 
The cattle tick, Rmi, is one of the most economically important ticks affecting the 
global cattle population [350]. Rmi and its associated pathogens can be transmitted 
to cattle and lead to severe agricultural losses in milk and beef production and 
restrict the movement of livestock [351]. The most affected regions of the world are 
tropical and sub-tropical countries including northern Australia, Mexico, South  
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America and South Africa, with threats to USA cattle populations at southern 
borders with Mexico [351].  
 
The genome sizes of three species of ixodid ticks, Ambylomma americanum [352], 
Boophilus (Rhipicephalus) microplus and Ixodes scapularis (Isc) [353] have been 
estimated using DNA reassociating kinetics. The Rmi genome has an estimated 
size of 7.1 Gb, three times the size of the Isc genome (2.3Gb) [353, 354]. The Rmi 
genome is found to be composed of fold back (FB), highly repetitive (HR) and 
moderately repetitive (MR) elements, in the following proportion 0.82% FB, 31% 
HR, 38% MR, and 30% unique DNA, similar to Isc [353]. A short interspersed 
repetitive element (SINE) Ruka element, containing RNA polymerase III promoters, 
is major component of eukaryotic genomes that are particularly abundant in the 
heterochromatic compartment of vertebrates and plants as reviewed Kidwell and 
Sunter [355, 356]. SINE transposable elements have the ability to move to new 
locations based on reverse transcription prior to genomic integration. Most SINEs 
are derived from tRNA [357], although some, such as the Alu family which 
accounts for approximately 10% of the human genome, are thought to originate 
from 7SL RNA sequences [358] (see chapter 3).  It has been shown in R. 
appendiculatus that secondary structure predictions indicate Ruka could adopt a 
tRNA structure similar to a serine tRNA [355]. 
 
The Isc Genome Project (IGP) [153, 359], is the first tick genome sequencing effort 
and currently a major resource for tick comparative genomic analyses. This project  
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has influenced the rapid rise in the number of sequences for tick DNA in NCBI 
[360]. The current Isc genome draft, represented by 369,492 supercontigs, (1.7 
Gb) of linear genomic sequence, was used in this analysis to identify conservation 
with available Rmi genomic DNA.  
To provide insights into the complexity of the tick genome and identify vaccine 
targets, the following Rmi sequence resources were available for analysis.  
1)  The BmiGI Version 2 gene index [361] containing 13,643 non-redundant 
tentative consensus transcript gene sequences.  
2)  Rmi Cot reassociating kinetics genomic sequence, that has been 
demonstrated as a useful tool to explore the gene space of large genome 
species [362].  
3)  A BAC end library, created with the view to probe the Rmi genome for BAC 
sequencing [363].  
4)  A suppressive subtractive hybridization (SSH) to identify transcripts 
associated with host attachment and/or feeding, which identified both a 
large increase in rRNA transcripts thought to be associated increase protein 
production during tick feeding, and the production of a number of enzymes 
including serine protease inhibitors (Serpins) [151].   
5.2  Materials and Methods 
5.2.1  BAC end sequences 
 
Glycerol plates with BAC clones (1,125 96-well plates) were submitted to Beckman 
Coulter Genomics (Beverley, MA, USA) to obtain approximately 12,000 reads 
using bi-directional sequencing of the clones. The Beckman Coulter Genomics  
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protocol is described as follows: clones were picked from the 96 well plates, 
cultured and DNA was purified using SPRI!; following dye-terminator fluorescent 
sequencing the product was purified using CleanSEQ! with sequencing fragments 
detected via ABI3730xl capillary electrophoresis. The total 10,582 BAC end 
sequences (BES) provided as trace files from Agencourt were clipped of the vector 
(pECBAC1) with cross_match, Phrap package version 0.990329 [364]. Sequences 
greater than 500bp have been deposited GenBank GSS under HN108288-
HN118367 [365].  
5.2.2  BAC genomic DNA extraction, library construction, and BAC 
screening and sequencing 
Ticks from the Deutsch strain of R. microplus were reared at the USDA-ARS Cattle 
Fever Tick Research Laboratory in Mission, TX [366]. Genomic DNA extraction, 
library construction, and BAC screening are as described by Guerrero et al., [362]. 
5.2.3  BAC sequencing 
 
The BAC vector used was pECBAC1 and the cloning site BamHI. BAC libraries 
were sequenced using 3-4kb insert high copy shotgun library methods, aiming for 
8-fold coverage of 1,008,000 bases (high copy) using Sanger Sequencing ABI 
technology (Beckman Coulter Genomics, MA, USA). Phred 20 read lengths were 
greater than 700 bp and had pass rates: > 90% and x 6 coverage.  
5.2.4  BAC assembly 
 
The Sanger BAC sequences were assembled with Phred/Phrap [162]. The 
following tools were also tested for assembly validation CAP3 [163] and Phusion  
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[164] and MIRA [165]. The BES were mapped to the assembly with BLAT [367] at 
100% percent sequence identity. Dot plot matrices were generated using Dotter64 
[368]. Beckman Coulter Genomics (MA, USA) closed the sequence gaps based on 
pair end read linkage. The sequencing of 5 of the BACs has been reported [362], 
and the sequences from another 10 BACs have been deposited in GenBank 
(Accessions HM748958-HM748967) [365]. This chapter focuses on BAC 
sequences, BM-005-G14 (HM748961) and BM-012-E08 (HM748964). 
 
The correct orientation and ordering of the contigs was based on pair-end read 
assembly linkage results, BAC end sequence alignment positions and gene 
annotation, as comparative analysis of Rmi papilin to a number of species show 
ordered domain conservation. The final BAC sequence length with gap closure 
was 135Kb, close to the estimated restriction digest size. In BM-005-G14 a papilin 
gene was first predicted with Genscan HumanIso model from the 2 large coding 
sequences CDS8 and CDS6 (6,663 and 4,077 bp respectively), which covered all 
the papilin protein domains, except the initial 5’ end thombospondin domain. In 
addition, CDS8 contained a helicase domain (not previously identified in papilin), 
an Adam-TS-spacer 1 and the second expected thombospondin domain. CDS6 
contained all the remaining papilin domains, Kunitz (KU) domains x10, Whey Acid 
Protein (WAP), Immunoglobulin (IG) x3 set, and the final 3’end Cytoplasmic 
phospholipase A2, catalytic subunit (PLAC) domain. Direct cDNA sequencing 
confirmed the BAC data and 5’ RACE assisted to confirm the presence of the 
missing thrombospondin domain and our model subsequently proposed the  
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presence of 2 genes, the papilin and the helicase. The papilins’ coding region of 
8Kbp spanned a genomic region of 86Kbp. 
5.2.5  BES analyses  
BlastN [33] nucleotide similarity searches were conducted on the Dana Faber 
Cancer Institute (DFCI) BmiGI Gene Indices [152, 361], the IscGI [369], subtraction 
library cDNA [151] and iscapularis.preliminary.TRANSCRIPTS_JCVI-IscaW1.0.5 
and NCBI [370] datasets that  included nucleotide (nr), EST, RefSeq, GSS, and 
WGS. 
 
BlastX [33] protein similarity searches were conducted on NCBI [370] (nr, patent), 
and Ixodes scapularis peptide gene predictions 1.1 iscapularis.PEPTIDES-
IscaW1.1 protein datasets. Domain and protein family identification was conducted 
with RPSBlast, on NCBI Conserved Domain Database (CDD) [148] database. 
Genome searches were conducted with BLAT [367] to compare to the 
ixodes_scapularis_supercontigs. 
5.2.6  Gene prediction 
 
Genscan [174]  (model for human isoforms) was used to assemble the BAC 
contigs. Bioperl [371] scripts were used to parse alignments and identify conserved 
regions. The in silico workflow was designed based on open source applications 
and CCG Grid computing [372]. Appendix 5.1 contains AutoFACT [373] annotation 
for 15 R. microplus BAC sequences.  
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5.2.7  Sequence alignment and phylogeny 
 
ClustalW [34] was used for multiple sequence alignments and multiple sequence 
alignments for the manuscript were displayed in Jalview [374].  
Phylogeny analysis was conducted with the Phylip version 3.6 [375] protein 
distance algorithm and the Neighbor-Joining method [376] and a bootstrap test of 
100 replicates.  
The molecular clock test was performed by comparing the ML value for the given 
topology with and without the molecular clock constraints under the Jones-Taylor-
Thornton (1992) model [377, 378]. Evolutionary analyses were conducted in 
MEGA4 [378]. The evolutionary history was inferred using the Neighbor-Joining 
method [376]. The bootstrap consensus tree inferred from 500 replicates was 
taken to represent the evolutionary history of the taxa analyzed. The percentage of 
replicate trees in which the associated taxa clustered together in the bootstrap test 
(500 replicates) is shown next to the branches. The tree is drawn to scale, with 
branch lengths in the same units as those of the evolutionary distances used to 
infer the phylogenetic tree. The evolutionary distances were computed using the 
molecular evolution and phylogenetics method [379] and are in the units of the 
number of amino acid differences per site. The analysis involved 7 amino acid 
sequences. All base positions containing gaps and missing data were eliminated. 
There were a total of 1124 base positions in the final dataset.  
5.2.8  Repeat identification 
 
Arthropod known repeats were identified with RepeatMasker version 3.2.6 [380]. 
Repeatscout [172] was used for the de-novo identification of repeat motifs. Perfect  
  115 
tandem repeats were identified with a SSR finder Perl program written by S. 
Cartinhour, in 2000.  Sine RUKA elements were identified based on BlastN [33] 
homology to GenBank: EU018139.1 (9,947-10,084 bp), percentage identity greater 
than 84% and coverage  greater than 69%.  
5.2.9  cDNA preparation 
 
Total RNA was extracted from tick samples using the Trizol reagent purchased 
from Invitrogen Corporation, CA, USA. Tissue was ground to a fine powder using a 
mortar and pestle with liquid nitrogen and the powder transferred to a tube of Trizol 
with 1 mm glass beads. This mix was further homogenised for 45 seconds in a 
MiniBeadbeater-96 (Biospec Products, Bartlesville, OK, USA) then the RNA was 
extracted using chloroform and isopropanol. Double stranded cDNA was created 
from 25 !g of total RNA using a SuperScript™ Double-Stranded cDNA Synthesis 
Kit following Kit protocols (Invitrogen Corporation, CA, USA).  
5.2.10 Papilin PCR amplification and sequencing 
Primers based on BAC sequences were designed with EMBOSS [295] eprimer3 
[296] and a minimum GC clamp of 2. Synthesis of primer sequences was by Sigma 
Aldrich (MO, USA) and sequences are presented in Appendix 5.2 tables 2 and 3. 
The full papilin cDNA was PCR amplified from cDNA extracted from frustrated 
larvae and cloned in three steps:  
1) A 7723 bp product was amplified between primers Papilin57383F and PapilinR3 
(designed from predicted coding sequence) using the Expand Long Template PCR 
System (Roche Applied Science, Mannheim, Germany) using Expand Long  
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Template Buffer 2. This reaction was thermocycled in a DNA Engine (PTC-200) 
Peltier Thermal Cycler (Biorad Laboratories, CA, USA). The purified product was 
transformed into chemically competent One Shot
® TOP10 cells using a TOPO-XL
 ® 
PCR Cloning Kit (Invitrogen Corporation, CA, USA). For each transformation, DNA 
was prepared from six clones using a QIAprep Spin Miniprep Kit (Qiagen, CA, 
USA).  Plasmid inserts were sequenced using Big Dye Vers 3.1 technology 
(Applied Biosystems, CA, USA) and were run on an Applied Biosystems 3130xl 
Genetic Analyser (Griffith University DNA Sequencing Facility, School of 
Biomolecular and Biomedical Science, Griffith University, Qld, Australia). 
Sequences were edited and aligned in Sequencher (Vers 4.8 Gene Codes 
Corporation, Ann Arbor, MI, USA). Additional sequencing primers were designed 
manually (Appendix 5.2). 
2) The start codon for the papilin gene was determined following 5’ amplification of 
the cDNA ends from larval cDNA using the SMARTer™ RACE cDNA Amplification 
Kit as described by the kit manufacturer (Clontech Laboratories Inc., CA, USA). 
The 5’-RACE PCR used an Advantage 2 PCR kit (Clontech Laboratories Inc., CA, 
USA) using the kit 5’ RACE Universal Primer A Mix (UPM) primer and the gene 
specific reverse primer AdamSR1 designed within the Adam spacer region of the 
papilin gene (Appendix 5.2). The gel-purified product was cloned into chemically 
competent One Shot
® TOP10 cells using a TOPO
® TA Cloning Kit (Invitrogen 
Corporation, CA, USA). Clone inserts were sequenced as described above. 
3) The papilin stop codon was determined from the predicted coding sequence and 
a primer was designed anchored at the stop position PapStopR1 (Appendix 5.2). A  
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611 bp product was PCR amplified between primers Pap12440F to PapStopR1. 
The product was cloned and sequenced as described above. 
5.2.11 Papilin cloned products 
The final papilin cDNA product was 8,761 bp. This was assembled from: 1) the 5’ 
Race to the AdamS_R1 primer, product of length 867 bp; 2) the region between 
primers papilin57383F and PapilinR3, product length 7,723 bp and pap12440F to 
pap13230R direct sequence.  
5.2.12 Helicase PCR amplification and sequencing 
A second large PCR product 4886 bp in length was amplified from the larval cDNA 
between primers PapilinORFF2 and Papilin54900R. The 3’ end of the product has 
a 229 bp overlap with the papilin gene (exon 2 and 3, 5’ of the Adam spacer).  The 
product  was  amplified  using  the  Expand  Long  Template  PCR  System  (Roche 
Applied  Science,  Mannheim,  Germany)  and  was  cloned  and  sequenced  as 
described  above  for  the  large  papilin  clone.  Internal  primers  were  designed  to 
sequence the complete clone that was found to contain a helicase gene (Appendix 
5.2). 
5.2.13 BM-012-E08 PCR 
The PCR 50 µl reaction contained Advantage 2 SA PCR buffer, 10mM of dNTP 
mix, 10µM of each primer, 100ng of DNA template and Advantage 2 polymerase 
mix as recommended by the manufacturer (Clontech Laboratories Inc., CA, USA), 
Cycling Parameters (BIORAD DNA Engine Cycler). The initial denaturation was for 
2 mins at 94
oC followed by 29 cycles of denaturation 1 min 94
oC, annealing 1 min  
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55
oC, and extension 1 min 72
oC, with a final extension of 7 mins 72
oC. The 
products were visualised following agarose gel electrophoresis (1.2%) containing 
Gel Red (Jomar Bioscience Pty Ltd, SA, Australia). PCR products and purified 
plasmid DNA were sequenced using Big Dye Vers 3.1 technology (Applied 
Biosystems, CA, USA) and were run on an Applied Biosystems 3130xl Genetic 
Analyser at Griffith University DNA Sequencing Facility (GUDSF). Sequences were 
edited and aligned in Sequencher (Vers 4.7 Gene Codes Corporation). 
 
Amplified products were cloned using the pCR2.1 – TOPO plasmid vector 
(Invitrogen Corporation, CA, USA).  Transformed cells were plated on to LB 
agarose plates containing 50µg/ml kanamycin and grown overnight at 37
oC.  
Colonies were picked and cultured in LB medium broth containing 50 µg/ml 
kanamycin.  PCR reactions were performed on 1µl of the cultured broths and 
analysed by agarose gel electrophoresis to confirm insertion.  Plasmid DNA was 
purified as described above. BAC BM-012-E08 primer sequences can be found in 
Appendix 5.2. 
5.2.14 BM-012-E08 Long range PCR 
Tick genomic DNA was prepared following tissue grinding as described above for 
cDNA preparation and subsequently purified using the QIAamp DNA mini-kit as 
described by the manufacture (QIAGEN, CA, USA). The Expand Long Template 
PCR system was used to amplify the DNA under conditions recommended by the 
manufacturer (Roche Applied Science, Mannheim, Germany) in a BioRad DNA 
Engine Peltier Thermal Cycler. Direct sequencing was undertaken as described  
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above. All sequence alignment graphs were generated using Bioperl Biographics 
modules [371]. 
5.2.15 qRT-PCR analysis 
Primers were designed manually within targeted exon regions for the helicase and 
papilin transcripts described in this study (Appendix file 5.2). Methods for qRT-PCR 
analysis were described previously by Lew-Tabor et al. in 2010 [381], utilising tick 
extracts prepared from different tick organs and stages, normalised against 2 
housekeeper genes (Actin and rRNA 18S) and against a pooled cDNA sample. 
5.2.16 Cot selected genomic DNA 
To enrich for single/low-copy and moderately repetitive DNAs, the Cot filtration of 
Rmi genomic DNA was performed as previously described [362]. The two 
"conditions" are called Cot69 and Cot696. Starting DNA concentrations for both 
were 200 micrograms of sheared genomic DNA. Time for renaturation was 1 hr, 48 
min, 6 sec for sample Cot696 (Cot of 695.6) and 10 min 49 sec for sample Cot69 
(Cot of 69.56). Renaturation was conducted at 70 degrees C, at 0.03 M NaPO4. 
Sequencing results form these two Cot-selected samples have been deposited in 
GenBank SRA, submission: SRA012677.4/SID00001. 
Cot DNA 454 read sequence was mapped to the BAC sequence using the Newbler 
GS-FLX reference mapper, version 2.0.00.20 [166], and BLAT [367]. The total read 
number was counted for each BAC window size 100bps (read number per 100 bp 
window). The percentage (read number per 100 bp window) / (Total BAC read  
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count) was then plotted for each BAC. The gnuplots were calculated by (Sum bp 
depth / window size) / (Sum total bp depth / BAC length). 
5.3  Results 
 





Figure 5.1 bioinformatics overview for the identification of genomic vaccine targets in R. 
microplus. BES = BAC end sequence, Cot DNA = sequenced DNA that has been filtered 
by reassociating method Concentration/time, HTP-VI = High Throughput Vaccine 
Identification workflow component. 
 
Further detail for the High Throughput Vaccine Identification (HTP-VI) 
bioinformatics workflow, shown boxed in green in Figure 5.1, follows in section 
5.3.7, and vaccine target (boxed in red) detail follows in section 5.3.8.  
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5.3.2  Genome sequence via BES and Cot DNA 
 
Due to the large extent of repeats in Rmi genome (70%), a reassociation kinetics 
approach for partial genome sequencing was applied. Total Rmi genomic DNA was 
prepared and processed by two Cot filtration experiments to enrich for single/low-
copy and moderately repetitive DNAs. Cot-filtered DNA was sequenced using 454 
FLX pyrosequencing. Two Cot filtrations, Cot696 and Cot69, were enriched for 
single or low-copy (LR), and moderately repetitive (MR) DNAs respectively [362]. 
The aim was to isolate all genomic DNA that did not reassociate by Cot value of 
696 M.s. and 69 M.s. The resulting ssDNA was used to make dsDNA by second 
strand synthesis and then digested to enrich for DNA fragments of sizes (250 to 
600 bp) suitable for 454 FLX sequencing [362]. Starting DNA concentrations for 
both conditions were 200 micrograms of sheared genomic DNA. Time for 
renaturation was 1 hr, 48 min, 6 sec for sample Cot696 (Cot of 695.6) and 10 min 
49 sec for sample Cot69 (Cot of 69.56). The two Cot short read data have been 
deposited in GenBank SRA, submission: SRA012677.4/SID00001. The two Cot 
filtrations were then used to estimate the frequency of a single full length Rmi 
RUKA element sequence in the genome to be at least 152,923 copies (discussed 
in further detail in section 5.3.8). 
 
Over 10,582 BAC ends sequences (BES) (7,290,530 bp) were produced; this is the 
first BES project for Rmi. Those BES greater than 500bp have been deposited in 
GenBank GSS as accessions HN108288-HN118367.   
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The two Cot experiments and BES were then reassembled with a previous cot 
experiment [362], this Whole Genome Shotgun project has been deposited at 
DDBJ/EMBL/GenBank GenBank:ADMZ00000000 [382]. Sixty nine percent of the 
BES assembled with the Cot DNA. 
The BES were comparatively analysed to the Isc representative genome 
comprising 369,492 Isc scaffolds (supercontigs), 58 Rmi BES aligned with greater 
than 80% BES coverage and 80% percent identity. The number of BES found in 
comparative databases searches at specified thresholds are, 2,418 (25%) at an 
expected alignment value (e-value) of 1e-05 to NCBI protein [370], 416 (3%) at an 
e-value 1e-20 to Isc proteins [97, 98], 2,559 (24%) BES at an e-value 1e-20 to Rmi 
gene indices [152], and 134 (1.2%) to Isc gene indices [369] at an e-value 1e-20. 
 
5.3.3  BAC Analysis 
 
In order to select BAC clones for sequencing, BAC end sequences (BES) were 
assessed against the complete protein resource at NCBI, the Rmi EST mixed 
library at the DFCI's Gene Indices, BmiGI [152, 361] accounting for approximately 
14,000 tentative consensus transcripts [383]. This identified Rmi transcripts 
associated with host attachment and feeding of larval, adult female and adult male 
ticks from a suppressive subtractive hybridization (SSH) study [151]. Ten BAC 
clones were selected for sequencing and de-novo assembly [382], based on the 
above comparative analyses for hybridization to known transcripts of interest 
involved in tick feeding. These BACs have been deposited in GenBank 
(Accessions HM748958-HM748967) [382]. Figure 5.2 shows the graphs for 15  
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BAC sequences (10 BACs [365] and 5 BACs [362]) the Cot DNA frequency and 
GC content plotted over 1000bp window and 100bp step size. Figure 5.3 
summarises the BAC sequence (x15) [362, 365] and gene predictions (CDS). The 
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Figure 5.3 Gene predictions and preliminary annotation for 15 Rmi BAC sequences. 
Shown for each BAC are, mRNA CDS as light blue glyphs, and the contig assemblies as 
dark blue glyphs. 
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Two BAC sequences were then selected for more in-depth analyses as follows.  
5.3.4  Selection of BAC clones for gene content: Serpin and rRNA 
In order to select BAC clones for sequence closure, BAC end sequences (BES) 
[382] were assessed against, the NCBI CDD [148], the BmiGI [152, 361] [383], and 
the SSH transcripts [151] (Appendix 5.3). The BAC clone BM-005-G14 
(GenBank:HM748961) was identified in the BAC end analysis with significant 
alignment to a serpin conserved domain (CDD) [148] cd00172, and BmiGI [152] 
transcript TC24850. The second BAC BM-012-E08 (GenBank:HM748964) was 
selected and sequenced based on significant alignment to Rmi EST sequence 
BEAE880F/R, a transcript highly expressed in tick responding to cattle [151].  
The following result section describes the genomic; gene and comparative 
analyses for the BAC sequences BM-005-G14 and BM-012-E08. 
The following section 5.3.5 details the analyses for BAC BM-005-G14 a low 
repetitive, gene rich genomic region. 
5.3.5  BAC BM-005-G14 assembly and analysis 
The BAC clone BM-005-G14 was sequenced at 6.7x coverage (1,536 Sanger 
reads, insert size 135Kb). The reads were de novo assembled with phred/phrap 
[364] into six contigs greater than 2Kb and length 136,422Kb. The BES positioning 
in two contigs confirmed the correct contig assembly. The final contig set was 
ordered and oriented by read linkage results, BES positioning and gene 
annotations. The BAC sequence was finished with gap closure into a 135Kb 
genomic sequence (GenBank:HM748961). Gene prediction and comparative  
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analysis identified regions of similarity to seven genes displayed in Figure 5.4. The 
forward strand contained: a papilin with a CDS length of 8,361bp consisting of forty 
exons that span BAC sequence position 2,190 to 88,307bp; a helicase with a CDS 
length of 4,800bp consisting of four exons that span BAC sequence position 6,015 
to 14,766 bp; a hypothetical protein (H1) with a CDS length of 2,394bp consisting 
of eleven exons that span BAC sequence position 93,878 to 10,9076 bp. On the 
complementary strand; a pogo transposable element with a CDS length of 615bp 
consisting of three exons that span BAC sequence position 49,728 to 50,977 bp; a 
hypothetical protein (H2) with a CDS length of 720bp consisting of two exons that 
span BAC sequence position 110,728 to 111,698 bp; a hypothetical protein with a 
CDS length of 2,931 bp consisting of eleven exons that span BAC sequence 
position 112,452 to 122,035 bp.  The hypothetical protein was conserved to Isc and 
similar to an endonuclease reverse transcriptase (ERT) in Bos taurus, the 
predicted CDS also contained a serpin domain (see later serine protease inhibitor 
result section). A final serpin with a CDS length of 2,766 bp consisting of ten exons 
that span BAC sequence position 123,297 to 133,688 bp (Figure 5.4).  
 
Two genes of particular interest to the study were the serine protease inhibitor 
(serpin) (cd00172), originally targeted to select this BAC sequence, and the large 
multiple domain papilin gene spanning approximately 90Kbp of the 135Kb BM-005-
G14 BAC sequence. The papilin, an extracellular matrix glycoprotein that shares a 
conserved protein domain order in orthologous genes was then selected for further 
investigation.  
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Figure 5.4 BAC BM-004-G14 (135 Kb) gene structure and Cot sequence frequency. 
Genes and Ruka elements (R1-R6) are displayed over a heatmap of Cot sequence 
frequency (log2), blue (low) = 0 and red (high) = 10, genes include a papilin, a nested 
helicase-like protein, a pogo element protein, two hypothetical proteins, an endonuclease 
reverse transcriptase protein and a serpin. Low complexity sequence is shown over the 
heatmap (green arrow). Exon overlaps are circled in read. 
 
5.3.5.1  Papilin and Helicase cDNA: resolving nested genes 
The final papilin product of 8,761 bp, was merged from three cloned products, the 
5’  Race  to  primer  AdamS_R1  product  length  of  867  bp,  primer  regions 
papilin57383F to PapilinR3 product length 7,723 bp and pap12440F to pap13230R 
direct sequence product length 813 bp (primers can be found in Appendix file 5.2). 
The conserved domains are as follows: a Thrombospondin type 1 protein (TSP) 
domain  (pfam00090)  positioned  349-510  bp,  an  ADAM-TS  Spacer  1  positioned 
823-1167 bp (pfam05986), a set of four TSP domains in sequence positions 1204-
1371,1387-1548,1561-1737,1724-1896  bp  (pfam00090);  ten  BPT1/Kunitz  family 
domains (KU) (cd00109) serine protease inhibitors can be found at positions 4654-
4815,4831-4992, 5008-5169, 5185-5343, 5371-5532, 5545-5706, 5749-5907,5920-
6081,6121-6279,6355-6510  bp;  a  whey  acidic  protein-type f o u r -disulphide  core  
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domain  (WAP)  (pfam00095)  in  position  6901-7065  bp;  a  set  of  three 
immunoglobulin family (IG) (pfam07679) domains in positions 7198-7434, 7447-
7680, 7864-8979; and a final protease and lacunin domain (PLAC) (pfam08686) 
positioned in the 8110-8208 bp region.   
 
Nested in intron 2 of the papilin, and on the same coding strand, is the helicase 
gene.  This helicase gene overlapped exon regions with papilin exons 2 and 3 
(Figure 5.1). Helicase exon 3 position 9,987-10,727 bp and papilin exon2 position 
10,625-10,727bp share 102 bp. The second shared exon region of 86 bp length 
was located between helicase exon4 position 14680-14766 bp and papilin exon3 
position 14,680-14,813 bp. The shared overlap regions, circled in red in Figure 5.4, 
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5.3.5.2  Papilin and Helicase qRT-PCR: gene expression in tick life stages 
The expression of the papilin and helicase were determined in a number of tick life 
stages. The gene expression fold change relative to pooled cDNA for a number of 
life stages were tested for both papilin and helicase genes. In quantitative real-time 
PCR (RT-PCR) analysis, it was demonstrated that expression of the papilin gene 
(grey bar) was the strongest in tick larvae sensing and trying to attach to the host 
(Figure 5.6). The helicase (white bar) shows greatest up regulation in the ovaries of 
female ticks semi-engorged (17days old) attach to the host. The papilin (grey bar) 
also showed differential up regulation in the ovaries. RT-PCR confirmed differential 
expression between these two genes in at least two tick life stages tested.  
 
As the papilin had increased expression in tick larvae sensing and trying to attach 
to the host, sequence level differences were examined between ixodid (tick) and 
mammalian (host) species for this gene, which is important in host and tick 
interaction.  
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Figure 5.6. Summary of helicase and papilin qRT-PCR fold change expression in tick life 
stages relative to eggs, graph bars are helicase (white) and papilin (grey). 
 
5.3.5.3  Tick papilin comparative studies: Identifying tick-specific 
sequence differences 
 
The mRNA sequence for C. elegans (NM_072616.3), D. melanogaster 
(NM_176574.2), A. mellifera (XM_396472.3), I. scapularis (preliminary data set 
cDNA jcvi 0.5 set 35859.m000024) and B. taurus (XM_002700672.1) was 
summarised to view domain differences, see Figure 5.7. The domain structure and 
number was closely conserved in the invertebrate species. Of interest however, the 
helicase domain nested in Rmi was also found in the Isc. The Isc papilin sequence 
is not found, and it is not clear why this is the case, in the later release 1.1. The 
number of conserved domains differed the greatest in Bos taurus (GenBank: 
XP_002700718.1) as compared to Rmi. The full papilin protein multiple sequence 
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in Appendix file 5.4. These differences in domains include an extra full TSP domain 
and two fragments highlighted in blue in Rmi, a single bovine BTI/Kunitz serine 
protease inhibitor compared to the set of ten in Rmi (red) and the absence of a 
WAP domain upstream of the IG-set. The multiple protein sequence alignment of 
Rmi 2,180-2,335 bp, human (sp|O95428.4) 999-1,046 bp and bovine 963-1,009 
(XP_002700718.1) displays the WAP domain region, boxed in blue in Rmi (Figure 
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Multiple sequence alignment [34] and phylogeny analysis [375] produced a 
mammalian clade for Bos taurus (XP_002700718.1) and Homo sapiens 
(NP_775733.3) and a tick clade for Rmi and Isc (35859.m000024_1 ), a hexapod 
clade for D. melanogaster (NP_788752.2 ) and Apis mellifera (XP_396472.3) and a 
single node for C. elegans (NP_505017.1 )  as shown in Figure 5.9A. Evolutionary 
analyses shows that mammalian (host) papilin diverge at an earlier time than the 
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The serpin downstream of the papilin on the negative strand was next investigated, 
to identify if the Rmi papilin-serpin gene synteny was conserved in other species. 
5.3.5.4  Serine protease inhibitor: Serpin pseudogenes 
Downstream of the papilin gene, a full CDS for serpin was predicted. The predicted 
serpin domain structure, however, was fragmented with the N-terminus and C-
terminus rearranged, exon2 residues 266-364 and exon9 1-63 residues. Attempts 
to sequence the serpin cDNA resulted in a 500bp product. A single PCR product 
based on forward primer (SerpF3) in exon5 and reverse primer (SerpR2) in exon9 
was sequenced (Appendix 5.5). The small product sequenced matched only 148 
bases of predicted exon5 and 231 bases of predicted exon9 (exons 6-8 were not in 
alignment). Conserved serpin domain analysis found also two fragments in 
predicted ERT gene exon2 residues 115-189 and exon4 residues 185-364. To 
determine whether the adjacent position of a serpin with papilin is common, a 
search of mosquito, fly genomes and Isc found no evidence of a serpin 
downstream from the papilin indicating this arrangement as not conserved within 
arthropods.  
5.3.5.5  BAC and Cot comparison: element genome wide frequency 
estimation 
To gain better insight to genomic structures a Cot DNA comparison to the BAC 
sequence was undertaken. DNA reassociating kinetics based Cot filtration of 
genomic DNA was used to reduce the concentration of repetitive DNA sequences 
that dominate the Rmi genome, in order to analyse the "gene-rich" single/low-copy 
and the moderate repetitive DNA fractions [362, 384].  Two fractions of moderate  
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to low repetitive regions of Rmi’s genome were selectively obtained from Cot 
filtration [362] and then analysed with BM-005-G14 BAC sequence, to assay the 
frequency of specific BAC sequence within the entire genome. Cot696 and Cot69 
DNA 454 sequences were mapped to BM-005-G14 to determine the frequency that 
the BM-005-G14 sequences were found in the Cot selected fraction of the tick 
genome. The read depth in a 100bp window over total mapped read (bp) was 
calculated and the log2 value plotted as a heatmap (Figure 5.4). Six SINE Ruka 
elements [355] (R1-R6) were identified in BM-005-G14 (Figure 5.4) at positions 
16,283-16,459, 37,204-37,398, 50,357-50,535, 83,819-83,996, 102,593-102,771, 
126,277-126,452, the Pogo gene appear in the white-red bands, and (as expected) 
low frequency papilin and serpin in blue bands. Other regions of high frequency 
were identified as a 321bp ATCT repeat positioned at 4,864-5186 and, a 124bp 
TTTC repeat positioned at 878-1,004bp and 241bp CAA repeat in region 122,719-
122,961, these are shown as green arrows over the heatmap in Figure 4.4. The 
overall estimate of BAC sequence coverage was 38.80% and 41.59% respectively 
for Cot 696 and Cot 69.  
 
Based on the proportion of mapped reads relative to the total sequenced reads 
from the two Cot DNA experiments the genome wide frequency of a single 195bp 
Ruka element (R2) at position 37,204-37,398 was estimated based on the 
extrapolation of the two Cot fractions back to time zero to represent 0.42% (29Mb) 
of the 7.2Gb genome (Appendix 5.6). Although this estimate is approximate, the 
frequency of this specific Rmi Ruka element in the genome is estimated to be at  
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least 152,923 copies.  
 
5.3.6  BAC BM-012-E08 assembly and analysis 
The BAC clone BM-012-E08 was sequenced (1536 Sanger reads) at an expected 
size based on restriction digest of 65Kb (not shown). Due to the complexity of BM-
012-E08 BAC, the assembly metrics were tested to de-convolute the sequences 
(Appendix 5.7). In summary, a conservative assembly approach [165] assembled 
less reads and produced more singletons but increased the length of the total 
assembly. BM-012-E08 was assembled into a 52Kb consensus based on 18 
contiguous sequences greater than 1kb in size.  
 
As very few arthropod retroelements and a large percentage of small RNA (17%) 
were identified with RepeatMasker [380], eight de novo interspersed repeat motifs 
were identified and masked for gene predictions. An almost complete, 18S 
ribosomal RNA gene, internal transcribed spacer 1 (ITS), 5.8S ribosomal RNA 
gene, ITS 2, and 28S ribosomal RNA gene, was identified by best sequence 
similarity to Amblyomma americanum (GenBank AF291874) (Appendix 5.8A). In 
the assembly, there is evidence of at least three ribosomal 18S 5’ and 28S 3’ units 
(Appendix 5.8B). In Figure 5.10, the rDNA BAC positions are shown as blue 
arrows, BAC end positions in green, and the intergenic regions in brown. The 
remaining sequence not accounted for contained repetitive DNA sequence, similar 
to the highly repetitive intergenic regions found between the repeating rDNA units. 
In Figure 5.8, the dot matrix of the best (parsimonious) ordered and oriented  
  143 
contigs display three rDNA units and repetitive intergenic regions aligned against a 




















































































































































































































































































































































































































































































































































  146 
 
The junction of the repeat motifs and the rRNA were tested by PCR, direct 
sequenced and clones sequenced to validate sequence and assembly accuracy. 
Three BAC repeat junction positions were confirmed by PCR and shown in Figure 
5.11 as red markers on the horizontal axis of the dot plot (17K, 22K and 38K). 
Primer sequences and gel pictures can be found in Appendix 5.2 and Appendix 5.9 
respectively. The marker 22K downstream of the 28S unit in the large repeat 
region (dark blue glyph) was confirmed by PCR, (lanes 1 and 2, Appendix 5.9A). 
The marker 38K upstream of the 18S unit in the large repeat region was also 
confirmed by PCR (Lanes 5 and 6 Appendix 5.9A). Marker 28K confirmed the 
region downstream of the 28S unit in the smaller dense repeat region in contig6, 
shown in Figure 5.11, this is repeated in contg-rep_c50 and contig1.  
5.3.6.1  Ribosomal DNA (rDNA) structure analysis 
At least three full ribosomal 18S and 5.8S repeat units could be ordered although 
the 28S unit assembly was partial in the first repeating unit1, and in unit 3 
contained a break point ITS (1Kb) as compared to the Ambylomma americanum 
rRNA sequence. The rDNA repeat elements and ribosomal units were then tested 
by PCR to validate the gene size and to reveal more detail on the rDNA repeat unit 
and a putative interrupter sequence in LSU sequence that had previously been 
identified in the Drosophila genome [385]. Long range PCR confirmed rRNA unit 
size of 7-8Kb (lane 2) and a large intergenic repetitive region of 8-9Kb (lane 6) 
(Appendix 5.9B). The 28S breakpoint/ large interrupter region could not be 
confirmed by PCR, position is highlighted yellow in Figure 5.11 (~42Kb), tested  
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primer sets 15K and 18K can be found in Appendix 5.2. The BAC assembly and 
long range PCR confirmed the rRNA unit size of 8Kb and a large intergenic 
repetitive region of at least 9Kb. The Rmi 18S sequences were then analysed for 
tick specific differences. 
5.3.6.2  Tick ribosomal DNA comparative studies: Identifying tick-specific 
sequence differences 
To identify sequence differences in rRNA protein binding sites the 18S small 
subunit (SSU) was aligned to the 16S E. coli SSU and bovine18S. 
Three E. coli complex binding sites [386] were analysed and a number of sites with 
conserved changes in tick as compared to mammals were found. Sites were also 
identified conserved in E. coli and mammals, and a conserved change found in tick 
(Figure 5.12). 
 
In Figure 5.12, regions for rRNA protein binding [387] have been highlighted to 
identify regions of differences in E. coli 16S (Embl: X80725) and tick and 
mammalian 18S sequences. Represented in the multiple sequence alignment are 
five tick species, A. americanum (GenBank:AF291874.1), A. glauerti 
(GenBank:AF115372.1), A. variegatum (GenBank:L76346.1), A. tuberculatum 
(GenBank:L76345.1), A. maculatum (GenBank:L76344.1) and R. microplus 18S 
RNAmmer prediction [388], the tick host B. taurus (GenBank:DQ222453.1) and H. 
sapiens (GenBank:NR_003286.2). Protein binding sites are highlighted in the 
following E. coli sequence regions: S7_S9_S19 complex (red) 936-965, 972-991, 
1208-1262, and 1285-1379bp; S8_S15_S17 complex (orange) 118-240, 576-606, 
629-685 and 706-769; S8_S17 complex (green) 1406-1442 and 1462-1494bp  
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[386]. The multiple sequence alignment and annotation can be found in Appendix 
5.10. The protein rRNA binding site for protein S7 in E. coli (1236-1240, 1373-
1383bp) shows a single SNP between the tick and mammalian sequences 
(Appendix 5.10). In Figure 5.9 an overview of Appendix 5.10 alignment is shown 
centre, the alignment subset (bottom blue box) shows a highly conserved region 
between 18S and 16S sequences (R. microplus 1122-1160bp) with an example 
conserved SNP change G->A in tick, this was confirmed in all three 18S units. The 
alignment subset (top box) (R. microplus 791-818bp) shows more sequence 
differences for the E. coli S8_S15_S17 binding complex region. In the Rmi 18S 
sequence, a total of 63 Rmi nucleotide positions showed conservation in all tick 
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To examine if this BAC sequence had the same variation at the R2 retrotransposon 
target site of the LSU [389], the Rmi rDNA LSU positioned at 19240-23971 bp (19K 
unit) and 35316-40798 bp (35K unit) were aligned. The specific variation of 
conserved SNPs guanine (G) and thymine (T) previously found for Ixodidae 
(hardback ticks) were confirmed, at positions 2,800 bp (G) and 2,801 bp (T) for the 
19K unit and 2,873 bp (G) and 2,874 bp (T) for the 35K unit. No R2 retroelements 
were identified, a small fragment of LINE/R1 element TRAS9_SC was however 
found in the 35K unit at position 1,801-1,889 bp. 
5.3.6.3  BAC and Cot comparison: element genome wide frequency 
estimation 
To estimate the genome wide frequency of elements in this highly repetitive BAC, a 
single Cot fraction Cot 696 was used to align to BM-012-E08. The reads were 
mapped to the BAC sequence at 100% identity and 90% read coverage, shown 
beneath the dot matrix in Figure 5.11. Reads could not be aligned to the densely 
repetitive rDNA intergenic regions, it was also noted that the short interspersed 
Ruka element found in BM-005-G14 was absent in BM-012-E08.   
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5.3.7  Bioinformatics workflow for vaccine candidate identification 
Effective and automated analysis of transcriptome sequences is critical with the 
advent of next-generation sequencing. This is even more of a challenge when 
dealing with largely uncharacterized tick transcriptome, and without a reference 
genome. In the absence of high throughput (HTP) bioinformatics pipelines for 
vaccine candidate identification (VI), a novel pipeline was constructed to identify 
vaccine candidates for bovine tick resistance using a global transcriptome 
approach. Figure 5.13 shows the bioinformatics workflow steps to prepare the data 
for high through put analysis for vaccine identification.  
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Figure 5.13 Workflow steps to prepare data for peptide analysis. The blue-boxed steps 
prepare the data for the green-boxed HTP-VI bio workflow to identify the vaccine targets 
(red box).  
 
 
HTP-VI pipeline draws together many bioinformatics processes for the fast and 
effective screening of sequences (including unknowns) based on a selection of 
protein properties to identify candidate genes for vaccine development (Figure 
5.14).  
 
To identify vaccine candidates for susceptible cattle, the complete DFCI BmiGI 
dataset of expressed genes for tick, and selected BAC genes from BM-005-G14  
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were screened. The database was annotated for domain & protein family 
identification, cell localization and host homology to ensure that an autoimmune 
response in the host would not occur. Candidate selection was based on protein 
localization (surface exposure), function (those functions being important to 
maintain pathogen feeding on the host), the availability of peptide epitope regions 
(correct residue physicochemical properties), no homology to bovine, and the 
unknowns that met criteria other than function. Selected candidates were clustered 
for B-Cell linear epitope predictions based on conserved domains in ‘knowns’ and 
predicted ORFs in ‘unknowns’.  
 
In over 14,600 sequences, HTP-VI identified 250+ vaccine candidate sequences 
that clustered and grouped into 41 known protein families and 58 unknown. To test 
the surface exposure of predicted epitope peptides, a large protein family with a 
highly conserved domain, the Histamine Binding Proteins (HBP), was selected for 
protein 3-D modeling. Further detail can be found in 5.3.8. 
 
HTP-VI effectively identified candidate genes in an under characterized genome for 
vaccine development. This is the first bioinformatics approached developed of this 
kind and on this scale. The identified pathogen peptides have been validated in 
host sera, and have entered vaccine trials. 
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Figure 5.14 High ThroughPut Vaccine Identification bioinformatics pipeline, HTP-VI. 
5.3.8  Vaccine candidate tests  
 
Out of the 250+ candidates identified, based on qPCR and microarray analysis a 
total of 81 candidates were selected. A total number of 1800+ epitope regions with 
a peptide length greater than or equal to 8 residues were predicted for the BAC 
genes and BmiGI, conserved subsets were then screened in sera and 14 
candidates selected for animal trial [381]. Focusing on 48 BAC peptides tested in 
sera, the following three genes papilin, serpin and tetraspanin tested positive. In 
Table 5.1, 6 tested positive in susceptible sera only, 2 tested positive in resistant 
sera only, and 8 tested positive in both susceptible and resistant sera.  
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A small number of candidates were supported by proteomic analysis conducted on 
unfed larvae [390] and microarray analysis in an acaracide-inducible gene 
expression experiment [339]. 
Table 5.1 IgG Bovine sera B-Cell peptides results for BAC genes papilin, serpin and 
tetraspanin 
 
Label  Peptide  Sera result 
Papilin1  GCCPDGETPAEGPDNE  Positive susceptible 
Papilin 2  GCCPDGRTPARGPEYDG  Positive resistant  
Papilin 3  CHGNNNRF  Positive resistant and susceptible 
Papilin 4  GGCQGNANNFATEDECS  Positive resistant and susceptible 
Papilin 5  GCDGNENN  Positive resistant and susceptible 
Papilin 6  GGCEGNDNRF  Positive resistant 
Papilin 7  CGGNRNRF  Positive susceptible 
Papilin 8   ELNCKPRG   Positive susceptible 
Papilin 9  AMSDGGEYSCQADNGHSNQS  Positive resistant and susceptible 
     
Serpin bac  RWNTPFDPCRTVPGDFH  Positive resistant and susceptible 
     
Tetraspanin_bac_139_189 
Tetraspanin 3.2 
TSTPPNRSAYTTENREE  Positive resistant and susceptible 
Tetraspanin 3.3   YTTENREEGGEHGPGVP   Positive susceptible 
Tetraspanin 3.4   GEHGPGVPPPGATPLMR  Positive susceptible 
Tetraspanin 3.5   PGATPLMRNETKTPEGE  Positive susceptible 
Tetraspanin_bac_28_38 
Tetraspanin 2.1 
VPAFQEDEGAV  Positive resistant and susceptible 
Tetraspanin_bac_45_53 
Tetraspanin 3.1 
RDKRPKEHV  Positive resistant and susceptible 
 
In the HBP family cluster of 48 sequences, the lipocalin sub families are 
represented. The phylogenetic tree in Figure 15.15 shows the clades for lipocalin 
and HBP sequences. Based on a single clade HBP sequences were selected for 
high conservation and epitope properties (Figure 5.16). The epitope prediction for 
the histamine binding protein family cluster of conserved sequence was then 
shown in a 3-D protein structure.  
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Figure 5.15 Phylogeny of Histamine Binding Protein (HBP) family for epitope conservation 
analysis, the red vertical line defines the clade colours  
 
 
Figure 5.16 Histamine binding protein conserved epitope prediction 
 
The Rmi 3-D sequence structure was modelled on the R. appendiculatus  “Rhiap 
PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN) lipocalin” which 
has two chains 1QFT.pdb chains A and B. The structure 3-D modeller template  
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was based on 1QFT and 1QFV and query TC17517 (Figure 5.17) using the iMOL 
application [391]. Figure 5.17 (A) shows the 3-D protein structure for female 
histamine binding protein 2 and the predicted HBP family conserved epitope 
peptide domain (blue in alpha chain and red in beta chain) that are surface 
exposed in Rmi. Figure 5.17 (B) shows the 3-D HBP structure in R. appendiculatus 
(left) and R. microplus (right) with the conserved epitope regions in sphere atom 
style. 
  159 
 
 
Figure 5.17 (A) 3-D Histamine binding protein surface-exposed conserved epitope shown 
as blue in alpha chain and red in beta chain 
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Figure 5.17 (B) R. appendiculatus (left) and R. microplus (right) 3-D HBP with conserved 
epitope regions in yellow sphere atom style. 
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5.4  Discussion 
 
In the absence of a reference genome we describe the de novo assembly and in-
depth analysis of two Rmi BAC clones, selected for gene content important for tick 
growth and development. In this study of two very different BAC regions newly 
reported features for eukaryotes and Chelicerate genomes are described. The 
following discussion sections address the study of both the selected BAC 
sequences. 
5.4.1  Tick genomic structure: assembly and predictive models 
 
The correct assembly of the tick genome is a challenge due its repetitive nature, 
and the lack of predictive models for gene structures. The Cot DNA assembled 
with 70% of the BES, this confirmed the composition of Cot selected DNA for the 
moderate repetitive and unique portions of the genome. The BAC assembly, due to 
low genome level synteny with the Ixodes scapularis assembly, depended on the 
comparative analysis of transcript and the positioning of BES. 
The correct assembly of the BM-005-G14 contig set was dependant on the correct 
BES positioning, while the ordering and orientation was aided by the BES 
positioning and transcript alignments. 
 
Given the complexity of BM-012-E08, different assembly tools were trialled under 
different options. Assembly tools with uniform read distribution take a cautionary 
approach in contig building, and sometimes create two contigs when it could have  
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created one. This feature reduces over-compression of repeats during the contig 
building phase and ensures that, for example rRNA stretches which are present 
multiple times in a the genome will also be present approximately the same 
number of times in the result files [165]. The repeat motifs, intergenic regions, 
rRNA sequences and rDNA unit size were confirmed by PCR. However the 
assembly gaps and insertions show clear deviations from the perfect repeat unit 
size. This is the first Rhipicephalinae assembly of rDNA and the first known attempt 
at assembly in Arthopoda of three external intergenic repetitive units between the 
rDNA repeating subunits.  
 
5.4.2  Tick gene structure: predictive models 
 
The complexities of gene predictions included intronic regions of nested repeat 
elements, multiple short exons and overlapping regions complicating the 
delineation of exon coding regions. Overlapping genes have been reported in 
Drosophila but these genes were on different strands [392]. In eukaryotic research 
this is the first description of same strand gene overlap between two genes, papilin 
and helicase.  
 
Papilin is an extracellular matrix glycoprotein. In Drosophila, papilin is found to be 
involved in, (1) forming thin matrix layers during gastrulation, (2) matrix associated 
with wandering, phagocytic hemocytes, (3) basement membranes and (4) space-
filling matrix during Drosophila development [393]. The gene is also essential for  
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normal embryonic development in Caenorhabditis elegans [394]. It has been 
reported that inhibiting papilin synthesis in Drosophila or Caenorhabditis causes 
defective cell arrangements and embryonic death. Ectopic expression of papilin in 
Drosophila causes lethal abnormalities in muscle, Malpighian tubule and trachea 
formation. It has been suggested that papilin influences cell rearrangements and 
may modulate metalloproteinases during organogenesis [393-396]. 
 
This is also the first Chelicerate full-length papilin cDNA sequence produced. Our 
papilin gene model (refer to methods) was confirmed by other arthropod species. 
The papilin-nested helicase was also found within the Isc genome supercontigs 
(version 1) and this inclusion of the helicase shows a level of gene synteny is 
present in this region between the two distant hard tick species. 
 
The function / activities of papilin relate to the following specific domains. An 
interesting gene domain complex the tick derived Kunitz type inhibitors act as 
antihemostatic factors [397]. Hematophagous organisms must overcome host 
hemostasis in order to locate blood and maintain its flow during ingestion [398]. 
Salivary components produce antihemostatic, anti-inflammatory, and 
immunosuppressive effects that may facilitate feeding, as well as transmission of 
tick-borne pathogens [398]. The number of Rmi KU domains (x10) present 
compared to bovine (x1) indicates, based on this domains function, an important 
change in this genes structure for tick survival.  
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The whey acidic protein-type four-disulphide core domain (WAP) has protein family 
members that include the whey acidic protein, elafin (elastase-specific inhibitor) 
known to have anti-microbial activity [399], catrin-like protein (a calcium transport 
inhibitor), and other extracellular proteinase inhibitors. A significant sequence 
variance in bovine was the absence of the WAP domain (Figure 5.8).  
Isoforms of papilin have been found in a number of Arthropoda species, six in 
Drosophila and two in Apis. Given the size and complexity of the Rmi papilin, 
isoforms may exist that are yet to be investigated. 
 
Helicase was identified nested as a separate gene between the first 5’ 
thrombospondin and the Adam-TS spacer of the Rmi papilin. RACE sequencing 
from the Adam-TS spacer domain exon in the 5’end direction produced the 
complete papilin product minus the helicase insertion, confirming our gene model.  
 
The discovery of shared exon regions for 2 eukaryote genes, papilin and helicase, 
is quite novel. Nested genes do occur in eukaryotes [392], nested genes in D. 
melanogaster and C. elegans have been found exclusively as embedded 
sequences in introns. It has been reviewed that in D. melanogaster nested intronic 
genes constitutes approximately 6% of the organism’s total gene complement, and 
85% of these nested genes are predicted to encode protein [392]. For example at 
the gart locus, the Pcp gene is nested in intron 1 of the ade3 gene on the 
complement strand. A nested ketoreductase was identified in an A. aegypti papilin 
– however not with exon overlap as shown for the helicase identified here. In the  
  165 
mouse genome, 28 overlapping gene pairs had partial overlapping exons, and did 
not encompass the entire coding sequence of either gene. In the human genome 
51 exon overlaps on opposite strands, again were partial. Neither the human nor 
the mouse genome contains any overlapping genes that share coding sequences 
on the same strand. Further the majority of nested intronic genes are functionally 
unrelated and typically not co-expressed with their external host genes. Therefore 
further functional analysis of this gene’s novel arrangement warrants investigation. 
No helicase element was found nested in the bovine intron region of papilin. 
 
The initial identification of the serpin domain led to the adjacent papilin gene 
described above. No syntenic evidence was found for the down stream serpin 
region in Isc. Full investigation of this gene family within Rmi genomic sequence 
and the I. scapularis genome remains. 
 
The genes for ribosomal DNA are tandem repeated clusters in the heterochromatic 
regions of metazoan genomes [385, 400], in Drosophila 77% of heterochromatin 
sequence is composed of fragmented and nested transposable elements and other 
repeated DNAs [400]. It has been reported in vertebrates that ribosomal RNA 
splicing of occurs, and during processing, in mammalian nuclear 28S pre-rRNA, 
tissue-speciﬁc elimination of an intron bearing a hidden break site occurs [401, 
402]. An almost complete, 18S ribosomal RNA gene, internal transcribed spacer 
(ITS) 1, 5.8S ribosomal RNA gene, ITS 2, and 28S ribosomal RNA gene, was 
identified by sequence similarity to Amblyomma americanum (GenBank AF291874;  
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[389]), which is the only other tick rDNA sequence analysed at this level of 
coverage. A similar unit was not identified in the Ixodes scapularis genome 
highlighting the difficulty in the assembly of this region. The Rmi rDNA units have 
been identified as novel due to the lack of the R2 retroelement previously identified 
in other hard tick sequence, even though the R2 retroelement binding site was 
conserved. The fragmented nature of the LSU makes it possible that the BM-012-
E08 BAC clones are derived from the end of an array of rDNA units in the genome 
where incomplete and rearranged rDNA units may occur.  
 
5.4.3  Tick DNA comparative studies: Identifying tick-specific sequence 
differences  
 
A number of conserved changes within rRNA protein binding sites between the 
ticks as compared to mammals were found. The hard tick specific sequence 
differences (SNPs) were also found in the LSU R2 retroelement target site. 
Due to the uniqueness of tick rDNA sequences it is feasible that tick rRNA could be 
a target for drug development analogous to the use of bacterial rRNA as antibiotic 
targets. Consistent with this possibility, a number of conserved changes within 
rRNA protein binding sites between ticks as compared to mammal were found. The 
hard tick specific sequence differences (SNPs) were also found in the LSU R2 
retroelement target site. 
 
5.4.4  Tick gene expression analysis  
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The qRT-PCR analysis of papilin described confirmed differential increased 
expression in two life stages, most prominently in larvae trying to attach to the host 
(Figure 5.6). It was also demonstrated that the helicase is strongly expressed in 
ovaries of feeding females. Helicases are often utilized to separate strands of a 
DNA double helix or a self-annealed RNA molecule using the energy from ATP 
hydrolysis, a process characterized by the breaking of hydrogen bonds between 
annealed nucleotide bases. The differential expression of both the papilin and 
helicase in adult female ovaries suggests that is perhaps a conserved functional 
arrangement.  
 
The abundance of RNA as identified in the subtraction library study was not 
surprising due to increased protein production during feeding. It has been reported 
that the abundance of ribosomal protein coding genes is not unusual for a 
transcriptome analysis and illustrates the high degree of redundancy found in such 
libraries, especially the occurrence of numerous sequences coding for proteins 
involved in protein synthesis such as ribosomal RNA, e.g. 40S, 60S and other 
ribosomal genes [403]. 
5.4.5  The analysis of genome sequence via BAC end sequencing and Cot 
DNA 
 
The Rmi genomic DNA that was enriched for single/low-copy and moderately 
repetitive DNAs [362] along with BAC end sequencing have provided valuable 
insights into Rmi genomic structure. Mapping the reads of the Cot DNA to the BAC 
sequencing identified regions of high repetitive content in BM-012-E08 complex  
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intergenic region by the absence of mapped reads. Also moderately repetitive 
regions could be identified such as the RUKA element in BM-005-G14. 
In particular using the two Cot filtrations, we were able to estimate the frequency of 
any specific genomic sequence within the entire genome. As an example 
presented, major frequency peaks were identifiable and the relative frequency of 
the SINE Ruka [355] element in the genome was estimated for BM-005-G14. 
Although absent from the euchromatic section of the relatively compact 1.8 Gb 
genome of Drosophila melanogaster [404], several distinct families of SINEs with 
copy numbers of up to 590 K per genome have been described in Aedes aeygpti, 
the mosquito vector of the yellow fever virus [405, 406] 
The frequency of Rmi Ruka element in the genome was estimated based on a 
single occurrence on the extrapolation of the two Cot fractions to represent 0.42% 
of the genome, at least 152,923 copies. 
 
A previous examination of 3 BAC sequences, and the (DFCI) Gene Indices [45] for 
the four ixodid tick species, A. variegatum [407], R. appendiculatus (Rap) [408], B. 
(R.) microplus [152] and I. scapularis [369], estimated that the Ruka repeat 
sequences comprise approximately 1.6% (4kb) of the 250Kb of Rap genome (BAC 
sequence). Then on the following assumptions (1) that these Rap BAC contigs are 
representative, and (2) a genome size for R. appendiculatus of 1Gb, that a total of 
65,000 copies of Ruka could be predicted [355]. Since our estimation in Rmi is 
based on a single element we expect the number of Ruka families will occupy a 
much larger fraction of the genome than previously estimated.   
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5.4.6  Vaccine candidate identification 
 
The HTP-VI bioinformatics workflow effectively identified candidate genes in an 
under characterized genome for vaccine development. This is the first 
bioinformatics approached developed of this kind and on this scale. The identified 
parasite peptides have been validated in sera, and a subset of 12 candidates have 
shown statistically significant increased damage to tick survival (80-100%) [381]. 
Two of six selected antigens have also shown greater than 70% efficacy in cattle 
vaccine trials (unpublished). 
 
 
5.5  Conclusion 
 
This analysis builds on the previous report by Guerrero et al. in 2010 [362], to 
characterise genomic DNA in the tick Rhipicelphalus microplus. The complete 
secreted extracellular matrix protein gene papilin primarily found in basement 
membranes and essential for embryonic development, was assembled and cDNA 
sequenced. This is the first reporting in eukaryotes of same strand exon overlap 
between the sequenced products of papilin and helicase. Detection of these types 
of overlaps is a complication for current de-novo gene prediction tools. In a second 
BAC clone, ribosomal DNA (rDNA) was assembled into three repeat units, the first 
rRNA assembly in Rhipicephalinae, and the first attempt to assemble sequence of 
the rDNA repeat units and intergenic spacer in arthropods.  
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In both papilin and rRNA, tick specific sites of sequence variation were identified in 
a detailed comparison of tick R. microplus relative to the host Bos taurus, in order 
to identify targets for disrupting the pathogen-host interaction. In addition 
expression analysis of papilin and helicase demonstrated striking tissue specific 
expression in response to sensing the host prior to attachment for feeding. 
 
The two Cot-filtration resources provided a means to estimate the frequency of an 
element in the context of the whole genome. In order to place the BAC sequences 
into a whole genome context, the BAC sequences were probed with 454 
sequenced Cot 69.56 secs and 696.6 secs DNA.  This analysis allowed the 
representation of specific BAC sequence to be estimated within the respective Cot 
DNA sequences and thus estimate the frequency of sequence occurrence in the 
whole R. microplus genome. 
 
The BAC, BAC end sequences (BES) and Cot DNA have allowed an in-depth 
analysis of selected R. microplus genomic DNA, and in terms of sequencing 
towards a whole genome provided a valuable insight into R. microplus genomic 
structure. 
 
In summary the key findings for this chapter are, 1) the bioinformatics approaches 
used in this chapter have in a complex understudied species identified genomic 
level detail and genome wide screening of available data 2) BAC analysis identified 
gene structure, validated for two genes (papilin and serpin), 3) the bioinformatics  
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approach for high through put identification of vaccine candidates in transcript is 
the first of this kind and on this scale, 4) Identified candidate peptides have been 
validated in host sera, and in preliminary Brazilian vaccine trials have shown 
greater than 70% efficacy in the host against tick, 5) the workflows from this 
chapter are being adapted to the prediction of peptide candidates involved in wheat 
allergy/hypersensitivity in humans. 
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6  Chapter Six - Conclusion 
 
6.1  Thesis contribution to the field of bioinformatics 
   
Bioinformatics approaches underpin the effective analysis of all biological data, 
influencing data and information at the following levels: 1) capture, storage and 
collation; 2) access, sharing and integration; 3) Increasing analysis predictive 
power and generating hypothesis driven analyses. In the framework of this thesis 
hypothesis, to identify functional genomic targets in diverse disease mechanisms, 
the developed in silico approaches integrated data from diverse resources that had 
variable data formats, qualities, availability and accessibility constraints, and 
demonstrated functional predictions for candidate genomic targets in diverse 
disease cases. The aims of this thesis relative to the case study chapters (light 
blue) are summarised in Figure 6.1. The major outcomes for the aims and chapters 
are also shown in Figure 6.1 (dark blue).  
 
In all three case studies (Chapter 3-5) in silico approaches were developed that 
overcame data and analysis constraints, made functional predictions based on 
comparative analysis and data integration, and identified disease and pathogenic 
genomic targets. The approaches developed to integrate and mine available data 
and information, contributed to hypothesis driven disease research in non-model 
organisms (bacteria and tick), and human.    
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Figure 6.1 Thesis aims (light blue) and related chapter outcomes (dark blue)  
 
Online research environments need to provide to the end user easy access, 
assembly and reuse of bioinformatics workflows across distributed computing 
resources. That also simplifies access to computer and data resources and leaves 
the infrastructure transparent to the end user. In relation to this, the developed and  
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demonstrated approaches in three diverse biological disease systems contribute to 
the supply of workflows for hypothesis driven research. 
 
The detailed results from the three case chapters are as follows. 
 
6.2  Case study chapter results 
 
Novel model predictions and findings for the possible role of the human Alu repeat 
element in human cancer are shown in Table 6.1. The charted organ transcript 
sequence was assigned to cancer or a normal phenotype and the transcript Alu 
element content and transcript functions were differentially measured between 
these two phenotypes. The transcription of Alu was reduced in cancer transcripts 
and an Alu-mediated siRNA model for the down regulation of Alu containing mRNA 
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Genomic diagnostic analysis findings for Campylobacter an important pathogen in 
cattle venereal disease are shown in Table 6.2. A Campylobacter sub species-
specific 80Kb genomic sequence that contained plasmid and virulence genes was 
identified for diagnostics. The candidate diagnostic specificity varied for CFV 
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The findings for the de-novo identification of tick vaccination targets in a large 
complex ectoparasite un-sequenced genome are detailed in Table 6.3. The 
available genomic and transcript sequence of Rhipicephalus microplus was 
characterised in depth to support future sequencing efforts and predictions in this 
organism. BAC sequences were assembled, annotated and genome wide 
predictions made on feature frequencies. Through the development of a high 
through put transcript workflow, vaccine candidates were identified that met 
peptide functional and structural requirements. These peptide vaccine targets 
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6.3  Discussion and future work 
 
In this thesis, bioinformatics approaches have been developed and implemented 
across organisms of diverse origins with variable data and information availability, 
and disease mechanisms to identify functional genomic candidates. Functional 
targets have been identified for Alu repeat element in human cancer, host parasite 
vaccination and the detection by diagnostics for bacterial subspecies known to 
induce different diseases and symptoms in the host.  
 
In the case of the Human Alu element, novel analysis bioinformatics approaches 
were implemented for the first time and a model put forward to the research 
community for validation.  
 
The diagnostic results from the Campylobacter analysis resulted in an ARC linkage 
project (LP0883837) with industry partners Pfizer Australia and Gribbles Veterinary 
Pathology to characterise and study Australian isolates (biovars) of Cfv. This 
project will use an integrated genomics sequencing approach, comparative 
genomics plus molecular and phenotypic screening to improve the understanding 
of the biology of genital campylobacteriosis in cattle.  
 
The tick analysis from this thesis has directly supported the development of a 
‘CattleTickBase’ resource, toward the sequencing of the R. microplus genome. The  
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findings for the tick investigation (Table 6.3) have provided opportunities for further 
tick control research and a patent application. As new transcriptomes are 
sequenced, the time to vaccine candidate identification in pests is reduced by the 
adoption of the high through put epitope workflow/pipeline developed in this thesis. 
This pipeline has been selected for wheat to identify immunological targets for 
allergies in EST libraries. The sequencing of the full-length papilin from BAC 
sequence contributed a validated gene structure required for training gene 
prediction tools. Many more sequences of laboratory evidence are needed to 
establish a tick gene set with known, not ab initio predicted, intron-exon structure. 
 
Finally, through the shared bioinformatics approaches used in this thesis, novel 
functional targets and models in disease can be determined in diverse organisms. 
These approaches applicable to future online research workflow environments. 
6.4  Summary Conclusion 
    
This thesis has developed in silico approaches that has delivered: 
1.  The collation, annotation and integration of available data sets, in three 
diverse systems each with varying data and integration constraints. 
2.  The identification of functional genomic targets in diverse biological systems 
with diverse disease mechanisms.  
3.  Novel functional analysis in three diverse systems each with varying data 
and integration constraints.   
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4.  Novel functional genomic targets independent of the disease system in 
study.  
5.  High throughput vaccine and diagnostic candidate identification in non-
model organisms.  
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Appendix 
 
Appendix 3.1 Please find excel file ‘appendix3.1.xlsx’ of Alu transcript records on 
the attached CD. 
 
Appendix 3.2 PostgreSQL database table information 
 
dev_goannotation=> \dt 
           List of relations 
 Schema |     Name     | Type  | Owner  
--------+--------------+-------+------- 
 public | cdna         | table | paula 
 public | gene         | table | paula 
 public | gene2go      | table | paula 
 public | go           | table | paula 
 public | goslim       | table | paula 
 public | repeatmasker | table | paula 
 (8 rows) 
 
dev_goannotation=> \d cdna 
        Table "public.cdna" 
   Column    |  Type   | Modifiers  
-------------+---------+----------- 
 accession   | text    | not null 
 loci        | text    |  
 gene_id     | text    |  
 tissue      | text    |  
 tissue_type | text    |  
 state       | text    |  
 cds_start   | integer |  
 cds_end     | integer |  
 fcfunction  | text    |  
 cdna_length | integer |  
Indexes: 
    "cdna_pkey" PRIMARY KEY, btree (accession) 
Foreign-key constraints: 
    "$1" FOREIGN KEY (gene_id) REFERENCES gene(gene_id) ON UPDATE 
RESTRICT ON DELETE RESTRICT 
 
dev_goannotation=> \d gene 
         Table "public.gene" 
      Column      | Type | Modifiers  
------------------+------+----------- 
 gene_id          | text | not null 
 taxa             | text |  
 gene_symbol      | text |  
 location         | text |  
 gene_description | text |  
Indexes:  
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    "gene_pkey" PRIMARY KEY, btree (gene_id) 
 
dev_goannotation=> \d gene2go  
     Table "public.gene2go" 
    Column    | Type | Modifiers  
--------------+------+----------- 
 go_id        | text | not null 
 gene_id      | text | not null 
 go_name      | text |  
 go_namespace | text |  
 evidence     | text |  
Indexes: 
    "genego_pkey" PRIMARY KEY, btree (gene_id, go_id) 
Foreign-key constraints: 
    "$1" FOREIGN KEY (gene_id) REFERENCES gene(gene_id) ON UPDATE 
RESTRICT ON DELETE RESTRICT 
 
dev_goannotation=> \d go  
      Table "public.go" 
  Column   | Type | Modifiers  
-----------+------+----------- 
 go_id     | text | not null 
 name      | text |  
 namespace | text |  
 go_isa    | text |  
Indexes: 
    "go_pkey" PRIMARY KEY, btree (go_id) 
 
dev_goannotation=> \d goslim  
        Table "public.goslim" 
      Column       | Type | Modifiers  
-------------------+------+----------- 
 go_id             | text | not null 
 go_slim_id        | text | not null 
 go_slim_name      | text |  
 go_slim_namespace | text |  
Indexes: 
    "go_slim_pk" PRIMARY KEY, btree (go_id, go_slim_id) 
Foreign-key constraints: 
    "go2slim_fk" FOREIGN KEY (go_id) REFERENCES go(go_id) 
 
dev_goannotation=> \d repeatmasker  
        Table "public.repeatmasker" 
   Column    |       Type       | Modifiers  
-------------+------------------+----------- 
 accession   | text             |  
 id          | integer          | not null 
 score       | double precision |  
 percdiv     | double precision |  
 percdel     | double precision |  
 percin      | double precision |  
 querystart  | integer          |   
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 queryend    | integer          |  
 queryleft   | integer          |  
 strand      | text             |  
 repeat      | text             |  
 class       | text             |  
 repeatstart | integer          |  
 repeatend   | integer          |  
 repeatleft  | integer          |  
Indexes: 
    "id_pkey" PRIMARY KEY, btree (id) 
Foreign-key constraints: 
    "repeat2cdna" FOREIGN KEY (accession) REFERENCES cdna(accession) 
ON UPDATE RESTRICT ON DELETE RESTRICT 
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Output Created  22-NOV-2007 10:48:31 
Comments   
Filter  <none> 
Weight  Count 
Split File  <none> 
Input 
N of Rows in Working 
Data File  99 
Definition of Missing  User-defined missing values are treated as missing. 
Missing Value 
Handling 
Cases Used  Statistics for each table are based on all the cases with valid data in the specified 
range(s) for all variables in each table. 
Syntax 
CROSSTABS 
/TABLES=Tissue BY Alu BY Condition 
/FORMAT= AVALUE TABLES 
/STATISTIC=CHISQ 
/CELLS= COUNT 
/COUNT ROUND CELL . 
Elapsed Time  0:00:00.27 
Dimensions Requested  3  Resources 
Cells Available  104924 
 
Case Processing Summary  
Cases 
Valid  Missing  Total 
 
 
N  Percent  N  Percent  N  Percent 
Tissue * Alu * Condition  106825  100.0%  0  .0%  106825  100.0% 
 
Tissue * Alu * Condition Crosstabulation  
Count  
Alu 
Condition     
no  yes 
 
Total 
disease  380  47  427 
Tissue 
normal  76  34  110  bladder 
Total  456  81  537  
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disease  451  61  512 
Tissue 
normal  255  80  335  bone 
Total  706  141  847 
disease  10131  637  10768 
Tissue 
normal  18352  4753  23105  brain 
Total  28483  5390  33873 
disease  2415  171  2586 
Tissue 
normal  201  155  356  cervix 
Total  2616  326  2942 
disease  2983  469  3452 
Tissue 
normal  893  360  1253  colon 
Total  3876  829  4705 
disease  158  71  229 
Tissue 
normal  11  9  20  esophagus 
Total  169  80  249 
disease  1203  198  1401 
Tissue 
normal  733  264  997  eye 
Total  1936  462  2398 
disease  203  50  253 
Tissue 
normal  1855  741  2596  kidney 
Total  2058  791  2849 
disease  135  33  168 
Tissue 
normal  3571  425  3996  liver 
Total  3706  458  4164 
disease  2144  222  2366 
Tissue 
normal  1331  580  1911  lung 
Total  3475  802  4277 
disease  932  142  1074 
Tissue 
normal  1652  795  2447  lymph 
Total  2584  937  3521 
disease  137  24  161 
Tissue 
normal  309  290  599  mammary 
Total  446  314  760 
disease  1061  116  1177 
Tissue 
normal  1000  163  1163  muscle 
Total  2061  279  2340  
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disease  404  241  645 
Tissue 
normal  764  200  964  oral 
Total  1168  441  1609 
disease  204  81  285 
Tissue 
normal  262  39  301  ovary 
Total  466  120  586 
disease  759  77  836 
Tissue 
normal  184  20  204  pancreas 
Total  943  97  1040 
disease  1485  219  1704 
Tissue 
normal  15468  1284  16752  placenta 
Total  16953  1503  18456 
disease  95  28  123 
Tissue 
normal  672  368  1040  prostate 
Total  767  396  1163 
disease  102  39  141 
Tissue 
normal  43  49  92  rectum 
Total  145  88  233 
disease  2705  395  3100 
Tissue 
normal  326  37  363  skin 
Total  3031  432  3463 
disease  36  3  39 
Tissue 
normal  1042  422  1464  stomach 
Total  1078  425  1503 
disease  741  136  877 
Tissue 
normal  7481  1854  9335  testis 
Total  8222  1990  10212 
disease  14  0  14 
Tissue 
normal  203  95  298  thyroid 
Total  217  95  312 
disease  1352  208  1560 
Tissue 
normal  1191  643  1834  uterus 
Total  2543  851  3394 
disease  18  2  20 
Tissue 
normal  841  531  1372  embryo 
Total  859  533  1392  
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Chi-Square Tests  
Condition    Value  df  Asymp. Sig. (2-sided)  Exact Sig. (2-sided)  Exact Sig. (1-sided) 
Pearson Chi-Square  27.048(b)  1  .000     
Continuity Correction(a)  25.517  1  .000     
Likelihood Ratio  23.457  1  .000     
Fisher's Exact Test        .000  .000 
bladder 
N of Valid Cases  537         
Pearson Chi-Square  20.898(c)  1  .000     
Continuity Correction(a)  20.045  1  .000     
Likelihood Ratio  20.441  1  .000     
Fisher's Exact Test        .000  .000 
bone 
N of Valid Cases  847         
Pearson Chi-Square  1179.042(d)  1  .000     
Continuity Correction(a)  1177.946  1  .000     
Likelihood Ratio  1364.484  1  .000     
Fisher's Exact Test        .000  .000 
brain 
N of Valid Cases  33873         
Pearson Chi-Square  433.061(e)  1  .000     
Continuity Correction(a)  429.321  1  .000     
Likelihood Ratio  301.892  1  .000     
Fisher's Exact Test        .000  .000 
cervix 
N of Valid Cases  2942         
Pearson Chi-Square  145.267(f)  1  .000     
Continuity Correction(a)  144.225  1  .000     
Likelihood Ratio  134.622  1  .000     
Fisher's Exact Test        .000  .000 
colon 
N of Valid Cases  4705         
Pearson Chi-Square  1.652(g)  1  .199     
Continuity Correction(a)  1.073  1  .300     
Likelihood Ratio  1.572  1  .210     
Fisher's Exact Test        .217  .150 
esophagus 
N of Valid Cases  249         
Pearson Chi-Square  57.087(h)  1  .000     
Continuity Correction(a)  56.296  1  .000     
eye 
Likelihood Ratio  56.321  1  .000      
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Fisher's Exact Test        .000  .000   
N of Valid Cases  2398         
Pearson Chi-Square  8.863(i)  1  .003     
Continuity Correction(a)  8.431  1  .004     
Likelihood Ratio  9.439  1  .002     
Fisher's Exact Test        .003  .001 
kidney 
N of Valid Cases  2849         
Pearson Chi-Square  13.362(j)  1  .000     
Continuity Correction(a)  12.457  1  .000     
Likelihood Ratio  11.233  1  .001     
Fisher's Exact Test        .001  .001 
liver 
N of Valid Cases  4164         
Pearson Chi-Square  305.061(k)  1  .000     
Continuity Correction(a)  303.686  1  .000     
Likelihood Ratio  309.072  1  .000     
Fisher's Exact Test        .000  .000 
lung 
N of Valid Cases  4277         
Pearson Chi-Square  141.876(l)  1  .000     
Continuity Correction(a)  140.891  1  .000     
Likelihood Ratio  155.223  1  .000     
Fisher's Exact Test        .000  .000 
lymph 
N of Valid Cases  3521         
Pearson Chi-Square  58.759(m)  1  .000     
Continuity Correction(a)  57.386  1  .000     
Likelihood Ratio  65.162  1  .000     
Fisher's Exact Test        .000  .000 
mammary 
N of Valid Cases  760         
Pearson Chi-Square  9.640(n)  1  .002     
Continuity Correction(a)  9.248  1  .002     
Likelihood Ratio  9.677  1  .002     
Fisher's Exact Test        .002  .001 
muscle 
N of Valid Cases  2340         
Pearson Chi-Square  53.634(o)  1  .000     
Continuity Correction(a)  52.802  1  .000     
Likelihood Ratio  52.938  1  .000     
oral 
Fisher's Exact Test        .000  .000  
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  N of Valid Cases  1609         
Pearson Chi-Square  21.498(p)  1  .000     
Continuity Correction(a)  20.559  1  .000     
Likelihood Ratio  21.817  1  .000     
Fisher's Exact Test        .000  .000 
ovary 
N of Valid Cases  586         
Pearson Chi-Square  .068(q)  1  .794     
Continuity Correction(a)  .016  1  .899     
Likelihood Ratio  .068  1  .795     
Fisher's Exact Test        .789  .441 
pancreas 
N of Valid Cases  1040         
Pearson Chi-Square  55.637(r)  1  .000     
Continuity Correction(a)  54.945  1  .000     
Likelihood Ratio  48.797  1  .000     
Fisher's Exact Test        .000  .000 
placenta 
N of Valid Cases  18456         
Pearson Chi-Square  7.801(s)  1  .005     
Continuity Correction(a)  7.250  1  .007     
Likelihood Ratio  8.286  1  .004     
Fisher's Exact Test        .005  .003 
prostate 
N of Valid Cases  1163         
Pearson Chi-Square  15.525(t)  1  .000     
Continuity Correction(a)  14.455  1  .000     
Likelihood Ratio  15.474  1  .000     
Fisher's Exact Test        .000  .000 
rectum 
N of Valid Cases  233         
Pearson Chi-Square  1.934(u)  1  .164     
Continuity Correction(a)  1.707  1  .191     
Likelihood Ratio  2.033  1  .154     
Fisher's Exact Test        .179  .093 
skin 
N of Valid Cases  3463         
Pearson Chi-Square  8.365(v)  1  .004     
Continuity Correction(a)  7.356  1  .007     
Likelihood Ratio  10.572  1  .001     
Fisher's Exact Test        .003  .001 
stomach 
N of Valid Cases  1503          
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Pearson Chi-Square  9.684(w)  1  .002     
Continuity Correction(a)  9.408  1  .002     
Likelihood Ratio  10.194  1  .001     
Fisher's Exact Test        .002  .001 
testis 
N of Valid Cases  10212         
Pearson Chi-Square  6.417(x)  1  .011     
Continuity Correction(a)  5.000  1  .025     
Likelihood Ratio  10.452  1  .001     
Fisher's Exact Test        .007  .005 
thyroid 
N of Valid Cases  312         
Pearson Chi-Square  211.809(y)  1  .000     
Continuity Correction(a)  210.654  1  .000     
Likelihood Ratio  221.277  1  .000     
Fisher's Exact Test        .000  .000 
uterus 
N of Valid Cases  3394         
Pearson Chi-Square  6.873(z)  1  .009     
Continuity Correction(a)  5.712  1  .017     
Likelihood Ratio  8.313  1  .004     
Fisher's Exact Test        .009  .005 
embryo 
N of Valid Cases  1392         
a Computed only for a 2x2 table 
b 0 cells (.0%) have expected count less than 5. The minimum expected count is 16.59. 
c 0 cells (.0%) have expected count less than 5. The minimum expected count is 55.77. 
d 0 cells (.0%) have expected count less than 5. The minimum expected count is 1713.44. 
e 0 cells (.0%) have expected count less than 5. The minimum expected count is 39.45. 
f 0 cells (.0%) have expected count less than 5. The minimum expected count is 220.77. 
g 0 cells (.0%) have expected count less than 5. The minimum expected count is 6.43. 
h 0 cells (.0%) have expected count less than 5. The minimum expected count is 192.08. 
i 0 cells (.0%) have expected count less than 5. The minimum expected count is 70.24. 
j 0 cells (.0%) have expected count less than 5. The minimum expected count is 18.48. 
k 0 cells (.0%) have expected count less than 5. The minimum expected count is 358.34. 
l 0 cells (.0%) have expected count less than 5. The minimum expected count is 285.81. 
m 0 cells (.0%) have expected count less than 5. The minimum expected count is 66.52. 
n 0 cells (.0%) have expected count less than 5. The minimum expected count is 138.67. 
o 0 cells (.0%) have expected count less than 5. The minimum expected count is 176.78. 
p 0 cells (.0%) have expected count less than 5. The minimum expected count is 58.36.  
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q 0 cells (.0%) have expected count less than 5. The minimum expected count is 19.03. 
r 0 cells (.0%) have expected count less than 5. The minimum expected count is 138.77. 
s 0 cells (.0%) have expected count less than 5. The minimum expected count is 41.88. 
t 0 cells (.0%) have expected count less than 5. The minimum expected count is 34.75. 
u 0 cells (.0%) have expected count less than 5. The minimum expected count is 45.28. 
v 0 cells (.0%) have expected count less than 5. The minimum expected count is 11.03. 
w 0 cells (.0%) have expected count less than 5. The minimum expected count is 170.90. 
x 1 cells (25.0%) have expected count less than 5. The minimum expected count is 4.26. 
y 0 cells (.0%) have expected count less than 5. The minimum expected count is 391.15. 
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Primers  sequence 5' - 3'  5' position 
PapStartF2  ATGAGGAGTAGGGGAGCTGTGCTCCT  175 
Papilin54900R  CCATTGACGCAAACATCAAG  728 
Papilin57383F  TGTGACAAGATGCTGGGTTC  748 
AdamSR1  CGATGGGATCAGCAGGATGTCGTT  891 
3425F  GACAAGGTTGAAGTTCTGGATGA  1651 
Pap5360F  CTGCTGTCCAGATGGCATCAC  2619 
Pap7260F  CGAAGGATGCACCTGTGAGCA  3453 
Pap8020F  TACTCCGGCTCGTGGACCTAA  4203 
Pap8760R  GCCTCGCACTCTTCCTCCGA  4805 
Pap9690R  GCACATCTGTTGGCACTCCAG  5703 
Pap9780R  CTGCAGCTCTTCGCAGTTGGA  6744 
pap12440F  CGAAACAGACGGTCATCGCGTT  7950 
PapilinR3  CATTTCCATTACTGTACCCATTGACGTA  8470 
PapStopR1  TTGCAGATTTGGCAAGATTCGCTTAGGC  8560 
pap13230R   TAATGTATTGGTATTAGACTATGGGT   8761 
papRT-F6   CCTGATGGCCGTACGGCAGCTA   4417 




Primers  sequence 5' - 3'  5' position 
PapilinORFF2  ATGGAAGGCAGTGGTGATCT  1 
PapRT-F  CCGACGCCTGGAGCTGTTA  124 
Pap1090F  CGAGTCGAAGGGACCAGTGTA  976 
Pap2440R  GTGACACTTCAATACTTGCCACT  2900 
Pap2110F  AGCACTCGTTTCAGACCGTCT  1981 
Pap2350R  ACACGCATAGACATGCACTAGT  3892 
papilin50819R  TGTAGTAAGGCACCCAGCTGTA  4759 
Papilin54900R*  CCATTGACGCAAACATCAAG  4886 
papRT-F3   ACCAGTGTACTCCTGTCGGCA   988 




Label  Primers  BAC position(bp) 
SerpF1  AAACGCGTGGCGATTGCCGACA  135040 
SerpF2  GTAGAAGATACGACAGATCTGAAGG  133688 
SerpF3  TCCTCTCGTAAGGTACGAGTGGA  129586 
SerpR1  CAAAGGTTGTTGTCACCTTGTGCG  123298 
SerpR2  GAAATCTTCGTCCCGTATGTTCTG  125843 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix 5.4. Papilin protein sequence alignment, R. microplus and B. taurus, domains 
are highlighted Kunitz BPTI (red), ADAM spacer1 (yellow), Ig-set (pink), PLAC (purple), 
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Appendix Figure 5.5 Serpin prediction in BAC BM-005-G14  
  225 
  
Appendix 5.6. R. microplus Genome wide estimation of the Ruka element frequency based 
on two Cot re-association experiments. 
 
 
Label  USDA696  USDA69 
Start [DNA] microgram  200  200 
Renaturation time  1hr 48min 6sec  10min 49sec 
Secs  6486  649 
M.s  696  69 
Cot  695.6  69.56 
Renturation Temp  70  70 
NaPO4 (M)  0.03  0.03 
Ass260  0.954    
ssDNA (microgram)  2.52  18.8 
dsDNA (microgram)  219.6  165 
Total microgram DNA (ss & ds)  222.12  183.8 
Fraction ssDNA  0.011345219  0.102285092 
ssDNA %  1.13452188  10.22850925 
Number reads  2,831,229  3,020,062 
Reads (bp)  708,482,408  762,341,121 
   8,037,888  77,976,132 
Read length (bp)  250  252 
G14 depth (bp)  869,692  1,063,349 
G14 number reads  62,126  66,096 
G14 length  135,000  135,000 
G14 average coverage  13.99884106  16.08794783 
  6.442162963  7.876659259 
SINE Ruka  USDA696  USDA69 
Total sequence read depth (bp)  46,048  40,997 
Sequence length (bp)  195  195 
Sequence average cov   236.1435897  210.2410256 
Fraction sequence (%)  0.05294748  0.038554604 
 Sequence % * ssDNA%   0.060070075  0.394356127 
Sequence micro = ssDNA microgram * 
Sequence %  0.13342765  0.724826562 
Seq micro% = seq micro / Total microgram 
DNA (ss & ds)  0.000600701  0.003943561 
% DNA at recovered time  0.060070075  0.394356127 
K*secs=  0.999399299  0.996056439 
K=  0.000154086  0.001534756 
RUKA frequency  0.42%    
Genome size (bp)  7,100,000,000    
Ruka genome sequence (bp)  29,820,000    
Number RUKA elements  152,923    
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Appendix 5.7 Table of BAC sequence assembly statistics BM-012-E08 
 
 
Mira Assembly  normal  repetitive  
Num. reads 
assembled  1116  1102 
Num. singlets  49  128 
        
Large contigs       
Num. contigs  16  7 
Total  44340  29969 
Largest  10619  13221 
N50  2685  4004 
N90  1682  1774 
N95  1393  1682 
Coverage       
Max  47  46 
Avg.  17.28  21.04 
Quality       
Average  76  75 
(WRMc):  16  9 
All       
Num. contigs  70  49 
Total  136767  169396 
Largest  10619  13221 
N50  1260  860 
N90  700  590 
N95  588  425 
Coverage       
Max  47  46 
Avg.  17.28  21.04 
Quality       
Average  51  48 
(WRMc):  16  14 
  





Appendix 5.8A. Dotmatrix of BAC BM-012-E08 non-redundant assembly reveals single 
unit Ctg11-14. Ambylomma rRNA (blue) fragments in Contigs 7,8,13,14. Lower horizontal 
axis shows regions confirmed (red), and those not confirmed by PCR (yellow), and the 
forward BES (green arrow) 
 
  
  229 
 
 
Appendix 5.8B. Dotmatrix of BAC BM-012-E08 redundant assembly reveals at least three 
units repeated, Ambylomma rRNA (blue).  






Appendix 5.9A. PCR results for BM-012-E08 repetitive elements. Lanes:  1) 22K.1 2) 
22K.2 3) 17K.1 4) 17K.2 5) 38K.1 6) 38K.2 7) -ve control 
 
  





Appendix 5.9B. Long primer sets used to amplify tick genomic DNA using Roche Expand 
Long Template PCR system, Lane 1 Fermentas Mass ruler 80bp-10kb (#SM0403), Lane 2 
rDNA.1, Lane 3 rDNA.1 PCR negative control, Lane 4 intergenic-region.1, Lane 5 
intergenic-region.1 PCR negative control, Lane 6 intergenic-region.2, Lane 7 intergenic-
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Appendix 5.10. Multiple sequence alignment: 5 tick species A. americanum, A. glauerti, A. 
variegatum, A. tuberculatum, A. maculatum and R. microplus; 2 fly species D. simulans, D. 
melanogaster; tick host B. taurus and E. coli 16S. In E. coli 16S protein binding sites are 
highlighted S7_S9_S19 complex (red), S8_S15_S17 complex (green), S8_S17 complex 
(aqua) (Weiner et al. 1988)  
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